Model: Yesimm/InfectaVec-v2
Author: Yesimm
Pipeline: sentence-similarity
Library: sentence-transformers
Tags: sentence-transformers, safetensors, xlm-roberta, sentence-similarity, feature-extraction, dense, generated_from_trainer, dataset_size:73517, loss:MatryoshkaLoss, loss:MultipleNegativesRankingLoss, multilingual, arxiv:1908.10084, arxiv:2205.13147, arxiv:1705.00652, base_model:BAAI/bge-m3, base_model:finetune:BAAI/bge-m3, license:apache-2.0, text-embeddings-inference, endpoints_compatible, region:us
Base models (finetune): id: BAAI/bge-m3
Card metadata: language: multilingual
license: apache-2.0
tags: sentence-transformers, sentence-similarity, feature-extraction, dense, generated_from_trainer, dataset_size:73517, loss:MatryoshkaLoss, loss:MultipleNegativesRankingLoss
base_model: BAAI/bge-m3
widget: source_sentence: 2001년부터 2010년까지 시도별 주혈흡충증 발생 수의 변화 추세는 어떠했는가?
sentences: Amid the ongoing threat of the global COVID-19 pandemic, the end of the year got more complicated as a new mutant has been discovered in the United Kingdom.
The UK believes there are still too many unknowns when it comes to this ‘mutated’ version of coronavirus.
On the effectiveness of the vaccine, Dr Mishra said that the vaccine against the deadly COVID-19 could be effective or there could be need to develop a new vaccine.
“We apply flu vaccine to patients with heart, kidney and other serious illness.
So it is not unexpected that new variants of SARS-CoV-2 (Covid-19) are emerging, we see this all the time in other human and animal coronaviruses,” Prof Julian Hiscox, Chair in Infection and Global Health, University of Liverpool, was quoted as saying. Trans R Soc Trop Med Hyg . 2024 Nov 4:trae082. doi: 10.1093/trstmh/trae082. Online ahead of print. How well do different COVID-19 vaccines protect against different viral variants? A systematic review and meta-analysis Thi Ngoc Anh Hoang 1 , Aisling Byrne 2 , Ha-Linh Quach 2 3 , Melanie Bannister-Tyrrell 4 , Florian Vogt 2 5 Affiliations PMID: 39495246 DOI: 10.1093/trstmh/trae082 Abstract While the efficacy of coronavirus disease 2019 (COVID-19) vaccines has been evaluated in numerous trials, comprehensive evidence on how protection by different vaccines has varied over time remains limited. We aimed to compare protective effects of different vaccines against different viral variants. To achieve this, we searched Medline, Cochrane Library and Embase for randomized controlled trials assessing the efficacy of COVID-19 vaccines. Forest plots using Mantel-Haenszel and random-effects models were generated showing risk ratios (RRs) and 95% CIs by vaccines and variants. We included 36 studies with 90 variant-specific primary outcomes. We found a RR of 0.26 (95% CI 0.21 to 0.31) against all variants overall, with the highest protective effects against the wild-type (RR 0.13; 95% CI 0.10 to 0.18), followed by Alpha (RR 0.26; 95% CI 0.18 to 0.36), Gamma (RR 0.34; 95% CI 0.21 to 0.55), Delta (RR 0.39; 95% CI 0.28 to 0.56) and Beta (RR 0.49; 95% CI 0.40 to 0.62) variants. Nucleic acid vaccines showed the highest protection levels against all variants (RR 0.11; 95% CI 0.08 to 0.15), followed by protein subunit, inactivated virus and viral vector. In conclusion, we found high but heterogenous levels of protection for most COVID-19 vaccines, with decreasing protective effects for vaccines based on traditional technologies as SARS-CoV-2 variants emerged over time. Novel nucleic acid-based vaccines offered substantially higher and more consistent protection. Keywords: COVID-19 vaccine efficacy; meta-analysis; systematic review; viral variants. ​ Whether it is the family gatherings for Christmas or people congregating in city centres as the bell strikes midnight on New Year's Eve, there is concern that large numbers of people mixing during the holiday season could result in spikes of COVID-19 infections.
Perhaps this holiday season, we can reflect on the injustice of vaccine inequity and increase public pressure on governments and manufacturers to do more to share licenses and transfer technology and know-how, especially with the new WHO-led mRNA Tech Transfer Hubs, the first of which has been established in South Africa.
The new variant appears to be the most transmissible so far and able to breakthrough vaccine protection more easily than Delta or other variants preceding it.
Given that COVID-19 is a respiratory virus, which spreads mainly through the air via aerosols (small droplets) and larger droplets, it is important to know how best to keep oneself safe.
By talking, singing and even just breathing, people with COVID-19 can easily pass the virus to others.
Luckily, new oral treatments which reduce the severity of COVID-19 are becoming available., <td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
</tr>
<tr>
<td></td>
<td>2005</td>
<td></td>
<td>1</td>
<td></td>
<td>1</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
</tr>
<tr>
<td></td>
<td>2006</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
</tr>
<tr>
<td></td>
<td>2007</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
</tr>
<tr>
<td></td>
<td>2008</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
</tr>
<tr>
<td></td>
<td>2009</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
</tr>
<tr>
<td></td>
<td>2010</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
</tr>
<tr>
<td>주혈흡충증</td>
<td>2001</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
</tr>
<tr>
<td></td>
<td>2002</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
</tr>
<tr>
<td></td>
<td>2003</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
</tr>
<tr>
<td></td>
<td>2004</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
</tr>
<tr>
<td></td>
<td>2005</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
</tr>
<tr>
<td></td>
<td>2006</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
</tr>
<tr>
<td></td>
<td>2007</td>
<td></td>
<td>2</td>
<td></td>
<td>2</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td></td>
<td>1</td>
<td></td>
<td>1</td>
</tr>
<tr>
<td></td>
<td>2008</td>
<td></td>
<td>1</td>
<td></td>
<td>0</td>
<td>1</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td></td>
<td>1</td>
<td></td>
<td>0</td>
</tr>
<tr>
<td></td>
<td>2009</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
</tr>
<tr>
<td></td>
<td>2010</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
</tr>
</tbody>
</table> 230ㆍ2010 감염병 감시연보
표 Ⅲ-1-4-30. 주혈흡충증 시도별 연도별 및 연령별 성별 발생수, 2001-2010
단위 : 환자수,명 232ㆍ2010 감염병 감시연보
표 Ⅲ-1-4-30. 주혈흡충증 시도별 연도별 및 연령별 성별 발생수, 2001-2010 (계속)
단위 : 환자수,명, "The municipality should not wait to act when there are pandemics like [Covid-19] to provide residents with basic services" says PE resident
Last week, three toilets were delivered to Powerline as part of the Nelson Mandela Bay Municipality response to the Covid-19 pandemic.
Nelson Mandela Bay Municipality spokesperson Mthubanzi Mniki said the City wanted residents to live in clean environments and it would "continue to improve services to all residents, more especially the most vulnerable". Philadelphia has reinstituted an indoor mask mandate
the one currently in place in Shanghai,
true : false;var configObj = {thumb: 'none',video: 'world/2022/04/12/shanghai-covid-lockdown-supply-shortage-culver-dnt-ebof-vpx.cnn',width: '100%',height: '100%',section: 'international',profile: 'expansion',network: 'cnn',markupId: 'body-text_4',theoplayer: {allowNativeFullscreen: true},adsection: 'const-article-inpage',frameWidth: '100%',frameHeight: '100%',posterImageOverride: {"mini":{"width":220,"type":"jpg","uri":"//cdn.cnn.com/cnnnext/dam/assets/220412095740-video-thumbnail-culver-shanghai-small-169.jpeg","height":124},"xsmall":{"width":307,"type":"jpg","uri":"//cdn.cnn.com/cnnnext/dam/assets/220412095740-video-thumbnail-culver-shanghai-medium-plus-169.jpeg","height":173},"small":{"width":460,"type":"jpg","uri":"//cdn.cnn.com/cnnnext/dam/assets/220412095740-video-thumbnail-culver-shanghai-large-169.jpeg","height":259},"medium":{"width":780,"type":"jpg","uri":"//cdn.cnn.com/cnnnext/dam/assets/220412095740-video-thumbnail-culver-shanghai-exlarge-169.jpeg","height":438},"large":{"width":1100,"type":"jpg","uri":"//cdn.cnn.com/cnnnext/dam/assets/220412095740-video-thumbnail-culver-shanghai-super-169.jpeg","height":619},"full16x9":{"width":1600,"type":"jpg","uri":"//cdn.cnn.com/cnnnext/dam/assets/220412095740-video-thumbnail-culver-shanghai-full-169.jpeg","height":900},"mini1x1":{"width":120,"type":"jpg","uri":"//cdn.cnn.com/cnnnext/dam/assets/220412095740-video-thumbnail-culver-shanghai-small-11.jpeg","height":120}}},autoStartVideo = false,isVideoReplayClicked = false,callbackObj,containerEl,currentVideoCollection = [],currentVideoCollectionId = '',isLivePlayer = false,mediaMetadataCallbacks,mobilePinnedView = null,moveToNextTimeout,mutePlayerEnabled = false,nextVideoId = '',nextVideoUrl = '',turnOnFlashMessaging = false,videoPinner,videoEndSlateImpl;if (CNN.autoPlayVideoExist === false) {autoStartVideo = false;autoStartVideo = typeof CNN.isLoggedInVideoCheck === 'function' ?
false : autoStartVideo;CNN.VideoPlayer.setPlayerProperties(configObj.markupId, autoStartVideo, isLivePlayer, isVideoReplayClicked, mutePlayerEnabled);CNN.VideoPlayer.setFirstVideoInCollection(currentVideoCollection, configObj.markupId);videoEndSlateImpl = new CNN.VideoEndSlate('body-text_4');function findNextVideo(currentVideoId) {var i,vidObj;if (currentVideoId && jQuery.isArray(currentVideoCollection) && currentVideoCollection.length > 0) {for (i = 0; i < currentVideoCollection.length; i++) {vidObj = currentVideoCollection[i];if (typeof vidObj !== 'undefined' && vidObj.videoId === currentVideoId) {if (i < currentVideoCollection.length - 1) {nextVideoId = currentVideoCollection[i + 1].videoId;nextVideoUrl = currentVideoCollection[i + 1].videoUrl;} else {nextVideoId = currentVideoCollection[0].videoId;nextVideoUrl = currentVideoCollection[0].videoUrl;}break;}}if (!nextVideoUrl) {nextVideoId = currentVideoCollection[0].videoId;nextVideoUrl = currentVideoCollection[0].videoUrl;}currentVideoCollectionId = (window.jsmd && window.jsmd.v && window.jsmd.v.eVar60) || nextVideoUrl.replace(/^.+\/video\/playlists\/(.+)\//, '$1');} else {nextVideoId = '';nextVideoUrl = '';}}findNextVideo('world/2022/04/12/shanghai-covid-lockdown-supply-shortage-culver-dnt-ebof-vpx.cnn');function navigateToNextVideo(currentVideoId, containerId) {var $endSlate,nextVideoPlayTimeout = 1500;findNextVideo(currentVideoId);if (nextVideoUrl) {moveToNextTimeout = setTimeout(function () {location.href = nextVideoUrl;}, nextVideoPlayTimeout);} else {$endSlate = jQuery(document.getElementById(containerId)).parent().find('.js-video__end-slate').eq(0);if ($endSlate.length > 0) {videoEndSlateImpl.showEndSlateForContainer();if (mobilePinnedView) {mobilePinnedView.disable();}}}}callbackObj = {onPlayerReady: function (containerId) {var playerInstance,containerClassId = '#' + containerId;CNN.VideoPlayer.handleInitialExpandableVideoState(containerId);CNN.VideoPlayer.handleAdOnCVPVisibilityChange(containerId, CNN.pageVis.isDocumentVisible());if (CNN.Features.enableMobileWebFloatingPlayer &&Modernizr &&(Modernizr.phone || Modernizr.mobile || Modernizr.tablet) &&CNN.VideoPlayer.getLibraryName(containerId) === 'fave' &&jQuery(containerClassId).parents('.js-pg-rail-tall__head').length > 0 &&CNN.contentModel.pageType === 'article') {playerInstance = FAVE.player.getInstance(containerId);mobilePinnedView = new CNN.MobilePinnedView({element: jQuery(containerClassId),enabled: false,transition: CNN.MobileWebFloatingPlayer.transition,onPin: function () {playerInstance.hideUI();},onUnpin: function () {playerInstance.showUI();},onPlayerClick: function () {if (mobilePinnedView) {playerInstance.enterFullscreen();playerInstance.showUI();}},onDismiss: function() {CNN.Videx.mobile.pinnedPlayer.disable();playerInstance.pause();}});/* Storing pinned view on CNN.Videx.mobile.pinnedPlayer So that all players can see the single pinned player */CNN.Videx = CNN.Videx || {};CNN.Videx.mobile = CNN.Videx.mobile || {};CNN.Videx.mobile.pinnedPlayer = mobilePinnedView;}if (Modernizr && !Modernizr.phone && !Modernizr.mobile && !Modernizr.tablet) {if (jQuery(containerClassId).parents('.js-pg-rail-tall__head').length) {videoPinner = new CNN.VideoPinner(containerClassId);videoPinner.init();} else {CNN.VideoPlayer.hideThumbnail(containerId);}}},onContentEntryLoad: function(containerId, playerId, contentid, isQueue) {CNN.VideoPlayer.showSpinner(containerId);},onContentPause: function (containerId, playerId, videoId, paused) {if (mobilePinnedView) {CNN.VideoPlayer.handleMobilePinnedPlayerStates(containerId, paused);}},onContentMetadata: function (containerId, playerId, metadata, contentId, duration, width, height) {var endSlateLen = jQuery(document.getElementById(containerId)).parent().find('.js-video__end-slate').eq(0).length;CNN.VideoSourceUtils.updateSource(containerId, metadata);if (endSlateLen > 0) {videoEndSlateImpl.fetchAndShowRecommendedVideos(metadata);}},onAdPlay: function (containerId, cvpId, token, mode, id, duration, blockId, adType) {/* Dismissing the pinnedPlayer if another video players plays an Ad */CNN.VideoPlayer.dismissMobilePinnedPlayer(containerId);clearTimeout(moveToNextTimeout);CNN.VideoPlayer.hideSpinner(containerId);if (Modernizr && !Modernizr.phone && !Modernizr.mobile && !Modernizr.tablet) {if (typeof videoPinner !== 'undefined' && videoPinner !== null) {videoPinner.setIsPlaying(true);videoPinner.animateDown();}}},onAdPause: function (containerId, playerId, token, mode, id, duration, blockId, adType, instance, isAdPause) {if (mobilePinnedView) {CNN.VideoPlayer.handleMobilePinnedPlayerStates(containerId, isAdPause);}},onTrackingFullscreen: function (containerId, PlayerId, dataObj) {CNN.VideoPlayer.handleFullscreenChange(containerId, dataObj);if (mobilePinnedView &&typeof dataObj === 'object' &&FAVE.Utils.os === 'iOS' && !dataObj.fullscreen) {jQuery(document).scrollTop(mobilePinnedView.getScrollPosition());playerInstance.hideUI();}},onContentPlay: function (containerId, cvpId, event) {var playerInstance,prevVideoId;if (CNN.companion && typeof CNN.companion.updateCompanionLayout === 'function') {CNN.companion.updateCompanionLayout('restoreEpicAds');}clearTimeout(moveToNextTimeout);CNN.VideoPlayer.hideSpinner(containerId);if (Modernizr && !Modernizr.phone && !Modernizr.mobile && !Modernizr.tablet) {if (typeof videoPinner !== 'undefined' && videoPinner !== null) {videoPinner.setIsPlaying(true);videoPinner.animateDown();}}},onContentReplayRequest: function (containerId, cvpId, contentId) {if (Modernizr && !Modernizr.phone && !Modernizr.mobile && !Modernizr.tablet) {if (typeof videoPinner !== 'undefined' && videoPinner !== null) {videoPinner.setIsPlaying(true);var $endSlate = jQuery(document.getElementById(containerId)).parent().find('.js-video__end-slate').eq(0);if ($endSlate.length > 0) {$endSlate.removeClass('video__end-slate--active').addClass('video__end-slate--inactive');}}}},onContentBegin: function (containerId, cvpId, contentId) {if (mobilePinnedView) {mobilePinnedView.enable();}/* Dismissing the pinnedPlayer if another video players plays a video.
CNN is only US outlet living through Shanghai lockdown.
{"@context": "https://schema.org","@type": "VideoObject","name": "CNN is only US outlet living through Shanghai lockdown.
See what it&#39;s like","description": "CNN&#39;s David Culver describes the stressful living conditions and supply shortages Shanghai residents face as he stays in the country through his second week of the Covid-19 lockdown.
","thumbnailURL": "https://cdn.cnn.com/cnnnext/dam/assets/220412095740-video-thumbnail-culver-shanghai-large-169.jpeg","image": "https://cdn.cnn.com/cnnnext/dam/assets/220412095740-video-thumbnail-culver-shanghai-large-169.jpeg","duration": "PT4M2S","uploadDate": "2022-04-12T09:07:25Z","contentUrl": "https://edition.cnn.com/videos/world/2022/04/12/shanghai-covid-lockdown-supply-shortage-culver-dnt-ebof-vpx.cnn","url": "https://edition.cnn.com/videos/world/2022/04/12/shanghai-covid-lockdown-supply-shortage-culver-dnt-ebof-vpx.cnn","embedUrl": "https://fave.api.cnn.io/v1/fav/?video=world/2022/04/12/shanghai-covid-lockdown-supply-shortage-culver-dnt-ebof-vpx.cnn&customer=cnn&edition=international&env=prod"}
CNN is only US outlet living through Shanghai lockdown.
To help us with these questions, I spoke with CNN Medical Analyst Dr. Leana Wen, an emergency physician and professor of health policy and management at the George Washington University Milken Institute School of Public Health.
That will reduce not only this coronavirus transmission but other respiratory and gastrointestinal pathogens, too.
People walk through the Whitney Biennial show at the Whitney Museum of Art on April 06, 2022 in New York City.
{"@context": "http://schema.org","@type": "ImageObject","name": "People walk through the Whitney Biennial show at the Whitney Museum of Art on April 06, 2022 in New York City. The COVID-19 crisis has only exacerbated these problems, with the health needs of women and newborns being overshadowed, midwifery services being disrupted and midwives being deployed to other health services.
Dr Natalia Kanem
“Midwives play a vital role in reducing the risks of childbirth for women all over the world, but many have themselves been exposed to risk during the COVID-19 pandemic., source_sentence: question_7: A형간염과 일본뇌염은 연도별 신고수의 변화에서 어떤 연관성을 찾을 수 있는가?
sentences: true : false;var configObj = {thumb: 'none',video: 'business/2020/05/22/moderna-chairman-vaccine-trial.cnn-business',width: '100%',height: '100%',section: 'international',profile: 'expansion',network: 'cnn',markupId: 'body-text_5',theoplayer: {allowNativeFullscreen: true},adsection: 'const-article-inpage',frameWidth: '100%',frameHeight: '100%',posterImageOverride: {"mini":{"width":220,"type":"jpg","uri":"//cdn.cnn.com/cnnnext/dam/assets/200522114609-moderna-cambridge-0518-small-169.jpg","height":124},"xsmall":{"width":307,"type":"jpg","uri":"//cdn.cnn.com/cnnnext/dam/assets/200522114609-moderna-cambridge-0518-medium-plus-169.jpg","height":173},"small":{"width":460,"type":"jpg","uri":"//cdn.cnn.com/cnnnext/dam/assets/200522114609-moderna-cambridge-0518-large-169.jpg","height":259},"medium":{"width":780,"type":"jpg","uri":"//cdn.cnn.com/cnnnext/dam/assets/200522114609-moderna-cambridge-0518-exlarge-169.jpg","height":438},"large":{"width":1100,"type":"jpg","uri":"//cdn.cnn.com/cnnnext/dam/assets/200522114609-moderna-cambridge-0518-super-169.jpg","height":619},"full16x9":{"width":1600,"type":"jpg","uri":"//cdn.cnn.com/cnnnext/dam/assets/200522114609-moderna-cambridge-0518-full-169.jpg","height":900},"mini1x1":{"width":120,"type":"jpg","uri":"//cdn.cnn.com/cnnnext/dam/assets/200522114609-moderna-cambridge-0518-small-11.jpg","height":120}}},autoStartVideo = false,isVideoReplayClicked = false,callbackObj,containerEl,currentVideoCollection = [],currentVideoCollectionId = '',isLivePlayer = false,mediaMetadataCallbacks,mobilePinnedView = null,moveToNextTimeout,mutePlayerEnabled = false,nextVideoId = '',nextVideoUrl = '',turnOnFlashMessaging = false,videoPinner,videoEndSlateImpl;if (CNN.autoPlayVideoExist === false) {autoStartVideo = false;if (autoStartVideo === true) {if (turnOnFlashMessaging === true) {autoStartVideo = false;containerEl = jQuery(document.getElementById(configObj.markupId));CNN.VideoPlayer.showFlashSlate(containerEl);} else {CNN.autoPlayVideoExist = true;}}}configObj.autostart = CNN.Features.enableAutoplayBlock ?
Moderna chairman on the early results of a coronavirus vaccine trial
{"@context": "https://schema.org","@type": "VideoObject","name": "Moderna chairman on the early results of a coronavirus vaccine trial","description": "Noubar Afeyan, Moderna chairman and CEO of Flagship Pioneering, discusses the positive interim results from the Phase 1 trial of a coronavirus vaccine.
Moderna chairman on the early results of a coronavirus vaccine trial
In mid-June, one of vaccine's trial centers,  the University of Illinois at Chicago, said it expected the trial to start July 9.
it "has previously disclosed that the Phase 3 trial of its COVID-19 vaccine candidate MRNA-1273 is expected to begin in July.
"These clinical findings for the BNT162b1 RNA-based vaccine candidate are encouraging and strongly support accelerated clinical development and at-risk manufacturing to maximize the opportunity for the rapid production of a SARS-CoV-2 vaccine to prevent COVID-19 disease," the researchers wrote in the pre-print paper, which was sponsored by BioNTech and designed by Pfizer.
The researchers found that the vaccine generated antibodies against the coronavirus in all of the participants by 28 days after receiving a single injection of 100 micrograms or seven days after receiving a second dose of either 10 or 30 micrograms.
true : false;var configObj = {thumb: 'none',video: 'health/2020/05/06/pfizer-vaccine-timeline-scientist-ebof-vpx.cnn',width: '100%',height: '100%',section: 'international',profile: 'expansion',network: 'cnn',markupId: 'body-text_24',theoplayer: {allowNativeFullscreen: true},adsection: 'const-article-inpage',frameWidth: '100%',frameHeight: '100%',posterImageOverride: {"mini":{"width":220,"type":"jpg","uri":"//cdn.cnn.com/cnnnext/dam/assets/200506202132-pfizer-vaccine-timeline-scientist-ebof-vpx-00000000-small-169.jpg","height":124},"xsmall":{"width":307,"type":"jpg","uri":"//cdn.cnn.com/cnnnext/dam/assets/200506202132-pfizer-vaccine-timeline-scientist-ebof-vpx-00000000-medium-plus-169.jpg","height":173},"small":{"width":460,"type":"jpg","uri":"//cdn.cnn.com/cnnnext/dam/assets/200506202132-pfizer-vaccine-timeline-scientist-ebof-vpx-00000000-large-169.jpg","height":259},"medium":{"width":780,"type":"jpg","uri":"//cdn.cnn.com/cnnnext/dam/assets/200506202132-pfizer-vaccine-timeline-scientist-ebof-vpx-00000000-exlarge-169.jpg","height":438},"large":{"width":1100,"type":"jpg","uri":"//cdn.cnn.com/cnnnext/dam/assets/200506202132-pfizer-vaccine-timeline-scientist-ebof-vpx-00000000-super-169.jpg","height":619},"full16x9":{"width":1600,"type":"jpg","uri":"//cdn.cnn.com/cnnnext/dam/assets/200506202132-pfizer-vaccine-timeline-scientist-ebof-vpx-00000000-full-169.jpg","height":900},"mini1x1":{"width":120,"type":"jpg","uri":"//cdn.cnn.com/cnnnext/dam/assets/200506202132-pfizer-vaccine-timeline-scientist-ebof-vpx-00000000-small-11.jpg","height":120}}},autoStartVideo = false,isVideoReplayClicked = false,callbackObj,containerEl,currentVideoCollection = [],currentVideoCollectionId = '',isLivePlayer = false,mediaMetadataCallbacks,mobilePinnedView = null,moveToNextTimeout,mutePlayerEnabled = false,nextVideoId = '',nextVideoUrl = '',turnOnFlashMessaging = false,videoPinner,videoEndSlateImpl;if (CNN.autoPlayVideoExist === false) {autoStartVideo = false;if (autoStartVideo === true) {if (turnOnFlashMessaging === true) {autoStartVideo = false;containerEl = jQuery(document.getElementById(configObj.markupId));CNN.VideoPlayer.showFlashSlate(containerEl);} else {CNN.autoPlayVideoExist = true;}}}configObj.autostart = CNN.Features.enableAutoplayBlock ?
{"@context": "https://schema.org","@type": "VideoObject","name": "Lead scientist reveals when vaccine may be ready","description": "As Pfizer&#39;s coronavirus vaccine moves into human trials, Dr. Mark Mulligan discusses when we&#39;ll know if it&#39;s safe and effective.
"These preliminary data are encouraging, showing that BNT162b1 which exploits RBD SARS-CoV-2 as a target antigen is able to produce neutralizing antibody responses in humans at or above the levels observed in convalescent sera -- and that it does so at relatively low dose levels.
Inovio said on Tuesday that its coronavirus vaccine
With big talk and hurled insults, the gloves come off in the race for the coronavirus vaccine
true : false;var configObj = {thumb: 'none',video: 'politics/2020/05/15/trump-operation-warp-speed-coronavirus-vaccine-vpx.cnn',width: '100%',height: '100%',section: 'international',profile: 'expansion',network: 'cnn',markupId: 'body-text_36',theoplayer: {allowNativeFullscreen: true},adsection: 'const-article-inpage',frameWidth: '100%',frameHeight: '100%',posterImageOverride: {"mini":{"width":220,"type":"jpg","uri":"//cdn.cnn.com/cnnnext/dam/assets/200515130015-trump-warp-speed-small-169.jpg","height":124},"xsmall":{"width":307,"type":"jpg","uri":"//cdn.cnn.com/cnnnext/dam/assets/200515130015-trump-warp-speed-medium-plus-169.jpg","height":173},"small":{"width":460,"type":"jpg","uri":"//cdn.cnn.com/cnnnext/dam/assets/200515130015-trump-warp-speed-large-169.jpg","height":259},"medium":{"width":780,"type":"jpg","uri":"//cdn.cnn.com/cnnnext/dam/assets/200515130015-trump-warp-speed-exlarge-169.jpg","height":438},"large":{"width":1100,"type":"jpg","uri":"//cdn.cnn.com/cnnnext/dam/assets/200515130015-trump-warp-speed-super-169.jpg","height":619},"full16x9":{"width":1600,"type":"jpg","uri":"//cdn.cnn.com/cnnnext/dam/assets/200515130015-trump-warp-speed-full-169.jpg","height":900},"mini1x1":{"width":120,"type":"jpg","uri":"//cdn.cnn.com/cnnnext/dam/assets/200515130015-trump-warp-speed-small-11.jpg","height":120}}},autoStartVideo = false,isVideoReplayClicked = false,callbackObj,containerEl,currentVideoCollection = [],currentVideoCollectionId = '',isLivePlayer = false,mediaMetadataCallbacks,mobilePinnedView = null,moveToNextTimeout,mutePlayerEnabled = false,nextVideoId = '',nextVideoUrl = '',turnOnFlashMessaging = false,videoPinner,videoEndSlateImpl;if (CNN.autoPlayVideoExist === false) {autoStartVideo = false;if (autoStartVideo === true) {if (turnOnFlashMessaging === true) {autoStartVideo = false;containerEl = jQuery(document.getElementById(configObj.markupId));CNN.VideoPlayer.showFlashSlate(containerEl);} else {CNN.autoPlayVideoExist = true;}}}configObj.autostart = CNN.Features.enableAutoplayBlock ? ) vaccine against COVID-19 could be rolled out by the end of this year, U.S. officials said on Monday, after the drugmaker announced the start of a 30,000-subject trial to demonstrate it is safe and effective, the final hurdle prior to approval by global regulators.
The trial is the first such late-stage study under the Trump administrations program to speed development of measures against the novel coronavirus, adding to hope that an effective vaccine will help end the pandemic.
Shares of Cambridge, Massachusetts-based Moderna rose 9%.
More than 150 coronavirus vaccine candidates are in various stages of development, with some two dozen prospects having advanced to human testing.
COVID-19 has killed more about 650,000 people worldwide and battered economies.
The large late-stage trial is designed to evaluate the safety of Modernas mRNA-1273 vaccine and determine if it can prevent symptomatic COVID-19 after two doses.
The study also seeks to determine whether the vaccine can prevent coronavirus-related deaths.
Results of a small early-stage study published earlier this month showed volunteers who got two doses of Modernas vaccine had levels of virus-killing antibodies that exceeded the average seen in people who had recovered from COVID-19. LONDON (Reuters) - AstraZenecas chief executive officer Pascal Soriot said on Monday that the lower first dose of its experimental COVID-19 vaccine meant more people can be vaccinated more quickly, as the British drugmaker unveiled interim late-stage trial results.
The British drugmaker said on Monday its vaccine for the novel coronavirus could be around 90% effective without any serious side effects., 0
0
0
1
0
1
1
1
0
0
0
1
2
0
0
0
0
0
2
2
0
1
0
5
1
0
0
0
1
0
1
0
1
0
0
0
0
0
0
1
0
0
0
0
1
0
1
0
0
0
1
0
1
0
0
0
2
1
0
0
1
0
0
0
1
0
0
0
0
2
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
22
19
32
9
22
16
12
17
25
7
12
12
16
27
36
57
22
27
16
5
7
15
14
18
10
34
12
9
14
45
76
9
20
206
118
12
2
3
1
2
2
2
1
9
0
6
42
21
1
1
7
2
4
0
1
0
2
2
1
0
0
0
0
0
0
0
2
0
0
0
0
4
2
0
2
0
0
0
1
0
0
0
0
2
5
0
0
6
0
0
0
0
0
1
0
0
2
0
0
0
1
0
0
0
0
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
6
3
9
1
8
0
1
1
0
4
2
5
7
3
1
1
0
10
2
1
14
3
0
0
2
0
1
2
16
7
10
0
5
15
0
0
2
1
0
0
0
0
2
0
0
4
2
0
1
2
1
0
3
7
14
1
25
8
7
8
5
2
2
7
11
16
9
2
5
7
11
0
5
0
1
2
0
3
3
11
1
12
15
6
4
15
32
3
0
1
0
1
1
1
0
9
0
2
0
10
2
0
0
1
1
3
1
7
0
17
6
2
1
3
2
1
1
7
5
10
1
4
5
3
0
0
0
2
4
1
0
1
7
3
1
2
1
2
4
14
1
0
1
0
0
0
0
1
6
0
0
0
2
0
3
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5
2
3
0
3
8
0
1
1
1
3
2
2
1
0
1
6
1
1
0
0
0
1
4
4
2
3
2
0
2
2
0
1
6
6
1
0
1
0
0
0
0
0
1
0
1
0
2
0
0
0
0
0
0
0
3
0
0
0
0
0
1
0
0
0
1
1
0
0
0
0
0
0
0
1
0
0
0
0
0
2
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
2
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
1
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
* HFRS : Hemorrhagic fever with renal syndrom
† SFTS : Severe fever with thrombocytopenia syndrom
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6
1
0
0
0
0
1
0
0
0
0
0
0
0
0
1
0
0
0
0
1
0
0
0
0
2
0
3
0
2
0
0
29
0
1
0
0
0
2
3
0
5
4
0
0
7
0
1
4
2
0
Gunpo city Gyeonggi
0
Gimpo city
0
Namyangju city
0
Dongducheon city
0
Bucheon city
0
0
Seongnam city Bundang district
0 Seongnam city Sujeong district
0 Seongnam city Jungwon district
0 Suwon city Gwonseon district
0 Suwon city Yeongtong district
Suwon city Jangan district
0
Suwon city Paldal district
0
0
Siheung city
Ansan city Danwon district
0
Ansan city Sangnok district
0
Anseong city
0
0 Anyang city Dongan district
0 Anyang city Manan district
0
Yangju city
Yangpyeong county
0
0
Yeoju city
Yeoncheon county
0
0
Osan city
0 Yongin city Giheung district
Yongin city Suji district
0
Yongin city Cheoin district
0
Uiwang city
0
Uijeongbu city
0
Icheon city
0
0
Paju city
Pyeongtaek city
0
Pocheon city
0
Hanam city
0
Hwaseong city
0
Gangwon-do Gangwon
2
1
Gangneung city
Goseong county
0
Donghae city
0
Samcheok city
1
Sokcho city
0
0
Yanggu county
Yangyang county
0
Yeongwol county
0
Wonju city
0
Inje county
0
Jeongseon county
0
Cheorwon county
0
Chuncheon city
0
0
Taebaek city
Pyeongchang county
0
Hongcheon county
0
Hwacheon county
0
Hoengseong county
0
.Ⅲ 법정감염병 전수감시 통계 • 275
Page 319 - Table 1
제
군3
(Group
)Ⅲ
제 군4
(Group
)Ⅳ
수막구
균성수
막염
Mening-
ococcal
meningitis
레지오
넬라증
Legion-
ellosis
비브리오
패혈증
Vibrio
vulnificus
sepsis
발진열
Murine
typhus
쯔쯔가
무시증
Scrub
typhus
렙토스
피라증
Lepto-
spirosis
브루셀
라증
Bruc-
ellosis
신증후
군출혈열
HFRS*
매독
Syphilis
크로이
츠펠트-
야콥병
Creutz-feldt
Jacob
disease
(CJD)
뎅기열
Dengue
fever
큐열
Q fever
라임병
Lyme
Borrel-
iosis
유비저
Melioi-
dosis
치쿤구
니야열
Chiku-
ngunya
fever
중증열
성혈소
판감소
증후군
SFTS†
지카
바이러스
Classification
감염증
Zika
virus
infection
선천성
기2
기1
Secon-
Conge-
Primary
dary
nital
Page 320
Page 320 - Text
표
Ⅲ
-2-2-1. 2016
년 시군구별 신고수
)
계속(
Ⅲ
법
정
감
염
병
전
수
감
시
통
계
:
단위 신고수
충북 소계
괴산군
단양군
보은군
영동군
옥천군
음성군
제천시
증평군
진천군
청주시 상당구
청주시 서원구
청주시 청원구
청주시 흥덕구
충주시
충남 소계
계룡시
공주시
금산군
논산시
당진시
보령시
부여군
서산시
서천군
아산시
예산군
천안시 동남구
천안시 서북구
청양군
태안군
홍성군
전북 소계
고창군
군산시
김제시
남원시
무주군
부안군
순창군
완주군
익산시
임실군
장수군
전주시
정읍시
진안군
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3
0
0
0
0
0
2
0
0
0
1
0
0
0
0
11
0
0
0
0
2
1
0
1
1
1
2
0
2
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4
0
0
0
1
0
0
2
0
0
0
0
0
1
0
1
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
4
0
0
0
0
0
0
0
0
0
0
0
4
0
0
5
0
0
0
0
0
1
0
0
0
1
1
1
1
0
5
0
0
0
0
0
1
0
0
0
1
2
0
0
0
0
1
5
0
0
0
0
0
0
0
0
0
0
0
5
0
0
3
0
0
0
0
2
0
0
0
0
0
0
0
1
0
4
0
0
0
0
1
0
0
0
1
1
0
0
0
0
0
1
4
0
1
0
0
1
0
0
0
0
0
0
2
0
0
139
2
1
4
1
4
8
13
3
7
15
17
26
26
12
270
5
8
3
13
13
10
4
46
7
36
14
28
45
4
9
25
242
3
52
17
5
3
2
2
14
54
2
1
78
8
1
4
0
0
1
1
1
0
0
0
0
0
1
0
0
0
4
1
0
0
0
0
0
0
0
1
1
0
1
0
0
0
0
5
0
0
0
0
0
1
0
0
0
0
0
4
0
0
2
0
0
0
0
0
0
0
0
0
0
0
0
2
0
2
0
0
0
0
0
1
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3
0
0
0
0
0
0
0
0
0
0
0
3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
314
2
8
1
8
12
21
42
4
7
46
36
32
25
70
640
21
45
9
26
15
6
8
51
4
156
16
97
120
7
12
47
957
12
191
11
22
6
10
6
25
144
9
4
343
168
6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
16
1
1
1
0
0
1
1
0
1
1
1
6
1
1
21
1
1
0
0
0
1
1
0
2
5
0
5
3
1
0
1
33
0
2
4
2
0
0
0
2
8
0
0
12
1
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,243
7
12
42
37
29
80
229
7
35
146
93
145
99
282
4
0
0
0
0
0
0
2
0
0
1
0
0
1
0
2,009
19
67
73
31
92
126
75
91
78
15
463
17
248
516
6
73
38
2,035
32
343
43
128
4
24
11
46
450
29
29
817
63
16
0
1
1
1
2
1
1
1
1
1
0
4
0
0
1
4
9
0
0
0
2
0
1
0
1
1
0
1
2
1
0
8
0
0
0
1
0
2
0
1
0
1
1
0
1
1
5
0
0
0
0
1
0
0
0
0
1
0
1
2
0
0
0
2
0
0
0
0
0
0
0
0
1
0
0
1
0
0
977
38
38
42
65
37
66
83
26
53
89
100
81
143
116
1,483
14
96
51
109
130
108
67
129
47
177
72
142
149
43
78
71
1,281
76
116
108
60
27
56
27
68
215
29
21
328
125
25
1
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
215
4
3
0
2
9
14
37
3
3
25
12
49
46
8
576
52
27
3
35
29
9
6
116
3
87
5
22
114
5
44
19
333
4
89
5
17
2
3
6
10
14
3
5
162
13
0
276 •
2016
감염병 감시연보
Page 320 - Table 1
제
군1
(Group
)Ⅰ
구 분
콜레라
Cholera
장티푸스
Typhoid
fever
파라티
푸스
Paratyp-
hoid fever
세균성
이질
Shigellosis
장출혈성
대장균
감염증
Enterohe-
morrhagic
Escherichi
-a coli
형간염
A
Viral
hepatitis A
제
군2
(Group
)Ⅲ
백일해
Pertussis
파상풍
Tetanus
홍역
Measles
유행성
이하선염
Mumps
풍진
Rubella
형간염
B
급성(
)
Viral
hepatitis B
(Acute)
일본뇌염
Japanese
encephalitis
수두
Varicella
폐렴구균
Streptoc-
occus
pneumon-
iae
제
군3
(Group
)Ⅲ
말라
리아
Malaria
결핵
Tuber-
culosis
한센병
Hansen's
disease
성홍열
Scarlet
fever
Page 321
Page 321 - Text
Ⅲ
법
정
감
염
병
전
수
감
시
통
계
Table -2-2-1. Reported cases of infectious diseases by administrative district, 2016 (Cont'd)
Ⅲ
Unit : No. of notifications
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3
0
0
0
0
0
0
1
1
0
0
0
1
0
0
4
0
0
1
0
0
0
0
2
0
0
0
0
0
0
1
0
3
0
0
0
0
0
0
0
0
0
0
0
1
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
0
0
0
0
0
0
0
0
1
0
0
0
1
0
0
0
2
0
0
0
0
0
0
0
0
1
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
252
13
3
13
23
28
3
2
7
6
57
32
20
41
4
2 1,006
0
0
0
0
0
0
0
1
0
0
0
0
1
0
0
0
21
111
43
68
55
68
48
116
72
106
52
51
35
30
82
48
0 1,029
0
0
0
0
0
0
0
0
0
0
0
0
0
0
69
41
68
130
37
48
70
57
102
33
25
195
120
34
5
0
0
0
0
1
2
0
0
0
0
1
0
0
1
7
0
1
0
0
0
0
1
0
0
1
1
0
2
0
0
1
8
0
0
0
1
0
0
2
0
1
0
1
1
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
43
13
1
3
2
3
4
1
0
1
5
3
1
3
3
20
11
1
1
1
0
0
1
2
0
4
1
2
3
2
2
0
0
0
0
0
0
2
0
1
0
1
1
2
4
65
40
16
0
4
1
6
16
3
8
1
1
3
5
4
7
3
2
1
1
1
0
4
1
3
2
2
0
7
0
8
9
1
1
0
45
16
0
2
1
1
1
5
5
9
2
1
1
6
7
4
2
3
1
1
0
3
0
0
2
0
0
3
1
0
0
0
0
0
2
0
0
2
0
2
0
2
7
0
1
0
5
0
0
0
0
0
0
0
0
3
0
0
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
2
0
1
1
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
1
3
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
2
2
0
1
0
0
0
0
0
0
1
0
0
0
0
0
4
0
0
0
0
0
1
0
0
0
2
0
0
1
0
8
0
0
0
1
3
0
0
1
0
1
1
0
1
0
0
0
8
0
0
0
0
0
0
0
1
1
0
0
6
0
0
18
2
0
1
1
0
0
1
1
1
1
3
3
3
1
12
0
0
0
0
1
1
0
0
0
5
1
2
1
1
0
0
6
0
0
2
0
0
1
1
0
1
0
0
1
0
0
1
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
1
0
0
0
1
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
1
0
0
11
0
1
0
1
0
0
3
1
1
0
0
1
2
1
9
0
3
0
0
0
0
1
0
1
1
0
1
0
0
2
0
3
0
0
0
0
1
0
0
1
0
0
0
1
0
0
* HFRS : Hemorrhagic fever with renal syndrom
† SFTS : Severe fever with thrombocytopenia syndrom
0
0
0
0
0
0
0
0
0
0
Chungcheongbuk-do Chungbuk
Goesan county
Danyang county
Boeun county
Yeongdong county
Okcheon county
Eumseong county
Jecheon city
Jeungpyeong county
Jincheon county
Cheongju city
0
0 Cheongju city Sangdang district
0 Cheongju city Seowon district
0 Cheongju city Cheongwon district
0 Cheongju city Heungdeok district
0
Chungcheongnam-do Chungnam
0
0
0
0
0
0
0
0
0
0
0
Gyeryong city
Gongju city
Geumsan county
Nonsan city
Dangjin city
Boryeong city
Buyeo county
Seosan city
Seocheon county
Asan city
Yesan county
0 Cheonan city Dongnam district
0 Cheonan city Seobuk district
Cheongyang county
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Taean county
Hongseong county
Jeollabuk-do
Gochang county
Gunsan city
Gimje city
Namwon city
Muju county
Buan county
Sunchang county
Wanju county
Iksan city
Imsil county
Jangsu conuty
Jeonju city
Jeongeup city
Jinan county
Jeonbuk
.Ⅲ 법정감염병 전수감시 통계 • 277
Page 321 - Table 1
제
군3
(Group
)Ⅲ
제 군4
(Group
)Ⅳ
수막구
균성수
막염
Mening-
ococcal
meningitis
레지오
넬라증
Legion-
ellosis
비브리오
패혈증
Vibrio
vulnificus
sepsis
발진열
Murine
typhus
쯔쯔가
무시증
Scrub
typhus
렙토스
피라증
Lepto-
spirosis
브루셀
라증
Bruc-
ellosis
신증후
군출혈열
HFRS*
매독
Syphilis
크로이
츠펠트-
야콥병
Creutz-feldt
Jacob
disease
(CJD)
뎅기열
Dengue
fever
큐열
Q fever
라임병
Lyme
Borrel-
iosis
유비저
Melioi-
dosis
치쿤구
니야열
Chiku-
ngunya
fever
중증열
성혈소
판감소
증후군
SFTS†
지카
바이러스
Classification
감염증
Zika
virus
infection
선천성
기2
기1
Secon-
Conge-
Primary
dary
nital
Page 322
Page 322 - Text
표
Ⅲ
-2-2-1. 2016
년 시군구별 신고수
)
계속(
Ⅲ
법
정
감
염
병
전
수
감
시
통
계
:
단위 신고수
8
0
0
0
0
0
0
0
3
3
0
1
0
1
0
0
0
0
0
0
0
0
0
3
2
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6
0
0
0
0
0
3 2018년  제41호
국내  주요  감염병  발생  현황
<중증열성혈소판감소증후군(SFTS),    유행절기  도래로  증가  예상>
●   제40주(9.30~10.6)  13명,  금년  총  203명(사망  331))
*  최근  3주  발생현황:  37주(9.9~9.15)  10명  →  38주(9.16~9.22)  12명  →  39주(9.23~9.29)  11명
*  환자  발생은  전년  동기간  대비  1.9%  감소  (’17년  207명→’18년  203명)
1)  사망자(33명)에서  농작업(텃밭  포함)(20),  임산물  채취(3),  풀접촉  (4)-풀뽑기  3,  풀베기  1,  산책(2),  등산(1),  벌초(1),도토리  줍기(1),
불명(1)  등의  노출력이  확인되었으며,  연령별로  60세  이상이  93.9%(31명)
*  봄부터  가을까지  발생하나  가을철(10월  경)에  환자  발생이  증가
<주별  중증열성혈소판감소증후군  발생현황  ‘18.1~40주>
*  참진드기  지수(T.I.)가  533.6으로  3년  평균(2015~2017)  동기간(283.6)  대비  88.1%  높은  수준이며,  전년
(2017)  동기간(337.4)  대비  58.2%  높은  수준
<매개체(참진드기)  연/월별    감시현황>
의심환자  진료  시  2차  감염,  특히  출혈성  증상이  확인되는  중증  환자의  경우  혈액  및  체액  노출에  주의하여
관할보건소  또는  1339  질병관리본부  콜센터로  신고하여  주시기  바랍니다.
1

2018년 제41호
2018. 10. 12
2018년 제21호(’18.5.18-5.24)
2018. 5. 25
국내·외  메르스  발생  현황
산발사례  발생  지속
국외  발생현황
전체  ‘18.1.1-10.12.  총  129명  발생,  35명  사망
주간  ’18.10.4-10.12일간  환자  1명*  추가발생
*  사우디아라비아  1차  감염사례  1건
<국가별  메르스  환자  발생현황(’18년)>
구분
계 1-6월 7월 8월 9월 10월
총계
129
사우디 126
카타르
0
UAE
오만
쿠웨이트
1
1
1
98
96
-
1
1
-
7
7
-
-
-
-
7
7
-
-
-
-
14-
13-
-
-
-
1
3
3
-
-
-
-
마지막
발생일
’17년
총 발생
-
250
’18.10월 238
’17.5월
’18.5월
’18.3월
’18.9월
3
6
3
0
<사우디  감염경로별  발생  현황  (’15-’18.10.12.)>
*  발생보고  지역이  아닌  감염지역  기준으로  집계
<사우디  주별  발생  현황  (’14-’18.10.12.)>
<사우디  발생현황>
전체  ‘18.1.1-10.12.  총  126명  발생,  35명  사망
주간  ’18.10.4-10.10일간  1차  감염사례  1명  발생
<’18년  사우디  감염경로별  환자  발생  현황>
국내  의심환자  신고  현황
전체  ‘18.1.1-10.10,  총  환자  1명
의심환자  241명(전원  MERS-CoV  음성)
주간  ‘18.10.2-10.10.  신규  의심환자  8명
계
1-6월
7월
8월
9월
10월
<신규  의심환자  현황검사결과  현황>
구분
계
1차감염
2차감염
126
95
31
96
72
20
7
5
4
7
7
2
13
9
4
3
2
1
1)  2차  감염  31명  중  병원  내  감염  11명(의료인  5,  환자  6),  가족  내
감염  20명
2)  Hafar  Al-Batin  시  병원  내,  무증상  감염  Cluster  1건
(환자접촉에  의한  의료인  3명),  개별  2차  감염사례  3명
3)  Najran  지역의  낙타농장  소유  가족  내  집단발생  1건(2차  감염
11명(’18.5.23~6.8))
성별/연령
국적
여행국가
여/60 대한민국
쿠웨이트
남/36
시리아
UAE
검사결과
메르스
음성
음성
호흡기바이러스 8종
Influenza    A(H3N2)
Influenza    A(H1N1)
여/50 대한민국 이스라엘,  요르단 음성
Rhinovirus
여/35 대한민국
UAE
음성
음성
남/34 대한민국 사우디,  UAE 음성
Influenza    A(H3N2)
남/4
남/4
대한민국
대한민국
UAE
UAE
남/51 대한민국
사우디
음성
Rhinovirus
음성
음성 Rhinovirus,    Influenza
Rhinovirus
A(H3N2)
*  메르스  신고대상  방문  국가(지역):  바레인,  이라크,  이란,  이스라엘,
요르단,  쿠웨이트,  레바논,  오만,  카타르,  시리아,  사우디아라비아,
UAE,  예멘
2

2018년 제41호
2018. 10. 12
2018년 제21호(’18.5.18-5.24)
2018. 5. 25
국외 감염병 발생 현황
유럽,  웨스트나일열  환자발생  급증
발생현황
-  ’18.1.1~10.4일까지  유럽  13개  국가*  에서  환자발생  총  1,317명(사망  142)으로  과거  5년간  누적  환자  수를  초과하여  발생
⦁  주요 발생국은 이탈리아(495건),  그리스(283건),  루마니아(256건),  헝가리(197건),  크로아티아(45건),  프랑스(16건)  등으로  확인
⦁  ‘18.9.28~10.4일까지  그리스(22건),  루마니아(19건),  헝가리(7건),  불가리아(1건),  체코(1건),  세르비아(30건)으로  80건  발생
⦁  최근  3년간  발생현황:  ’15년  108명  →  ’16년  225명  →  ’17년  204명
<유럽,  웨스트나일열  연도/주별  발생  현황/‘14~’18.9월(ECDC)>
<유럽,  웨스트나일열  발생지역  현황/‘14~’18.9월(ECDC)>
상황평가
-  현재까지  발생된  환자는  과거(‘14~’17년)  발생지역에서  보고되고  있으나  신규지역으로  확산  가능성이  있으며,
말(馬)에서도  유행이  지속되고  있는  상황
*  웨스트나일열의  경우  감염된  조류에서  매개  모기(Culex)를  통해  인간과  말에  전파,  수혈이나  장기이식,
모유수유를  통한  제한적인  전파도  가능
-  유럽  지역  내  웨스트나일열  유행  시기는  매년  5월-11월로,  유행  시기  동안  높은  환자  발생이  지속될  것으로  예상
-  국내는  숙주인  조류,  매개체인  모기  모두  시식하지만  바이러스  확인  사례  및  국내  인체감염사례는  없는  상황이나
철새  등을  통해  바이러스가  유입되는  겨우  모기를  통한  전파  가능성이  있음
-  유증상자  내원  시  해외  여행력,  모기물림  여부  등의  확인이  필요하며  의심환자  확인  시  관할  보건소  또는  1339로  신고
3

2018년 제41호
2018. 10. 12
2018년 제21호(’18.5.18-5.24)
2018. 5. 25
미국,  급성이완성  척수염(AFP)  환자발생
발생현황
Acute  flaccid  myelitis(AFM)은  Acute  flaccid  paralysis(AFP)  subtype으로  급격한  사지  근력저하와  MRI상  척수회백질
(Spinal  cord  gray  matter)에  뚜렷한  이상이  발생,  신경계증상이  유발되는  질환으로  대부분  15세  미만  어린이에서  발생
*  미국은  ‘14년  8~12월까지  34개주에서  120건의  사례  보고,  ’15년  17개주에서  22건,  ‘16년  39개주에서  149건,  ’17년  16개주에서  33건
‘18년 16개주에서 38건 발생보고
* 2014년  AFM사례의  증가는  엔테로바이러스  D-68(EV-D68)로  인한  대규모의  심각한  호흡기질환자의  확산과  일치하였으나  AFM
으로  확인된  모든  환자에서  EV-D68을  일관되게  감지하지  못한  상황으로,  정확한  원인을  알  수  없음
<미국,  연도/월별  AFM  발생현황/‘14.8~’18.9월(미국CDC)>
-  (콜로라도)  ‘18.10.9일  주보건부는  어린이  신경계  질환과  관련된  41건의  엔테로바이러스  A71  유행과  관련된
Acute  flaccid  myelitis(AFM)  14건*  발생보고
*  Acute  flaccid  myelitis(AFM)  14건  중  엔테로바이러스  A71  11건,  엔테로바이러스  D68  1건  확인
*  초기에는  콧물과  기침  증상(약  1주일)  후  급격한  팔과  다리의  근력약화로  인한  보행  장애  그  외  호흡곤란,  심한  두통,  뻣뻣한
목  또는  경련,  발열,  현기증,  눈부심  증상  동반
*  2014년  콜로라도에서  D68이  원인으로  추정되는  호흡기질환이  어린이  사이에서  유행,  그  중  급성이완성  척수염환자  11명  발생
*  2003년,  2005년에  엔테로바이러스  A71에  의한  발생  양상이,  현재  콜로라도에서  발생하고  있는  것과  유사하며  ,  8건의  중추
신경계 감염자  발생
- (미네소타)  Vaccine-derived  poliovirus에  의한  Acute  Flaccid  Paralysis(AFP)  사례  발생
*  ‘18년  9월  중순부터  미네소타  주  트윈시티와  미네소타  북동부에서  10세  미만의  어린이에서  AFM  6명  발생
*  2014년  전국적으로  AFM사례가  증가하였으며  엔테로바이러스  D68과  관련  있을  것으로  추정,  미네소타에서  건  발생  후  매년  1건
정도  발생하고  있는  상황
상황평가
∙‘14년부터  AFM이  증가한  정확한  원인은  확인되지  않은  상황
∙모든  엔테로바이러스는  감염된  사람의  대변  및  눈,  코  및  입  분비물(타액,  코점액  또는  가래)과의  접촉에  의해
전염,  무증상자도  다른  사람에게  바이러스  전염  가능
∙엔테로바이러스  A71,  엔테로바이러스  D68  감염  시  다른  엔테로바이러스  감염으로  발생되지  않는  신경계  질환
(뇌염,  수막염,  급성이완성  척수염)  발생
∙미국  CDC는  AFM에  대한  표준화된  감시체계를  수립하여  조사  진행  중
4

2018년 제41호
2018. 10. 12
2018년 제21호(’18.5.18-5.24)
2018. 5. 25
세네갈,  뎅기열 유행
사우디아라비아,  메르스  환자발생  지속
발생현황
발생현황
-  ‘18.1.1.∼10.2일까지  총  558명(확진  24)  발생
*  ’18.9.19일  뎅기열  환자  3건보고  되어  추가조사  중  뎅기열
사례정의를  충족하는  180건  확인
*  Institute  Pasteur  Dakar(IPD)에서  실시한  분석결과  뎅기
열  바이러스  혈청형  1(DENV-1)의  순환  확인
-  ‘18.6.1.∼9.16일까지  총  32건(사망  10)  발생
*  32건  중  12건이  5개  cluster(의료기관  1,  가정  4)로  발생
•  6.1~8일  Najran  지역  가족  내  감염에  의해  4명
•  7.9~14일  Riyadh  Afif시에서  가족  내  감염  2명
•  9.3~4일  Al-Quassim  지역의  Buraidah  City에있는  의료
시설  내에서  2명
•  9.1~16일까지  Al-Quassim  지역의  Buraidah시에서  가족
*  확인된  사례  중  여성이  71%,  연령대는  24~59세가  50%
내  감염  2명
*  주요  발생지역은  Ndiaye-Ndiaye(33%)와  Peulgha–Poukham
•  9.10~16일  Riyadh  지역에서  가족  내  감염  2명
(33%)지역,  Aedes  aegypti가  주  벡터이며  주간  활동과  옥
*  ‘12.9.16~’18.9.16일까지  WHO에  보고된  환자는  총  2,254
외에서  모기물림  경향이  높게  나타남
*  조사결과  해당지역에  물웅덩이,  화분  및  바나나  농장을  비롯
하여  여러  곳에서  벡터  번식지  확인
*  가장  최근  발생은  2017  년  4/4  분기이며  그  기간  동안  Louga,
Fatick,  Dakar  및  Thies의  네  지역에서  100건  발생
(사망  800)
<사우디아라비아,  메르스  사례  지리적  분포/‘18.9월(ECDC)>
<세네갈,  뎅기열  사례  지리적  분포/‘18.9.19~10.2(WHO)>
상황평가
-  보건당국은  의심되는  전  사례의  표본을  체계적으로
수집,  사례를  문서화하고  있으며  의심사례의  검체를
신속히  분석하고  진단하기  위해  현장(Fatick)에  이동
진단실험실을  설치하여  검사  진행  중
-  뎅기열사례  관리를  위한  Fact  sheet를  개발하여  모
든  지역에  보급
-  도시  전체를  훈증소독하고  집주변  반경  100m에  성
<전세계,  월별  메르스  발생현황/‘12.3~’18.9월ECDC>
상황평가
-  지금까지  확인된  사람  간  전염은  주로  의료  환경에서
발생,  사우디아라비아  의료기관  내  2차  감염사례의
감소는  중동지역  전체  환자발생률을  감소시킴
-  그러나,  WHO는  MERS-CoV  감염  사례는  지속보고  될
것이며  낙타  또는  낙타제품에  노출  된  후에  감염된
사례가  다른  국가로  유입될  가능성  있어,
충  매개체  통제를  위한  살충제  유포
-  의료  시설에서의  감염  예방  및  조기  통제조치는  MERS-
-  현재의  유행은  다른  지역으로  추가  확산되지  않은
CoV의  확산을  방지하는데  중요함을  강조
것으로  확인
-  현재  상황과  이용  가능한  정보에  근거하여  모든  회원
국이  급성  호흡기  감염에  대한  감시를  계속하고  비정상
적인  패턴을  면밀히  검토하도록  함
5

2018년 제41호
2018. 10. 12
2018년 제21호(’18.5.18-5.24)
2018. 5. 25
알  림  사  항
질병관리본부에서는  의약품안전사용서비스(DUR)  시스템을  활용한  해외감염병  및  발생국가  정보를  안내해  드리고
있습니다.  최근  약  처방이  없어도  정보  확인이  가능하도록  기능을  수정하였으니  확인하여  주시기  바랍니다.
1.  개선사항
(기존  DUR  프로그램)  약  처방  시  해외여행력  확인  가능  →  (새로운  ITS  프로그램)  약  처방  없이  접수,  진료  시에도
해외여행력  확인가능
◆  해외감염병  및  발생국가  정보-  4개  감염병  16개국(2018.6월  기준)
①  메르스(중동지역  13개국*)
* 레바논, 바레인, 사우디아라비아, 시리아, 아랍에미리트, 오만, 요르단, 예멘, 이라크, 이란,
이스라엘, 카타르, 쿠웨이트
②  라싸열(나이지리아)    ③  에볼라바이러스병(콩고민주공화국)    ④  페스트(마다가스카르)
2.  이용방법
기존  DUR  사용기관의  경우  청구SW업체  통해  “DUR시스템  기능검증”  후  이용가능,  미사용  기관의  경우
건강보험심사평가원  홈페이지에서  전용  프로그램  다운*받아  이용가능
*  건강보험심사평가원  홈페이지(http://www.hira.or.kr)에  프로그램  및  매뉴얼  게재
3.  설치문의:  건강보험심사평가원  DUR  정보부(033-739~0422~4)로  문의하여  주시기  바랍니다
6 2018년  제17호
(’18.4.20-4.26)
국내  주요  감염병  발생  현황
<중증열성혈소판감소증후군(SFTS),  첫  사망자  발생>
충청남도  청양군  거주자(여자/62세)로,  4월  13일  발열  및  설사  증상으로  4월  15일  병원  응급실  방문하여  치료,
증상  호전  없어  16일  대학병원으로  전원  후  중환자실에서  치료받던  중  4월  20일  21시경  사망(패혈증  쇼크,  간
기능  상승,  백혈구  감소,  혈소판  감소)  사례  발생
*  증상  발생  전  밭농사,  고사리  채취,  나물  캐기  등의  야외  활동력  확인
●  중증열성혈소판감소증후군(SFTS)은  4~11월  사이에  호발하며,  야외활동  후  2주  이내에  고열(38-40도),  소화기증상
(오심,  구토,  설사  등)  등의  유증상자  진료  시  SFTS  감염여부  확인을  위한  검사가  신속히  진행될  수  있도록  유의,
중증환자  심폐소생술이나  기도삽관  시술  시  2차  감염에  주의
<말라리아,  위험지역  여행시  감염주의>
●  ‘00년  환자발생이  정점에  이른  후  지속적으로  감소하여  최근  5년간  연  700명  이하로  발생하고  있으나  해외여행을
통한  유입사례가  지속  발생하고  있음(연평균  70건  내외)
*  모기  활동이  활발한  5-10월에  인천,  경기,  강원(휴전선  접경지역)의  거주자(군인  포함)  및  동남아시아  여행객에서
집중적으로  발생
<  말라리아  연도별  환자  발생  현황,  2003-2017  >
*  말라리아  감염시  초기에  권태감,  서서히  상승하는  발열  증상이  수일간  지속되고,  이후  오한,  발열,  땀흘림  후  해
열이  반복되면서  두통,  구역,  설사  등의  증상  발생,  유증상자  진료시  여행력  확인  필요
*  치료제  비축  지정기관:  국립중앙의료원,  부산  중구보건소,  광주  동구보건소,  국립제주검역소
*  국내·외  말라리아  위험지역  및  예방약  정보,  예방수칙  등은  질병관리본부  홈페이지(http://cdc.go.kr)  또는  질병관
리본부  모바일  사이트(http://m.cdc.go.kr)를    통해  확인  가능
의심환자(환자)  진료  시  관할보건소  또는  1339로  신고  당부  드립니다
1

<table>
<tbody>
<tr>
<td>구분/연도</td>
<td>2003</td>
<td>2004</td>
<td>2005</td>
<td>2006</td>
<td>2007</td>
<td>2008</td>
<td>2009</td>
<td>2010</td>
<td>2011</td>
<td>2012</td>
<td>2013</td>
<td>2014</td>
<td>2015</td>
<td>2016</td>
<td>2017</td>
</tr>
<tr>
<td>총계</td>
<td>1,171</td>
<td>864</td>
<td>1,369</td>
<td>2,051</td>
<td>2,227</td>
<td>1,052</td>
<td>1,345</td>
<td>1,772</td>
<td>826</td>
<td>542</td>
<td>445</td>
<td>638</td>
<td>699</td>
<td>673</td>
<td>515</td>
</tr>
<tr>
<td>민간인<br/>국내<br/>군인<br/>발생<br/>소계</td>
<td>560<br/>547<br/>1,107</td>
<td>424<br/>402<br/>826</td>
<td>769<br/>555<br/>1,324</td>
<td>1,278<br/>743<br/>2,021</td>
<td>1,283<br/>909<br/>2,192</td>
<td>566<br/>457<br/>1,023</td>
<td>639<br/>680<br/>1,319</td>
<td>996<br/>725<br/>1,721</td>
<td>323<br/>439<br/>762</td>
<td>330<br/>159<br/>489</td>
<td>227<br/>158<br/>385</td>
<td>402<br/>156<br/>558</td>
<td>361<br/>267<br/>628</td>
<td>307<br/>295<br/>602</td>
<td>280<br/>156<br/>436</td>
</tr>
<tr>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>해외유입</td>
<td>64</td>
<td>38</td>
<td>45</td>
<td>30</td>
<td>35</td>
<td>29</td>
<td>26</td>
<td>51</td>
<td>64</td>
<td>53</td>
<td>60</td>
<td>80</td>
<td>71</td>
<td>71</td>
<td>79</td>
</tr>
</tbody>
</table>

2018년 제17호(’18.4.20-4.26)
2018. 4. 27
국내  말라리아  위험지역(2018)
말라리아  헌혈  제한지역(‘17.8.15  기준)
2

<table>
<tbody>
<tr>
<td>여행/거주년도</td>
<td>지  역</td>
<td></td>
<td>2015년</td>
<td>2016년</td>
<td>2017년</td>
</tr>
<tr>
<td>2015년<br/>∼<br/>2017년</td>
<td>인  천</td>
<td>강화군</td>
<td>제한</td>
<td>제한</td>
<td>제한</td>
</tr>
<tr>
<td></td>
<td></td>
<td>옹진군</td>
<td>제한</td>
<td>제한</td>
<td>제한</td>
</tr>
<tr>
<td></td>
<td></td>
<td>영종·용유도지역(중구  남북동,  덕교동,  운남동,  운북동, <br/>운서동,  을왕동,  중산동)  및  무의도  지역(중구  무의동)</td>
<td>제한</td>
<td>제한</td>
<td>제한</td>
</tr>
<tr>
<td></td>
<td>강  원</td>
<td>철원군</td>
<td>제한</td>
<td>제한</td>
<td>제한</td>
</tr>
<tr>
<td></td>
<td>경  기</td>
<td>파주시</td>
<td>제한</td>
<td>제한</td>
<td>제한</td>
</tr>
<tr>
<td></td>
<td></td>
<td>김포시</td>
<td>제한</td>
<td>제한</td>
<td>제한</td>
</tr>
<tr>
<td></td>
<td></td>
<td>연천군</td>
<td></td>
<td></td>
<td>제한</td>
</tr>
<tr>
<td></td>
<td>북  한</td>
<td>백두산  제외  전지역</td>
<td>제한</td>
<td>제한</td>
<td>제한</td>
</tr>
</tbody>
</table>

2018년 제17호(’18.4.20-4.26)
2018. 4. 27
국내·외  메르스  발생  현황
낙타접촉에  의한  1차  감염사례  보고
국외  발생현황
전체  ‘18.1.1-4.26  총  73명  발생,  21명  사망
주간  ’18.4.20-4.26  환자  1명*발생
*  사우디아라비아  1명(낙타접촉)
<국가별  메르스  환자  발생현황(’18년)>
<주별  발생  현황  (’14-’18.4.26)>
구분
계
1월 2월 3월
4월
총계
사우디
카타르
UAE
오만
쿠웨이트
73
72
0
0
1
0
23
23
-
-
-
-
23
23
-
-
-
-
19
18
-
-
1
-
8
8
-
-
-
-
마지
막
발 생
’16년
총계
’17년
총계
-
252
250
’18.4
243
238
’17.5
’17.9
’18.3
’16.8
2
3
3
1
3
6
3
0
*  발생보고  지역이  아닌  감염지역  기준으로  집계
<감염경로별  환자  현황  (’15.1.1-’18.4.26)>
사우디  발생현황
전체  ‘18.1.1-4.26  총  72명  발생,  21명  사망
주간    ’18.4.20-4.26  환자  1명,  사망  1명  발생
<’18년  사우디  감염경로별  환자  발생  현황>
구분
계
1차감염
2차감염
계
72
58
14
1월
23
21
2
2월
23
16
71)
3월
4월
18
14
4
8
7
1
1)  Hafar  Al-Batin  시  병원  내  2차  감염에  의한  집단발생  1건
(무증상  의료인  3)-‘18.2.4
국내  의심환자  신고  현황
전체 ‘18.1.1-4.19.  총  의심환자 91명(전원  MERS-CoV 음성)
주간  ‘18.4.11-4.19.  의심환자  7명
<신규  의심환자  현황(’18.4.11-4.19)>
성별/연령
국적
여행국가
검사결과
메르스
호흡기바이러스 8종
여/57 대한민국
UAE
음성
Rhinovirus
남/37
인도
UAE
음성
Human parainfluenza
Ⅲ
*  메르스  신고대상  방문  국가(지역):  바레인,  이라크,  이란,  이스라엘,
요르단,  쿠웨이트,  레바논,  오만,  카타르,  시리아,  사우디아라비아,
아랍에미리트,  예멘
3

2018년 제17호(’18.4.20-4.26)
2018. 4. 27
국외  A형간염  발생  현황
약  150만  건의  HAV  감염사례가  전  세계적으로  발생하며  만성  간질환을  일으키지는  않으나  급성
간  장애와  같은  심각한  증상을  유발하며  반복적으로  재발됨.
*  High:  90%이상의  아이들이  감염,  대부분이  면역을  획득하며  유행발생률  낮음
*  Intermediate:  면역력이  없는  감수성자가  축적되어  노령층에서  질병발생률이  높고  지역사회  대규모  유행발생  가능성이  있음
*  Low:  위생상태가  좋은  선진국으로  감염률이  낮으나  마약  사용자,  남성  동성애자,  풍토지역  여행자에서  발생
유럽지역  발생현황
-  ‘16.6.1~’18.3.19일까지  22개  EU/EEA  국가에서  보고된  확진사례는  4,101건이며  성별이  확인된
3,873건의  남성과  여성의  비율은  7.2:1이었고  남성과  성관계를  갖는  남성들  사이에서  3개의  유행균주와
유사변종  외  다른  계통의  변종이  없는  것으로  보고
<확진자의  유전염기서열  분포(‘16.1~’18.3.19)>
-  ’16.1월~12월까지  26개국에서  보고  된  20,089건의  사례는  ‘12~’15년  동기간  발생보고  된  건의  4배
이상  증가.  ‘17년  5월  남:여  비율은  4.9:1로  가장  높았으나  그  이후  감소.  성별을  확인할  수  있는
20,067건  중  남성이  1,559명,  여성이  4,476건으로  ‘12~’15년  보고된  남성건보다  413%,  여성은
70%  증가
*  남성  확진  건의  대부분이  불법마약사용자  및  남성  동성애자에서  발생
*  체코,  프랑스,  이탈리아는  어린이가  증가한  것으로  보고했으며,  프랑스와  이탈리아에서  노인층이
증가한  것으로  보고
4

2018년 제17호(’18.4.20-4.26)
2018. 4. 27
<확진자의  성별  분포(‘13.1~’18.1월)>
미국  발생현황
<캘리포니아>
-  ‘16.11월~’18.4.11일까지  704명(사망  21)  발생
*  발병은  샌디에고  카운티에서  시작되어  산타크루즈,  로스앤젤리스  및  몬테레이  카운티로  확산,
지금까지  샌디에고(587명)와  산타크루즈(76명)에서  가장  많이  발생.
*  위생환경이  불량한  지역,  불법  약물  사용자에서  대부분  발생
*  보건부는  지금까지  12만3천  도스의  백신  공급,  모니터링  진행  중
<미시간>
-  ‘16.8월~’18.4.18일까지  815명(사망  25)  발생
*  발병은  마컴(218명),  디트로이트시(168명),  웨인(140명),  오클랜드(110명)  순으로  발생이  높고  비
위생적인  주사바늘  사용,  노숙자  등에서  발생하여  공중보건  인식향상  교육  및  백신접종  캠페인  진행
<유타>
-  ‘17.1월~’18.4.23일까지  226명  발생
*  솔트레이크(156명),  유타(45),  베어리버(5명)  순으로  발생이  높고  노숙자  및  약물사용자에서
39%  이상  발생하고  있으며  염기서열  분석결과  캘리포니아  주와  동일
*  확진자  입원율이  이전  40%  미만이었으나  현  유행은  70%이상으로  기저질환자나  간염  등의  합병증
환자가  증가하고  있음
<켄터키>
-  ‘17.8월~’18.4.14일까지  352명(사망  3)  발생
*  노숙자,  마약사용자에서  주로  발생하였고  ‘17년  11월에  주  전역에서  환자  발생,  발생한  여러  건의
사례가  바이러스  유전자  염기서열  분석결과  캘리포니아  주  및  유타  주와  동일
상황평가
- ECDC는  유행이  지속되면서  여성,  아동  및  노인에서  발생이  증가하였으나  그  수는  제한적이며  남성
동성애자의  환자발생이  높지만  유행균주의  변이는  확인되지  않으며  백신접종  및  위생개선  등을  통한
방역조치로  ‘17.5월  이후  감소추세임
- 미국의  경우  캘리포니아  주의  마약중독자,  노숙자에서  시작된  유행이  다른  주로  확산되고  있으며,  최근
캔터키  주에서  환자발생이  지속  보고되고  있음
- 해당국가의  발생환자  중  여행자에서도  보고되고  있어,  위험국가  여행자를  통한  국내  유입  및  유입
사례의  밀접접촉을  통한  전파  가능성이  있어  여행  전  백신접종  권장
- 유증상자  진료시  여행력  확인,  의심환자  진료  시  관할보건소  또는  1339로  신고  당부
5, 표  Ⅲ-3-1-6.  A형간염  연도별  지역별  사망신고수
Table  Ⅲ-3-1-6.  Death  cases  of  Viral  hepatitis  A  by  year  and  province
단위 : 신고수                                                                                                                                                            Unit : No. of  notifications
구분
2011
2012
2013
2014
2015
2016
2017
2018
2019
계
Total
서울
Seoul
부산
Busan
대구
Daegu
인천
Incheon
광주
Gwangju
대전
Daejeon
울산
Ulsan
세종
Sejong
경기
Gyeonggi
강원
Gangwon
충북
Chungbuk
충남
Chungnam
전북
Jeonbuk
전남
Jeonnam
경북
Gyeongbuk
경남
Gyeongnam
제주
Jeju
3
0
1
0
1
2
3
2
10
1
0
1
0
0
0
0
0
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
-
0
0
0
0
0
0
0
1
1
0
0
0
0
0
0
1
3
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
1
0
2
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
표  Ⅲ-3-1-7.  파상풍  연도별  지역별  사망신고수
Table  Ⅲ-3-1-7.  Death  cases  of  Tetanus  by  year  and  province
단위 : 신고수                                                                                                                                                            Unit : No. of  notifications
구분
2011
2012
2013
2014
2015
2016
2017
2018
2019
계
Total
서울
Seoul
부산
Busan
대구
Daegu
인천
Incheon
광주
Gwangju
대전
Daejeon
울산
Ulsan
세종
Sejong
경기
Gyeonggi
강원
Gangwon
충북
Chungbuk
충남
Chungnam
전북
Jeonbuk
전남
Jeonnam
경북
Gyeongbuk
경남
Gyeongnam
제주
Jeju
2
1
1
0
0
2
0
2
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
-
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
0
1
0
1
0
0
1＊
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
*  2016년  경북  사망  1건은  2015년  발생건임
표  Ⅲ-3-1-8.  풍진  연도별  지역별  사망신고수
Table  Ⅲ-3-1-8.  Death  cases  of  Rubella  by  year  and  province
단위 : 신고수                                                                                                                                                            Unit : No. of  notifications
구분
2011
2012
2013
2014
2015
2016
2017
2018
2019
계
Total
서울
Seoul
부산
Busan
대구
Daegu
인천
Incheon
광주
Gwangju
대전
Daejeon
울산
Ulsan
세종
Sejong
경기
Gyeonggi
강원
Gangwon
충북
Chungbuk
충남
Chungnam
전북
Jeonbuk
전남
Jeonnam
경북
Gyeongbuk
경남
Gyeongnam
제주
Jeju
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
표  Ⅲ-3-1-9.  급성B형간염  연도별  지역별  사망신고수
Table  Ⅲ-3-1-9.  Death  cases  of  Acute  Viral  hepatitis  B  by  year  and  province
단위 : 신고수                                                                                                                                                            Unit : No. of  notifications
구분
2011
2012
2013
2014
2015
2016
2017
2018
2019
계
Total
서울
Seoul
부산
Busan
대구
Daegu
인천
Incheon
광주
Gwangju
대전
Daejeon
울산
Ulsan
세종
Sejong
경기
Gyeonggi
강원
Gangwon
충북
Chungbuk
충남
Chungnam
전북
Jeonbuk
전남
Jeonnam
경북
Gyeongbuk
경남
Gyeongnam
제주
Jeju
0
0
1
1
0
0
1
2
4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-  301  -
Ⅲ. 법정감염병  전수감시  통계 • 301

표  Ⅲ-3-1-10.  일본뇌염  연도별  지역별  사망신고수
Table  Ⅲ-3-1-10.  Death  cases  of  Japanese  encephalitis  by  year  and  province
단위 : 신고수                                                                                                                                                            Unit : No. of  notifications
구분
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
계
Total
서울
Seoul
부산
Busan
대구
Daegu
인천
Incheon
광주
Gwangju
대전
Daejeon
울산
Ulsan
세종
Sejong
경기
Gyeonggi
강원
Gangwon
충북
Chungbuk
충남
Chungnam
전북
Jeonbuk
전남
Jeonnam
경북
Gyeongbuk
경남
Gyeongnam
제주
Jeju
4
9
10
15
0
0
0
--
--
0
0
0
1
0
0
0
0
0
0
0
0
1
0
1
0
1
0
1
0
0
7
0
5
3
4
2
3
2
1
6
1
0
--
--
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
1
0
1
0
1
0
1
1
0
0
--
--
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-
0
--
--
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
-
0
--
--
0
0
0
--
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
0
0
0
1
-
-
-
-
-
-
-
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
1
-
-
-
-
-
-
-
-
-
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
0
0
0
0
0
0
0
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
0
0
0
0
0
0
0
0
1
3
--
--
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
1
0
1
2*
2
0
0
0
0
2
0
0
--
--
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3
0
0
0
0
0
0
1
0
0
0
0
--
--
0
0
0
0
--
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3
--
--
0
0
0
--
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
1
0
0
0
1
1
--
--
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
2
--
--
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
--
--
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
1
0
0
1
0
--
--
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
1
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
--
--
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
*  2013년  경기  사망  2건  중  1건은  2012년  발생건임
302  • 2019  감염병  감시연보
-  302  -

표  Ⅲ-3-1-11.  수두  연도별  지역별  사망신고수
Table  Ⅲ-3-1-11.  Death  cases  of  Varicella  by  year  and  province
단위 : 신고수                                                                                                                                                            Unit : No. of  notifications
구분
2011
2012
2013
2014
2015
2016
2017
2018
2019
계
Total
서울
Seoul
부산
Busan
대구
Daegu
인천
Incheon
광주
Gwangju
대전
Daejeon
울산
Ulsan
세종
Sejong
경기
Gyeonggi
강원
Gangwon
충북
Chungbuk
충남
Chungnam
전북
Jeonbuk
전남
Jeonnam
경북
Gyeongbuk
경남
Gyeongnam
제주
Jeju
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
표  Ⅲ-3-1-12.  폐렴구균  연도별  지역별  사망신고수
Table  Ⅲ-3-1-12.  Death  cases  of Streptococcus pneumoniae  by  year  and  province
단위 : 신고수                                                                                                                                                            Unit : No. of  notifications
구분
2011
2012
2013
2014
2015
2016
2017
2018
2019
계
Total
서울
Seoul
부산
Busan
대구
Daegu
인천
Incheon
광주
Gwangju
대전
Daejeon
울산
Ulsan
세종
Sejong
경기
Gyeonggi
강원
Gangwon
충북
Chungbuk
충남
Chungnam
전북
Jeonbuk
전남
Jeonnam
경북
Gyeongbuk
경남
Gyeongnam
제주
Jeju
-
-
-
6
34
18
67
115
75
-
-
-
0
3
5
14
23
16
-
-
-
0
1
1
4
6
4
-
-
-
0
0
1
0
3
3
-
-
-
0
7
1
3
12†
4
-
-
-
0
0
0
2
0
2
-
-
-
0
0
0
0
1
1
-
-
-
0
3
0
2
2
0
-
-
-
0
0
0
0
1
0
-
-
-
3
5
1
19
28
22
-
-
-
0
1
1
5
6
4
-
-
-
0
0
0
2
0
2
-
-
-
0
1
0
1
5
2
-
-
-
0
4*
1
3
6
8
-
-
-
0
0
1
2
5
0
-
-
-
1
4
4
3
3
4
-
-
-
2
5
1
6
8
1
-
-
-
0
0
1
1
6
2
*  2015년  전북  사망  4건  중  1건은  2014년  발생건임
표  Ⅲ-3-1-13.  말라리아  연도별  지역별  사망신고수
Table  Ⅲ-3-1-13.  Death  cases  of  Malaria  by  year  and  province
단위 : 신고수                                                                                                                                                            Unit : No. of  notifications
구분
2011
2012
2013
2014
2015
2016
2017
2018
2019
계
Total
서울
Seoul
부산
Busan
대구
Daegu
인천
Incheon
광주
Gwangju
대전
Daejeon
울산
Ulsan
세종
Sejong
경기
Gyeonggi
강원
Gangwon
충북
Chungbuk
충남
Chungnam
전북
Jeonbuk
전남
Jeonnam
경북
Gyeongbuk
경남
Gyeongnam
제주
Jeju
2
0
2
5
0
1
3
4
1
0
0
0
2
0
0
1
1
0
0
0
0
2
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
1
0
0
0
0
0
0
0
0
0
-
0
0
0
0
0
0
0
0
1
0
1
1
0
0
1
2
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
표  Ⅲ-3-1-14.  결핵  연도별  지역별  사망신고수
Table  Ⅲ-3-1-14.    Death  cases  of  Tuberculosis  by  year  and  province
단위 : 신고수                                                                                                                                                            Unit : No. of  notifications
구분
2011
2012
2013
2014
2015
2016
2017
2018
2019
계
Total
2,364
2,466
2,230
2,305
2,209
2,186
1,816
1,800
-
서울
Seoul
부산
Busan
대구
Daegu
인천
Incheon
광주
Gwangju
대전
Daejeon
울산
Ulsan
세종
Sejong
경기
Gyeonggi
강원
Gangwon
충북
Chungbuk
충남
Chungnam
전북
Jeonbuk
전남
Jeonnam
경북
Gyeongbuk
경남
Gyeongnam
제주
Jeju
361
376
388
388
347
358
270
351
-
150
163
145
140
150
136
102
116
-
116
132
111
131
118
119
111
107
-
98
116
117
129
106
91
81
83
-
60
67
73
73
60
62
47
33
-
48
40
48
45
44
36
46
41
-
35
38
38
29
29
35
25
25
-
-
5
9
9
3
3
8
7
-
421
453
421
391
422
396
327
298
-
132
102
100
124
99
92
98
87
-
74
72
71
77
67
68
78
73
-
173
130
96
114
125
119
135
112
-
112
120
104
107
90
130
78
86
-
182
200
150
176
181
140
112
94
-
217
243
200
191
183
244
182
134
-
165
188
135
164
166
142
102
144
-
20
21
24
17
19
15
14
9
-
주)  2019년  결핵  사망자수는  2019  사망원인통계연보가  발간되는  10월경  공표됨
-  303  -
Ⅲ. 법정감염병  전수감시  통계 • 303 6
5
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
2
0
1
1
0
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
0
0
8
0
1
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
0
0
0
0
1
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
0
0
0
0
0
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
1
0
1
0
4
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
0
0
0
0
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
3
13
9
8
15
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
3
2
3
0
1
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
2
2
5
4
2
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
1
0
3
3
2
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
0
0
0
1
1
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
0
0
0
0
0
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
0
0
3
2
1
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
8
4
8
2
8
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
1
0
0
0
0
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
0
0
0
0
0
-
주 형간염은 감염병의 진단기준 고시 개정
(2016.1.7)
에 따라 급성 형간염에 한해 신고토록 변경되었으며
B
, 2016.1.6
까지 신고된 주산기 형간염은 건
B
1
) B
(
경기 건 임
1 )
.Ⅲ 법정감염병 전수감시 통계 • 85
Page 128
Page 128 - Text
Ⅲ
-1-2-17.
일본뇌염 연도별 지역별 신고수
표
Ⅲ
Table -1-2-17. Reported cases of Japanese encephalitis by year and province
:
단위 신고수
Unit : No. of notifications
Ⅲ
법
정
감
염
병
전
수
감
시
통
계
구분
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
계
Total
서울
Seoul
부산
Busan
대구
Daegu
인천
Incheon
광주
Gwangju
대전
Daejeon
울산
Ulsan
세종
Sejong
경기
Gyeonggi
강원
Gangwon
충북
Chungbuk
충남
Chungnam
전북
Jeonbuk
전남
Jeonnam
경북
Gyeongbuk
경남
Gyeongnam
제주
Jeju
미상
Unknown
107
194
1,197
139
8
22
192
18
0
0
0
3
1
0
1
3
3
4
3
0
0
0
3
1
0
1
6
1
0
6
0
7
6
6
26
3
20
14
26
40
28
0
0
0
0
0
0
0
1
1
1
0
0
0
0
0
0
0
0
1
0
0
1
0
2
0
1
3
0
3
1
11
10
16
1
0
22
-
1
19
-
3
22
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
2
0
4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
1
1
0
3
4
1
2
2
1
0
0
0
2
0
0
0
0
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
1
0
0
0
1
3
1
-
-
-
-
-
-
-
0
0
0
-
0
0
0
0
-
-
-
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
-
-
-
-
-
-
-
-
-
0
-
0
0
0
0
-
-
-
0
0
0
0
0
0
0
0
0
0
0
0
1
0
3
0
0
3
1
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
0
0
0
0
0
19
24
121
4
0
0
0
0
0
0
0
0
1
1
1
0
0
0
0
1
0
0
0
0
0
1
0
3
1
1
6
0
4
1
8
11
3
4
0
4
1
0
0
0
0
0
0
1
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5
0
0
1
0
0
0
6
2
23
52
103
196
1
0
0
0
0
1
0
0
0
0
1
0
0
0
0
0
0
0
0
1
0
0
1
0
0
2
1
1
0
1
2
1
1
0
0
0
0
0
1
0
0
0
0
0
0
1
0
0
0
0
0
0
0
1
0
0
0
0
0
1
0
2
2
0
0
2
3
1
14
14
129
23
17
61
198
55
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
1
0
0
0
0
1
0
2
0
0
1
2
2
4
83
9
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
1
0
0
1
0
1
1
0
2
0
2
2
0
3
0
12
5
98
19
0
0
0
0
0
0
0
1
0
0
0
0
0
0
2
0
0
1
1
1
0
0
0
0
0
1
2
0
1
0
1
1
0
1
6
10
4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
86 •
2016
감염병 감시연보
Page 129
Page 129 - Text
Ⅲ
-1-2-18.
표
Ⅲ
Table -1-2-18. Reported cases of Varicella by year and province
:
단위 신고수
수두 연도별 지역별 신고수
Unit : No. of notifications
계
Total
서울
Seoul
부산
Busan
대구
Daegu
인천
Incheon
광주
Gwangju
대전
Daejeon
울산
Ulsan
세종
Sejong
경기
Gyeonggi
강원
Gangwon
충북
Chungbuk
충남
Chungnam
전북
Jeonbuk
전남
Jeonnam
경북
Gyeongbuk
경남
Gyeongnam
제주
Jeju
미상
Unknown
구분
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
1,934
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
187
637
199
677
2
74
776
1,001
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
8
343
396
266
352
522
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
19
67
253
617
741
652
520
487
629
20
646
1,051
980
1,198
747
1,167
1,206
1,376
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
87
524
404
542
834
1,144
753
659
918
827
Ⅲ
법
정
감
염
병
전
수
감
시
통
계
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
0
0
0
0
0
0
0
0
0
0
0
0
2006
11,027
2007
20,284
1,688
2,829
1,380
1,805
2008
22,849
2,065
2,817
1,627
2,117
2009
25,197
2,307
2,678
2,663
1,787
2010
24,400
2,168
2,656
2,088
1,899
2011
36,249
3,557
3,608
3,176
3,684
1,043
2012
27,763
3,410
2,348
1,745
2,465
758
2013
37,361
3,622
2,472
2,501
2,886
1,109
2014
44,450
4,641
3,389
2,945
2,525
962
1,238
1,189
2015
46,330
5,603
2,936
2,238
2,453
1,128
1,245
1,349
397
599
2,785
1,741
5,650
1,844
5,629
2,643
5,632
3,050
5,875
2,465
34
316
559
603
795
801
0
22
184
210
565
768
8,930
2,430
1,415
1,159
53
450
585
521
258
316
513
940
115
306
516
388
657
725
131
578
692
933
1,124
812
9
158
448
891
556
762
1,026
1,075
2,193
554
871
1,587
1,250
15
78
36
83
6,909
1,893
10,306
2,257
13,584
2,189
13,671
1,527
666
825
704
933
1,842
1,717
1,489
1,314
2,020
1,917
2,294
2,041
1,569
2,400
1,837
1,921
2,378
1,723
4,297
1,008
2016
54,060
6,266
3,188
2,749
2,597
1,531
1,808
1,742
540
14,826
1,978
1,243
2,009
2,035
2,443
3,109
4,676
1,320
.Ⅲ 법정감염병 전수감시 통계 • 87
Page 130
Page 130 - Text
Ⅲ
-1-2-19. b
표
Ⅲ
Table -1-2-19. Reported cases of
:
단위 신고수
형헤모필루스인플루엔자 연도별 지역별 신고수
Haemophilusinfluenzatype b by year and province
Unit : No. of notifications
Ⅲ
법
정
감
염
병
전
수
감
시
통
계
구분
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
계
Total
서울
Seoul
부산
Busan
대구
Daegu
인천
Incheon
광주
Gwangju
대전
Daejeon
울산
Ulsan
세종
Sejong
경기
Gyeonggi
강원
Gangwon
충북
Chungbuk
충남
Chungnam
전북
Jeonbuk
전남
Jeonnam
경북
Gyeongbuk
경남
Gyeongnam
제주
Jeju
미상
Unknown
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
0
0
0
0
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
0
0
0
0
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
0
0
0
0
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
0
0
0
0
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
0
0
0
0
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
0
0
0
0
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
0
0
0
0
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
0
0
0
0
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
0
0
0
0
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
0
0
0
0
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
0
0
0
0
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
0
0
0
0
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
0
0
0
0
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
0
0
0
0
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
0
0
0
0
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
0
0
0
0
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
0
0
0
0
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
0
0
0
0
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
0
0
0
0
주
) 2013 -2016
년
년 통계는 확진환자만 집계함
88 •
2016
감염병 감시연보
Page 131
Page 131 - Text
Ⅲ
-1-2-20.
표
Ⅲ
Table -1-2-20. Reported cases of
:
단위 신고수
폐렴구균 연도별 지역별 신고수
Streptococcuspneumoniaeby year and province
Unit : No. of notifications
Ⅲ
법
정
감
염
병
전
수
감
시
통
계
구분
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
계
Total
서울
Seoul
부산
Busan
대구
Daegu
인천
Incheon
광주
Gwangju
대전
Daejeon
울산
Ulsan
세종
Sejong
경기
Gyeonggi
강원
Gangwon
충북
Chungbuk
충남
Chungnam
전북
Jeonbuk
전남
Jeonnam
경북
Gyeongbuk
경남
Gyeongnam
제주
Jeju
미상
Unknown
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
36
228
441
8
40
111
1
18
36
0
1
10
1
21
31
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
0
0
5
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
0
1
10
4
14
12
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
0
1
1
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
13
57
86
1
15
25
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
0
1
4
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
0
6
19
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
1
6
9
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
2
4
13
1
12
21
3
30
42
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
- 표 Ⅲ-3-1-5. A형간염 연도별 지역별 사망신고수
Table Ⅲ-3-1-5. Death cases of Viral hepatitis A by year and province
단위 : 신고수                                                                                                                     Unit : No. of notifications
구분
2011
2012
2013
2014
2015
2016
2017
2018
계
Total
서울
Seoul
부산
Busan
대구
Daegu
인천
Incheon
광주
Gwangju
대전
Daejeon
울산
Ulsan
세종
Sejong
경기
Gyeonggi
강원
Gangwon
충북
Chungbuk
충남
Chungnam
전북
Jeonbuk
전남
Jeonnam
경북
Gyeongbuk
경남
Gyeongnam
제주
Jeju
3
0
1
0
1
2
3
2
1
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
-
0
0
0
0
0
0
0
1
0
0
0
0
0
0
1
0
0
0
0
0
1
0
0
0
0
0
0
0
0
1
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
표 Ⅲ-3-1-6. 파상풍 연도별 지역별 사망신고수
Table Ⅲ-3-1-6. Death cases of Tetanus by year and province
단위 : 신고수                                                                                                                     Unit : No. of notifications
구분
2011
2012
2013
2014
2015
2016
2017
2018
계
Total
서울
Seoul
부산
Busan
대구
Daegu
인천
Incheon
광주
Gwangju
대전
Daejeon
울산
Ulsan
세종
Sejong
경기
Gyeonggi
강원
Gangwon
충북
Chungbuk
충남
Chungnam
전북
Jeonbuk
전남
Jeonnam
경북
Gyeongbuk
경남
Gyeongnam
제주
Jeju
2
1
1
0
0
2
0
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
1
0
1
0
0
1＊
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
* 2016년 경북 사망 1건은 2015년 발생건임
표 Ⅲ-3-1-7. 풍진 연도별 지역별 사망신고수
Table Ⅲ-3-1-7. Death cases of Rubella by year and province
단위 : 신고수                                                                                                                     Unit : No. of notifications
구분
2011
2012
2013
2014
2015
2016
2017
2018
계
Total
서울
Seoul
부산
Busan
대구
Daegu
인천
Incheon
광주
Gwangju
대전
Daejeon
울산
Ulsan
세종
Sejong
경기
Gyeonggi
강원
Gangwon
충북
Chungbuk
충남
Chungnam
전북
Jeonbuk
전남
Jeonnam
경북
Gyeongbuk
경남
Gyeongnam
제주
Jeju
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
표 Ⅲ-3-1-8. 급성B형간염 연도별 지역별 사망신고수
Table Ⅲ-3-1-8. Death cases of Acute Viral hepatitis B by year and province
단위 : 신고수                                                                                                                     Unit : No. of notifications
구분
2011
2012
2013
2014
2015
2016
2017
2018
계
Total
서울
Seoul
부산
Busan
대구
Daegu
인천
Incheon
광주
Gwangju
대전
Daejeon
울산
Ulsan
세종
Sejong
경기
Gyeonggi
강원
Gangwon
충북
Chungbuk
충남
Chungnam
전북
Jeonbuk
전남
Jeonnam
경북
Gyeongbuk
경남
Gyeongnam
제주
Jeju
0
0
1
1
0
0
1
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
298  • 2018  감염병  감시연보

표 Ⅲ-3-1-9. 일본뇌염 연도별 지역별 사망신고수
Table Ⅲ-3-1-9. Death cases of Japanese encephalitis by year and province
단위 : 신고수                                                                                                                     Unit : No. of notifications
구분
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
계
Total
서울
Seoul
부산
Busan
대구
Daegu
인천
Incheon
광주
Gwangju
대전
Daejeon
울산
Ulsan
세종
Sejong
경기
Gyeonggi
강원
Gangwon
충북
Chungbuk
충남
Chungnam
전북
Jeonbuk
전남
Jeonnam
경북
Gyeongbuk
경남
Gyeongnam
제주
Jeju
4
9
10
15
0
0
0
--
--
0
0
0
1
0
0
0
0
0
0
0
0
1
0
1
0
1
0
1
0
0
7
0
5
3
4
2
3
2
1
1
0
--
--
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
1
0
1
0
1
0
1
0
0
--
--
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-
0
--
--
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-
0
--
--
0
0
0
--
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
0
0
0
-
-
-
-
-
-
-
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
-
-
-
-
-
-
-
-
-
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
0
0
0
0
0
0
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
0
0
0
0
0
0
0
1
3
--
--
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
1
0
1
2*
2
0
0
0
0
0
0
--
--
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3
0
0
0
0
0
0
1
0
0
0
--
--
0
0
0
0
--
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3
--
--
0
0
0
--
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
1
0
0
1
1
--
--
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
2
--
--
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
--
--
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
1
0
1
0
--
--
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
1
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
--
--
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
* 2013년 경기 사망 2건 중 1건은 2012년 발생건임
Ⅲ. 법정감염병  전수감시  통계 • 299

표 Ⅲ-3-1-10. 수두 연도별 지역별 사망신고수
Table Ⅲ-3-1-10. Death cases of Varicella by year and province
단위 : 신고수                                                                                                                     Unit : No. of notifications
구분
2011
2012
2013
2014
2015
2016
2017
2018
계
Total
서울
Seoul
부산
Busan
대구
Daegu
인천
Incheon
광주
Gwangju
대전
Daejeon
울산
Ulsan
세종
Sejong
경기
Gyeonggi
강원
Gangwon
충북
Chungbuk
충남
Chungnam
전북
Jeonbuk
전남
Jeonnam
경북
Gyeongbuk
경남
Gyeongnam
제주
Jeju
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
표 Ⅲ-3-1-11. 폐렴구균 연도별 지역별 사망신고수
Table Ⅲ-3-1-11. Death cases of Streptococcus pneumoniae by year and province
단위 : 신고수                                                                                                                     Unit : No. of notifications
구분
2011
2012
2013
2014
2015
2016
2017
2018
계
Total
서울
Seoul
부산
Busan
대구
Daegu
인천
Incheon
광주
Gwangju
대전
Daejeon
울산
Ulsan
세종
Sejong
경기
Gyeonggi
강원
Gangwon
충북
Chungbuk
충남
Chungnam
전북
Jeonbuk
전남
Jeonnam
경북
Gyeongbuk
경남
Gyeongnam
제주
Jeju
-
-
-
6
34
18
67
115
-
-
-
0
3
5
14
23
-
-
-
0
1
1
4
6
-
-
-
0
0
1
0
3
-
-
-
0
7
1
3
12†
-
-
-
0
0
0
2
0
-
-
-
0
0
0
0
1
-
-
-
0
3
0
2
2
-
-
-
0
0
0
0
1
-
-
-
3
5
1
19
28
-
-
-
0
1
1
5
6
-
-
-
0
0
0
2
0
-
-
-
0
1
0
1
5
-
-
-
0
4*
1
3
6
-
-
-
0
0
1
2
5
-
-
-
1
4
4
3
3
-
-
-
2
5
1
6
8
-
-
-
0
0
1
1
6
* 2015년 전북 사망 4건 중 1건은 2014년 발생건임
표 Ⅲ-3-1-12. 말라리아 연도별 지역별 사망신고수
Table Ⅲ-3-1-12. Death cases of Malaria by year and province
단위 : 신고수                                                                                                                     Unit : No. of notifications
구분
2011
2012
2013
2014
2015
2016
2017
2018
계
Total
서울
Seoul
부산
Busan
대구
Daegu
인천
Incheon
광주
Gwangju
대전
Daejeon
울산
Ulsan
세종
Sejong
경기
Gyeonggi
강원
Gangwon
충북
Chungbuk
충남
Chungnam
전북
Jeonbuk
전남
Jeonnam
경북
Gyeongbuk
경남
Gyeongnam
제주
Jeju
2
0
2
5
0
1
3
4
0
0
0
2
0
0
1
1
0
0
0
2
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
-
0
0
0
0
0
0
0
1
0
1
1
0
0
1
2
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
표 Ⅲ-3-1-13. 결핵 연도별 지역별 사망신고수
Table Ⅲ-3-1-13.  Death cases of Tuberculosis by year and province
단위 : 신고수                                                                                                                     Unit : No. of notifications
구분
2011
2012
2013
2014
2015
2016
2017
2018
계
Total
서울
Seoul
부산
Busan
대구
Daegu
인천
Incheon
광주
Gwangju
대전
Daejeon
울산
Ulsan
세종
Sejong
경기
Gyeonggi
강원
Gangwon
충북
Chungbuk
충남
Chungnam
전북
Jeonbuk
전남
Jeonnam
경북
Gyeongbuk
경남
Gyeongnam
제주
Jeju
2,364
2,466
2,230
2,305
2,209
2,186
1,816
-
361
376
388
388
347
358
270
-
150
163
145
140
150
136
102
-
116
132
111
131
118
119
111
-
98
116
117
129
106
91
81
-
60
67
73
73
60
62
47
-
48
40
48
45
44
36
46
-
35
38
38
29
29
35
25
-
-
5
9
9
3
3
8
-
421
453
421
391
422
396
327
-
132
102
100
124
99
92
98
-
74
72
71
77
67
68
78
-
173
130
96
114
125
119
135
-
112
120
104
107
90
130
78
-
182
200
150
176
181
140
112
-
217
243
200
191
183
244
182
-
165
188
135
164
166
142
102
-
20
21
24
17
19
15
14
-
주) 2018년 결핵 사망자수는 2018 사망원인통계연보가 발간되는 10월경 공표됨
300  • 2018  감염병  감시연보, source_sentence: How has the CDC been monitoring the spread of mpox across different states in the United States?
sentences: MPOX UPDATE (18): WHO, PAKISTAN, USA, SOCIOBEHAVIORAL FACTORS ************************************************************* A ProMED-mail post http://www.promedmail.org -- Source: Centers for Disease Control and Prevention (CDC) [edited] -- Communicated by: ProMED ****** -- Communicated by: ****** Thus, the indirect role of the vaccination campaign in implementing mpox exposure mitigation strategies adapted by MSM was probably essential in reducing mpox cases, as observed.
20230324.8709105 Monkeypox update (01) 20220521.8703393 ProMED-mail is a program of the International Society for Infectious Diseases http://www.isid.org In this update: [1] Cases around the world [2] USA: cases by state [3] WHO assures assistance to contain mpox in Pakistan [4] Pakistan: 1st confirmed case of mpox reported in Karachi [5] USA: isolated ocular mpox without skin lesions [6] The effect of sociobehavioral factors and public health actions ****** [1] Cases around the world Date: Wed 26 Apr 2023 17:30 EDT Source: Centers for Disease Control and Prevention (CDC) [edited] https://www.cdc.gov/poxvirus/monkeypox/response/2022/world-map.html [The CDC report will be only updated every 2 weeks.
Please see last week's post for the latest update (Mpox update (17): cases, South Korea, Japan, Pakistan, UK 20230501.8709757 ). -
Mod.
CS] Communicated by: ProMED ****** [2] USA: cases by state Date: Wed 26 Apr 2023 14:00 EDT https://www.cdc.gov/poxvirus/monkeypox/response/2022/us-map.html [The CDC report will be only updated every 2 weeks.
Please see last week's post for the latest update (Mpox update (17): cases, South Korea, Japan, Pakistan, UK 20230501.8709757 ). -
Mod.
CS] -- Communicated by: ProMED ****** [3] WHO assures assistance to contain mpox in Pakistan Date: Sat 29 April 2023 Source: Geo News [edited] https://www.geo.tv/latest/484554-who-assures-assistance-to-contain-monkeypox-in-pakistan The World Health Organisation (WHO) Saturday [29 Apr 2023] assured to assist Pakistan as per its requirement to contain the mpox virus.
In a statement, the organisation said it has been working and probing the spread of the virus alongside Pakistan's government, as the situation continues to evolve.
WHO has assured assistance to the government, especially in the lab testing process, points of entry and providing testing kits.
An official of the Ministry of National Health Services stated that no evidence of localised transmission of mpox in Pakistan has been found so far, while the risk of its international spread from the country remains low.
WHO also does not recommend any restrictions on trade on the currently available information regarding mpox outbreaks.
Earlier this week, Pakistan detected its 1st 2 cases of mpox in people who travelled to the country from abroad.
According to health officials, the mpox patient was deported from Saudi Arabia and landed in Pakistan on 17 Apr 2023 with symptoms of mpox.
Meanwhile, another person sitting with him on the flight also exhibited symptoms of the mpox.
Meanwhile, in Karachi, Sindh health department officials told The News that no case of the virus was detected after samples of 4 people were sent to the Dow University of Health Sciences (DUHS) tested negative, while results of the 5th sample are yet to arrive. "
Four people, including a 14-year-old boy and his father, as well as 2 Pakistanis who were deported from broad have tested negative for mpox, so at the moment, no person is infected with the infectious disease in Karachi or any other part of Sindh," an official of the provincial health department said.
The federal and provincial governments have put health authorities on high alert and imposed certain SOPs to ensure that the virus is detected in a bid to ensure that it does not spread in the country.
Health authorities have also reactivated "COVID-19 protocols" at all entry points -- including international airports -- to prevent the entry of people carrying the mpox virus into the country, while special attention is being paid to the screening of hundreds of Pakistanis deported from different countries on monthly basis. [
Aid from WHO, in addition to precautions already being taken by the country, will be very helpful in minimizing this outbreak of mpox.
Inbound travelers should watch out for signs and symptoms of mpox. -
Mod.
CS] [4] Pakistan: 1st confirmed case of mpox reported in Karachi Date: Thu 4 May 2023 Source: Oye Yeah [edited] https://www.oyeyeah.com/news/first-confirmed-case-of-monkeypox-reported-in-karachi/ First confirmed case of mpox reported in Karachi ------------------------------------------------ The 1st confirmed case of mpox has been reported in Karachi on Thursday [4 May 2023].
The infected person is a 30-year-old expatriate who had been working as a driver in Jeddah, Saudi Arabia.
He tested positive for the mpox virus on Thursday [4 May 2023] on his return to Pakistan. [
MM] was isolated after his symptoms were identified.
According to the health department, the patient had recently arrived in Karachi from Jeddah and he is believed to have contracted the virus from abroad. "
The traveller who was working as a driver in Jeddah and made his way back to Pakistan via Oman has had his test results confirmed to have mpox," said the department in a statement. "
He was being isolated since he presented with these symptoms and his contact tracing is underway."
The Sindh Health Department has advised the public to take precautions.
This is the 4th mpox case reported in Pakistan.
The 1st 2 cases were reported in Islamabad and another in Lahore. --
Communicated by: ProMED [It is unclear if this is the final test that results were pending on from the previous article.
Either way, it seems that this case was imported and not due to community transmission. -
Mod.
CS] ****** [5] USA: isolated ocular mpox without skin lesions Date: Tue 2 May 2023 Source: Centers for Disease Control and Prevention (CDC) [edited] https://wwwnc.cdc.gov/eid/article/29/6/23-0032_article Citation: Nguyen MT, Mentreddy A, Schallhorn J, Chan M, Aung S, Doernberg SB, et al.
Isolated ocular mpox without skin lesions, United States.
Emerg Infect Dis.
June 2023 -------------------------------------------------------------------------------- We report a case of ocular-only mpox infection in a 53-year-old man in San Francisco, California, USA.
His medical history included chronic lymphocytic leukemia (CLL), inactive 2 years after treatment with obinutuzumab and venetoclax but with persistent lymphopenia.
He reported male sexual partners but was HIV negative.
Symptoms in his right eye began August 2022 as itching and nasal scleral redness.
There was no fever, rash, or lymphadenopathy.
Eye redness worsened; the patient sought care at an urgent care facility and was given erythromycin ointment.
Continued vision loss led to an emergency department visit, resulting in a diagnosis of preseptal cellulitis.
The treatment was trimethoprim/sulfamethoxazole plus amoxicillin/clavulanic acid.
In early September 2022, the patient sought care at a county eye clinic for purulent conjunctivitis and corneal epithelial defects.
Clinicians suspected gonococcal conjunctivitis and administered intramuscular ceftriaxone and topical moxifloxacin 0.5%.
Bacterial and fungal ocular cultures and herpetic viral PCR returned negative results.
Topical prednisolone acetate 1% and oral valacyclovir failed to control the eye inflammation.
Three weeks after initial symptoms appeared, the patient's ocular inflammation increased; keratic precipitates and a moderate corneal opacity developed.
Uveitis and scleritis workups did not yield a specific diagnosis.
In late September 2022, at a 2nd opinion examination at a University of California clinic, the patient's right eye acuity was 20/640.
Examination showed a nasal patch of avascular scleral necrosis (Figure, panel B) [Figures available at source URL], and corneal epithelial sloughing with microcystic edema.
Repeat ocular surface cultures and PCR were negative.
Given the negative results of extensive infectious etiology testing, we prescribed oral prednisone (40 mg/d) for presumed undifferentiated necrotizing anterior scleritis and keratitis.
One week later, corneal inflammation worsened.
Clinical deterioration on systemic steroids continued to raise suspicion for ocular infection; we stopped steroid treatments.
Again, cultures and PCR remained negative.
Without prednisone, the patient's limbal infiltrates worsened, with progressive corneal haze.
White corneal endothelial plaques appeared.
We performed anterior chamber paracentesis for cultures, viral PCR, and an RNA deep-sequencing (RNA-seq) protocol previously described.
The patient's scleritis, keratitis, and anterior uveitis worsened.
Right eye vision decreased to hand motion only.
We performed a diagnostic scleral and corneal biopsy and initiated voriconazole for presumed fungal infection.
The biopsy results returned negative for infection, and voriconazole was stopped.
Given the progressive clinical disease and negative infectious workup, we processed residual aqueous fluid for RNA-seq, which revealed a high number of reads aligning to mpox virus (MPXV).
Orthogonal testing from corneal and scleral swab specimens also returned positive results for MPXV by PCR.
A nasal swab specimen obtained on the same day tested negative for MPXV by PCR.
When presented with those findings, the patient offered additional information regarding high-risk sexual activities, previously withheld because his definition of sexual activity included only penetrative intercourse.
He described an encounter with a male partner with semen deposition into his right eye 2 weeks before the onset of his symptoms.
He received the 1st dose of mpox vaccine for higher risk groups the week after this encounter.
Several months later, during casual text messaging, the partner from this activity revealed a subsequent penile mpox diagnosis. Coronavirus map of the US: latest cases state by state ; ;
New York State, United States | COVID-19 | Humans
New Jersey, United States | COVID-19 | Humans
Massachusetts, United States | COVID-19 | Humans
Illinois, United States | COVID-19 | Humans
California, United States | COVID-19 | Humans
Pennsylvania, United States | COVID-19 | Humans
Michigan, United States | COVID-19 | Humans
Florida, United States | COVID-19 | Humans
Texas, United States | COVID-19 | Humans
Louisiana, United States | COVID-19 | Humans
Connecticut, United States | COVID-19 | Humans
Georgia, United States | COVID-19 | Humans
Maryland, United States | COVID-19 | Humans
Ohio, United States | COVID-19 | Humans
Indiana, United States | COVID-19 | Humans
Virginia, United States | COVID-19 | Humans
Colorado, United States | COVID-19 | Humans
Washington, United States | COVID-19 | Humans
North Carolina, United States | COVID-19 | Humans
Tennessee, United States | COVID-19 | Humans
Rhode Island, United States | COVID-19 | Humans
Missouri, United States | COVID-19 | Humans
Arizona, United States | COVID-19 | Humans
Iowa, United States | COVID-19 | Humans
Alabama, United States | COVID-19 | Humans
Wisconsin, United States | COVID-19 | Humans
Mississippi, United States | COVID-19 | Humans
South Carolina, United States | COVID-19 | Humans
Minnesota, United States | COVID-19 | Humans
Nevada, United States | COVID-19 | Humans
Delaware, United States | COVID-19 | Humans
Kentucky, United States | COVID-19 | Humans
Utah, United States | COVID-19 | Humans
Kansas, United States | COVID-19 | Humans
Washington, DC, United States | COVID-19 | Humans
Nebraska, United States | COVID-19 | Humans
Oklahoma, United States | COVID-19 | Humans
New Mexico, United States | COVID-19 | Humans
Arkansas, United States | COVID-19 | Humans
Oregon, United States | COVID-19 | Humans
South Dakota, United States | COVID-19 | Humans
New Hampshire, United States | COVID-19 | Humans
Idaho, United States | COVID-19 | Humans
Puerto Rico | COVID-19 | Humans
West Virginia, United States | COVID-19 | Humans
Maine, United States | COVID-19 | Humans
North Dakota, United States | COVID-19 | Humans
Vermont, United States | COVID-19 | Humans
Hawaii, United States | COVID-19 | Humans
Wyoming, United States | COVID-19 | Humans
Montana, United States | COVID-19 | Humans
Alaska, United States | COVID-19 | Humans
Guam [USA] | COVID-19 | Humans
U.S. Virgin Islands, U.S. Virgin Islands | COVID-19 | Humans
United States | COVID-19 | Humans https://www.cidrap.umn.edu/news-pers...urope-americas 
 
Monkeypox epicenter moves from Europe to Americas 
 
Filed Under: 
 Monkeypox 
 Stephanie Soucheray | News Reporter | CIDRAP News 
 
Aug 25, 2022 
 
Today World Health Organization (WHO) Director-General Tedros Adhanom Ghebreyesus, PhD, said monkeypox transmission has dropped in Europe, which was the initial epicenter of the current outbreak, but now rising cases are rising in the Americas, making the region the main hot spot.

 
"In the early stages of the outbreak, most reported cases were in Europe, with a smaller proportion in the Americas," Tedros said during weekly remarks . "
That has now reversed, with less than 40% of reported cases in Europe and 60% in the Americas. "

 
Tedros applauded Europe for effective public health measures and behavior changes, which have tamped down disease spread.

 
"However, in Latin America in particular, insufficient awareness of public health measures are combining with a lack of access to vaccines to fan the flames of the outbreak, " he said.

 
 Steep rise in cases in the Americas 
 
 
In an external situation report published today, the WHO said the number of cases reported in the Americas from Aug 15 to Aug 21 reflects a steep rise.

 
As of Aug 22, 41,664 laboratory-confirmed cases of monkeypox and 12 deaths have been reported to the WHO from 96 countries and territories.
In the past week, 23 counties have reported an increase, with the United States reporting the steepest.

 
Following the United States, Spain, Brazil, Germany, the United Kingdom, France, Canada, the Netherlands, and Peru have the most cases, accounting for 88.9% of the global case count.

 
The average age of monkeypox case-patients is 36, and 98.2% of cases worldwide are in men.
Among all cases with sexual identity information provided, 95.8% identify as men who have sex with men (MSM).
Sexual transmission was noted among 82.1% of cases, with 60.6% of case-patients likely exposed in a party setting with sexual contacts.

 
 Exposure, monkeypox in European health workers 
 
 
The WHO and the European Centre for Disease Prevention and Control (ECDC) released a joint summary on the situation in Europe.
Notably, a retrospective sample taken from cases suggests that the earliest specimen date in the region is now Mar 7, with the earliest illness onset on Apr 3.

 
The report also mentions 64 cases of monkeypox infection among healthcare workers, including 3 cases of occupational exposure.

 
"In all three cases of occupational exposure, health workers were wearing recommended personal protective equipment but were exposed to body fluid while collecting samples," the WHO and ECDC said.

 
 US total tops 16,600 
 
 
The Centers for Disease Control and Prevention (CDC) yesterday reported 694 new US case, raising the national total to 16,603 .

 
Four more pediatric cases were reported in the country yesterday, including a case in a child from California's Orange County and 3 cases in children younger than 17 in Georgia.
One of the Georgia patients is an elementary school student, and the state is investigating another suspected case at an elementary school.

 
 Officials said they do not know if the cases are connected, as the schools are 13 miles apart.

 
ABC News reports that nine states have reported 13 pediatric cases so far.
Late last week, the CDC published monkeypox guidance for schools and daycares, saying the overall risk is low.

 
 FDA warns about fecal microbiota transplant risk 
 
 
The Food and Drug Administration (FDA) earlier this week warned that fecal microbiota transplant (FMT) donors should be screened for monkeypox, as rectal swabs show the presence of the virus .

 
FMT is being used for patients with multidrug-resistant infections.

 
Brazil, meanwhile, has reported a monkeypox case in a puppy that had contact with a person who had monkeypox, the second known case of its kind globally., Unit : case
Ⅲ. 법정전염병 감시 통계 · 369
표 Ⅲ-2-2-30.  2010년 성별 발생수-대전
Table Ⅲ-2-2-30. Reported cases of notifiable diseases
by sex in Daejeon, 2010
단위 : 환자수,명
‡  EIDS : Emerging infectious disease syndrome
(EIDS of 2010 is pandemic influenza A/H1N1(2009))
9월 30일까지 신고·보고된 자료임

<table>
<tbody>
<tr>
<td>55-59</td>
<td>60-64</td>
<td>65+</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>남자</td>
<td>여자</td>
<td>계</td>
<td></td>
<td></td>
</tr>
<tr>
<td></td>
<td></td>
<td></td>
<td>Classification</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>구  분</td>
<td></td>
</tr>
<tr>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>Male</td>
<td>Female</td>
<td>Both sexes</td>
<td></td>
<td></td>
</tr>
<tr>
<td>0</td>
<td>0</td>
<td>0</td>
<td>Cholera</td>
<td>Group Ⅰ</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>콜레라</td>
<td>제1군</td>
</tr>
<tr>
<td>0</td>
<td>0</td>
<td>0</td>
<td>Plague</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>페스트</td>
<td></td>
</tr>
<tr>
<td>0</td>
<td>0</td>
<td>2</td>
<td>Typhoid fever</td>
<td></td>
<td>3</td>
<td>1</td>
<td>4</td>
<td>장티푸스</td>
<td></td>
</tr>
<tr>
<td>0</td>
<td>0</td>
<td>0</td>
<td>Paratyphoid fever</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>파라티푸스</td>
<td></td>
</tr>
<tr>
<td>0</td>
<td>0</td>
<td>0</td>
<td>Shigellosis</td>
<td></td>
<td>2</td>
<td>1</td>
<td>3</td>
<td>세균성이질</td>
<td></td>
</tr>
<tr>
<td>0</td>
<td>0</td>
<td>0</td>
<td>Enterohemorrhagic E. coli</td>
<td></td>
<td>1</td>
<td>0</td>
<td>1</td>
<td>장출혈성대장균감염증</td>
<td></td>
</tr>
<tr>
<td>0</td>
<td>0</td>
<td>0</td>
<td>Diphtheria</td>
<td>Group Ⅱ</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>디프테리아</td>
<td>제2군</td>
</tr>
<tr>
<td>0</td>
<td>0</td>
<td>0</td>
<td>Pertussis</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>백일해</td>
<td></td>
</tr>
<tr>
<td>0</td>
<td>1</td>
<td>0</td>
<td>Tetanus</td>
<td></td>
<td>0</td>
<td>1</td>
<td>1</td>
<td>파상풍</td>
<td></td>
</tr>
<tr>
<td>0</td>
<td>0</td>
<td>0</td>
<td>Measles</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>홍역</td>
<td></td>
</tr>
<tr>
<td>0</td>
<td>1</td>
<td>0</td>
<td>Mumps</td>
<td></td>
<td>144</td>
<td>55</td>
<td>199</td>
<td>유행성이하선염</td>
<td></td>
</tr>
<tr>
<td>0</td>
<td>0</td>
<td>0</td>
<td>Rubella</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>풍진</td>
<td></td>
</tr>
<tr>
<td>0</td>
<td>0</td>
<td>0</td>
<td>Poliomyelitis</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>폴리오</td>
<td></td>
</tr>
<tr>
<td>0</td>
<td>0</td>
<td>0</td>
<td>Japanese encephalitis</td>
<td></td>
<td>0</td>
<td>1</td>
<td>1</td>
<td>일본뇌염</td>
<td></td>
</tr>
<tr>
<td>2</td>
<td>0</td>
<td>1</td>
<td>Varicella</td>
<td></td>
<td>347</td>
<td>305</td>
<td>652</td>
<td>수두</td>
<td></td>
</tr>
<tr>
<td>0</td>
<td>0</td>
<td>0</td>
<td>Malaria</td>
<td>Group Ⅲ</td>
<td>14</td>
<td>1</td>
<td>15</td>
<td>말라리아</td>
<td>제3군</td>
</tr>
<tr>
<td>89</td>
<td>68</td>
<td>421</td>
<td>Tuberculosis</td>
<td></td>
<td>737</td>
<td>585</td>
<td>1,322</td>
<td>결핵</td>
<td></td>
</tr>
<tr>
<td>0</td>
<td>0</td>
<td>1</td>
<td>Hansen's disease</td>
<td></td>
<td>1</td>
<td>0</td>
<td>1</td>
<td>한센병</td>
<td></td>
</tr>
<tr>
<td>0</td>
<td>0</td>
<td>0</td>
<td>Scarlet fever</td>
<td></td>
<td>2</td>
<td>0</td>
<td>2</td>
<td>성홍열</td>
<td></td>
</tr>
<tr>
<td>0</td>
<td>0</td>
<td>0</td>
<td>Meningococcal meningitis</td>
<td></td>
<td>1</td>
<td>0</td>
<td>1</td>
<td>수막구균성수막염</td>
<td></td>
</tr>
<tr>
<td>0</td>
<td>0</td>
<td>0</td>
<td>Legionellosis</td>
<td></td>
<td>1</td>
<td>0</td>
<td>1</td>
<td>레지오넬라증</td>
<td></td>
</tr>
<tr>
<td>0</td>
<td>0</td>
<td>0</td>
<td>Vibrio vulnificus  sepsis</td>
<td></td>
<td>1</td>
<td>0</td>
<td>1</td>
<td>비브리오패혈증</td>
<td></td>
</tr>
<tr>
<td>0</td>
<td>0</td>
<td>0</td>
<td>Epidemic typhus</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>발진티푸스</td>
<td></td>
</tr>
<tr>
<td>1</td>
<td>1</td>
<td>0</td>
<td>Murine typhus</td>
<td></td>
<td>2</td>
<td>0</td>
<td>2</td>
<td>발진열</td>
<td></td>
</tr>
<tr>
<td>43</td>
<td>41</td>
<td>132</td>
<td>Scrub typhus</td>
<td></td>
<td>139</td>
<td>203</td>
<td>342</td>
<td>쯔쯔가무시증</td>
<td></td>
</tr>
<tr>
<td>0</td>
<td>0</td>
<td>0</td>
<td>Leptospirosis</td>
<td></td>
<td>2</td>
<td>1</td>
<td>3</td>
<td>렙토스피라증</td>
<td></td>
</tr>
<tr>
<td>1</td>
<td>0</td>
<td>2</td>
<td>Brucellosis</td>
<td></td>
<td>2</td>
<td>2</td>
<td>4</td>
<td>브루셀라증</td>
<td></td>
</tr>
<tr>
<td>0</td>
<td>0</td>
<td>0</td>
<td>Anthrax</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>탄저</td>
<td></td>
</tr>
<tr>
<td>0</td>
<td>0</td>
<td>0</td>
<td>Rabies</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>공수병</td>
<td></td>
</tr>
<tr>
<td>1</td>
<td>1</td>
<td>2</td>
<td>HFRS†</td>
<td></td>
<td>3</td>
<td>6</td>
<td>9</td>
<td>신증후군출혈열</td>
<td></td>
</tr>
<tr>
<td>0</td>
<td>0</td>
<td>0</td>
<td>Dengue fever</td>
<td>Group Ⅳ</td>
<td>2</td>
<td>4</td>
<td>6</td>
<td>뎅기열</td>
<td>제4군</td>
</tr>
<tr>
<td>0</td>
<td>0</td>
<td>0</td>
<td>Leishmaniasis</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>리슈마니아증</td>
<td></td>
</tr>
<tr>
<td>0</td>
<td>0</td>
<td>0</td>
<td>Q fever</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>큐열</td>
<td></td>
</tr>
<tr>
<td>30</td>
<td>13</td>
<td>26</td>
<td>EIDS‡</td>
<td></td>
<td>725</td>
<td>752</td>
<td>1,477</td>
<td>신종전염병증후군*</td>
<td></td>
</tr>
<tr>
<td>†  HFRS : Hemorrhagic fever with renal syndrome</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td>* 2010년 신종전염병증후군은 인플루엔자 A/H1N1(2009)으로</td>
<td></td>
<td></td>
<td></td>
</tr>
</tbody>
</table>

370 · 2010 감염병 감시연보
표 Ⅲ-2-2-31. 2010년 월별 발생수-울산
Table Ⅲ-2-2-31. Reported cases of notifiable diseases by month in Ulsan, 2010
† 2010년 신종전염병증후군은 인플루엔자 A/H1N1(2009)으로 9월 30일까지 신고·보고된 자료임
‡ EIDS : Emerging infectious disease syndrome (EIDS of 2010 is pandemic influenza A/H1N1(2009)) 표 Ⅲ-2-2-27. 2010년 환자분류별 발생수-대전
Table Ⅲ-2-2-27. Reported cases of notifiable diseases
by case classification in Daejeon, 2010
단위 : 명
Ⅲ. 법정전염병 감시 통계 · 367
표 Ⅲ-2-2-28. 2010년 감염지역별 발생수-대전
Table Ⅲ-2-2-28. Reported cases of notifiable diseases
by infected area in Daejeon, 2010
확진환자
Confirmed
병원체
보유자
Carrier
의사환자
계
Suspected
Total
국내
Domestic
국외
Imported
Classification
구 분
제1군 콜레라
페스트
장티푸스
파라티푸스
세균성이질
장출혈성대장균감염증
제2군 디프테리아
백일해
파상풍
홍역
유행성이하선염
풍진
폴리오
일본뇌염
수두
제3군 말라리아
결핵
한센병
성홍열
수막구균성수막염
레지오넬라증
비브리오패혈증
발진티푸스
발진열
쯔쯔가무시증
렙토스피라증
브루셀라증
탄저
공수병
신증후군출혈열
제4군 뎅기열
리슈마니아증
큐열
0
0
4
0
3
1
0
0
1
0
49
0
0
1
201
15
618
1
2
1
1
1
0
2
228
2
1
0
0
9
5
0
0
0
-
0
0
0
0
-
-
-
-
-
-
-
-
-
0
-
-
-
0
-
-
-
-
-
-
-
-
-
-
-
-
-
-
0
-
0
0
0
0
0
0
-
0
0
0
4
0
3
1
0
0
1
0
0
0
3
0
2
1
0
0
1
0
0  Cholera
0  Plague
1  Typhoid fever
0  Paratyphoid fever
1  Shigellosis
0  Enterohemorrhagic E. coli
0  Diphtheria
0  Pertussis
0  Tetanus
0  Measles
150
199
199
0  Mumps
0
0
0
451
-
0
0
1
652
15
704
1,322
-
-
-
-
0
0
0
1
2
1
1
1
0
2
0
0
1
652
13
1,322
1
2
1
1
1
0
2
0  Rubella
0  Poliomyelitis
0  Japanese encephalitis
0  Varicella
2  Malaria
0  Tuberculosis
0  Hansen's disease
0  Scarlet fever
0  Meningococcal meningitis
0  Legionellosis
0  Vibrio vulnificus  sepsis
0  Epidemic typhus
0  Murine typhus
114
342
342
0  Scrub typhus
1
3
0
0
0
1
0
0
1
3
4
0
0
9
6
0
0
2
4
0
0
9
0
0
0
1,477
1,477
1  Leptospirosis
0  Brucellosis
0  Anthrax
0  Rabies
0  HFRS†
6  Dengue fever
0  Leishmaniasis
0  Q fever
0  EIDS‡
신종전염병증후군*
1,476
주) - : 법정전염병 신고범위가 아님
†  HFRS : Hemorrhagic fever with renal syndrome
* 2010년 신종전염병증후군은 인플루엔자 A/H1N1(2009)으로
‡  EIDS : Emerging infectious disease syndrome
9월 30일까지 신고·보고된 자료임
(EIDS of 2010 is pandemic influenza A/H1N1(2009))
Unit : case
Group Ⅰ
Group Ⅱ
Group Ⅲ
Group Ⅳ

368 · 2010 감염병 감시연보
표 Ⅲ-2-2-29.  2010년 연령별 발생수-대전
Table Ⅲ-2-2-29. Reported cases of notifiable diseases by age group in Daejeon, 2010
단위 : 환자수, 명

<table>
<tbody>
<tr>
<td></td>
<td></td>
<td>계</td>
<td>0-4</td>
<td>5-9</td>
<td>10-14</td>
<td>15-19</td>
<td>20-24</td>
<td>25-29</td>
<td>30-34</td>
<td>35-39</td>
<td>40-44</td>
<td>45-49</td>
<td>50-54</td>
</tr>
<tr>
<td></td>
<td>구   분</td>
<td>Total</td>
<td>Age</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>제1군</td>
<td>콜레라</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td></td>
<td>페스트</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td></td>
<td>장티푸스</td>
<td>4</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>1</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>1</td>
</tr>
<tr>
<td></td>
<td>파라티푸스</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td></td>
<td>세균성이질</td>
<td>3</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>1</td>
<td>1</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>1</td>
<td>0</td>
</tr>
<tr>
<td></td>
<td>장출혈성대장균감염증</td>
<td>1</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>1</td>
<td>0</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td>제2군</td>
<td>디프테리아</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td></td>
<td>백일해</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td></td>
<td>파상풍</td>
<td>1</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td></td>
<td>홍역</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td></td>
<td>유행성이하선염</td>
<td>199</td>
<td>14</td>
<td>34</td>
<td>39</td>
<td>71</td>
<td>18</td>
<td>8</td>
<td>6</td>
<td>3</td>
<td>0</td>
<td>2</td>
<td>3</td>
</tr>
<tr>
<td></td>
<td>풍진</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td></td>
<td>폴리오</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td></td>
<td>일본뇌염</td>
<td>1</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>1</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td></td>
<td>수두</td>
<td>652</td>
<td>168</td>
<td>372</td>
<td>60</td>
<td>15</td>
<td>14</td>
<td>5</td>
<td>5</td>
<td>7</td>
<td>2</td>
<td>0</td>
<td>1</td>
</tr>
<tr>
<td>제3군</td>
<td>말라리아</td>
<td>15</td>
<td>1</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>8</td>
<td>2</td>
<td>2</td>
<td>0</td>
<td>1</td>
<td>1</td>
<td>0</td>
</tr>
<tr>
<td></td>
<td>결핵</td>
<td>1,322</td>
<td>3</td>
<td>0</td>
<td>4</td>
<td>41</td>
<td>82</td>
<td>111</td>
<td>79</td>
<td>104</td>
<td>97</td>
<td>117</td>
<td>106</td>
</tr>
<tr>
<td></td>
<td>한센병</td>
<td>1</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td></td>
<td>성홍열</td>
<td>2</td>
<td>1</td>
<td>1</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td></td>
<td>수막구균성수막염</td>
<td>1</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>1</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td></td>
<td>레지오넬라증</td>
<td>1</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>1</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td></td>
<td>비브리오패혈증</td>
<td>1</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>1</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td></td>
<td>발진티푸스</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td></td>
<td>발진열</td>
<td>2</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td></td>
<td>쯔쯔가무시증</td>
<td>342</td>
<td>4</td>
<td>0</td>
<td>1</td>
<td>4</td>
<td>9</td>
<td>9</td>
<td>6</td>
<td>15</td>
<td>13</td>
<td>25</td>
<td>40</td>
</tr>
<tr>
<td></td>
<td>렙토스피라증</td>
<td>3</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>1</td>
<td>0</td>
<td>1</td>
<td>1</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td></td>
<td>브루셀라증</td>
<td>4</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>1</td>
<td>0</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td></td>
<td>탄저</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td></td>
<td>공수병</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td></td>
<td>신증후군출혈열</td>
<td>9</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>2</td>
<td>0</td>
<td>1</td>
<td>2</td>
</tr>
<tr>
<td>제4군</td>
<td>뎅기열</td>
<td>6</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>2</td>
<td>1</td>
<td>1</td>
<td>0</td>
<td>1</td>
<td>0</td>
<td>1</td>
</tr>
<tr>
<td></td>
<td>리슈마니아증</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td></td>
<td>큐열</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td></td>
<td>신종전염병증후군*</td>
<td>1,477</td>
<td>182</td>
<td>193</td>
<td>172</td>
<td>202</td>
<td>151</td>
<td>167</td>
<td>108</td>
<td>101</td>
<td>52</td>
<td>40</td>
<td>40</td>
</tr>
</tbody>
</table>

Unit : case
Ⅲ. 법정전염병 감시 통계 · 369
표 Ⅲ-2-2-30.  2010년 성별 발생수-대전
Table Ⅲ-2-2-30. Reported cases of notifiable diseases
by sex in Daejeon, 2010
단위 : 환자수,명
‡  EIDS : Emerging infectious disease syndrome
(EIDS of 2010 is pandemic influenza A/H1N1(2009))
9월 30일까지 신고·보고된 자료임 300 · 2010 감염병 감시연보
표 Ⅲ-2-1-3. 2010년 질병별 연령별 발생수
Table Ⅲ-2-1-3. Reported cases of selected notifiable diseases by age group, 2010
단위 : 환자수, 명
* 결핵, 한센병 자료는 신규등록자 현황임
† 2010년 신종전염병증후군은 인플루엔자 A/H1N1(2009)으로 9월 30일까지 신고·보고된 자료임

<table>
<tbody>
<tr>
<td>구  분</td>
<td></td>
<td></td>
<td>5-9</td>
<td>10-14</td>
<td>15-19</td>
<td>20-24</td>
<td>25-29</td>
<td>30-34</td>
<td>35-39</td>
<td>40-44</td>
<td>45-49</td>
<td>50-54</td>
</tr>
<tr>
<td></td>
<td>Total</td>
<td>Age</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>제1군  콜레라</td>
<td>8</td>
<td>0</td>
<td>0</td>
<td>1</td>
<td>2</td>
<td>0</td>
<td>0</td>
<td>1</td>
<td>0</td>
<td>1</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td>페스트</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td>장티푸스</td>
<td>133</td>
<td>6</td>
<td>5</td>
<td>7</td>
<td>15</td>
<td>5</td>
<td>7</td>
<td>13</td>
<td>9</td>
<td>5</td>
<td>14</td>
<td>13</td>
</tr>
<tr>
<td>파라티푸스</td>
<td>55</td>
<td>12</td>
<td>2</td>
<td>0</td>
<td>3</td>
<td>7</td>
<td>2</td>
<td>3</td>
<td>4</td>
<td>4</td>
<td>3</td>
<td>4</td>
</tr>
<tr>
<td>세균성이질</td>
<td>228</td>
<td>4</td>
<td>13</td>
<td>4</td>
<td>18</td>
<td>30</td>
<td>24</td>
<td>6</td>
<td>1</td>
<td>20</td>
<td>13</td>
<td>25</td>
</tr>
<tr>
<td>장출혈성대장균감염증</td>
<td>56</td>
<td>31</td>
<td>8</td>
<td>1</td>
<td>1</td>
<td>0</td>
<td>2</td>
<td>3</td>
<td>2</td>
<td>0</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td>제2군  디프테리아</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td>백일해</td>
<td>27</td>
<td>22</td>
<td>2</td>
<td>1</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>1</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td>파상풍</td>
<td>14</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>1</td>
<td>1</td>
<td>0</td>
<td>1</td>
<td>3</td>
</tr>
<tr>
<td>홍역</td>
<td>114</td>
<td>16</td>
<td>1</td>
<td>78</td>
<td>16</td>
<td>0</td>
<td>2</td>
<td>0</td>
<td>1</td>
<td>0</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td>유행성이하선염</td>
<td>6,094</td>
<td>526</td>
<td>1,229</td>
<td>1,459</td>
<td>2,279</td>
<td>215</td>
<td>115</td>
<td>83</td>
<td>72</td>
<td>40</td>
<td>27</td>
<td>18</td>
</tr>
<tr>
<td>풍진</td>
<td>43</td>
<td>23</td>
<td>2</td>
<td>5</td>
<td>1</td>
<td>1</td>
<td>5</td>
<td>3</td>
<td>1</td>
<td>2</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td>폴리오</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td>일본뇌염</td>
<td>26</td>
<td>0</td>
<td>0</td>
<td>1</td>
<td>0</td>
<td>0</td>
<td>1</td>
<td>0</td>
<td>1</td>
<td>3</td>
<td>6</td>
<td>7</td>
</tr>
<tr>
<td>수두</td>
<td>24,400</td>
<td>8,931</td>
<td>12,000</td>
<td>2,135</td>
<td>386</td>
<td>193</td>
<td>195</td>
<td>205</td>
<td>192</td>
<td>76</td>
<td>28</td>
<td>18</td>
</tr>
<tr>
<td>제3군  말라리아</td>
<td>1,772</td>
<td>6</td>
<td>6</td>
<td>24</td>
<td>54</td>
<td>720</td>
<td>129</td>
<td>76</td>
<td>121</td>
<td>136</td>
<td>154</td>
<td>117</td>
</tr>
<tr>
<td>결핵*</td>
<td>36,305</td>
<td>41</td>
<td>51</td>
<td>267</td>
<td>2,071</td>
<td>2,369</td>
<td>2,905</td>
<td>2,542</td>
<td>2,548</td>
<td>2,501</td>
<td>2,844</td>
<td>2,901</td>
</tr>
<tr>
<td>한센병*</td>
<td>6</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>1</td>
</tr>
<tr>
<td>성홍열</td>
<td>106</td>
<td>44</td>
<td>61</td>
<td>1</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td>수막구균성수막염</td>
<td>12</td>
<td>2</td>
<td>1</td>
<td>3</td>
<td>2</td>
<td>1</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>2</td>
<td>1</td>
</tr>
<tr>
<td>레지오넬라증</td>
<td>30</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>1</td>
<td>1</td>
<td>1</td>
<td>0</td>
<td>0</td>
<td>6</td>
</tr>
<tr>
<td>비브리오패혈증</td>
<td>73</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>1</td>
<td>4</td>
<td>13</td>
<td>20</td>
</tr>
<tr>
<td>발진티푸스</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td>발진열</td>
<td>54</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>1</td>
<td>0</td>
<td>1</td>
<td>3</td>
<td>0</td>
<td>3</td>
<td>7</td>
</tr>
<tr>
<td>쯔쯔가무시증</td>
<td>5,671</td>
<td>27</td>
<td>33</td>
<td>35</td>
<td>42</td>
<td>60</td>
<td>73</td>
<td>95</td>
<td>155</td>
<td>248</td>
<td>422</td>
<td>633</td>
</tr>
<tr>
<td>렙토스피라증</td>
<td>66</td>
<td>0</td>
<td>0</td>
<td>1</td>
<td>1</td>
<td>3</td>
<td>2</td>
<td>4</td>
<td>4</td>
<td>9</td>
<td>8</td>
<td>5</td>
</tr>
<tr>
<td>브루셀라증</td>
<td>31</td>
<td>0</td>
<td>0</td>
<td>1</td>
<td>0</td>
<td>0</td>
<td>1</td>
<td>0</td>
<td>2</td>
<td>3</td>
<td>2</td>
<td>4</td>
</tr>
<tr>
<td>탄저</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td>공수병</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td>신증후군출혈열</td>
<td>473</td>
<td>0</td>
<td>0</td>
<td>1</td>
<td>7</td>
<td>21</td>
<td>18</td>
<td>16</td>
<td>20</td>
<td>27</td>
<td>29</td>
<td>48</td>
</tr>
<tr>
<td>제4군  뎅기열</td>
<td>125</td>
<td>0</td>
<td>0</td>
<td>9</td>
<td>4</td>
<td>13</td>
<td>26</td>
<td>22</td>
<td>17</td>
<td>11</td>
<td>7</td>
<td>9</td>
</tr>
<tr>
<td>리슈마니아증</td>
<td>1</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>1</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td>큐열</td>
<td>13</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>1</td>
<td>1</td>
<td>0</td>
<td>1</td>
<td>2</td>
<td>5</td>
</tr>
<tr>
<td>신종전염병증후군 †</td>
<td>56,850</td>
<td>12,005</td>
<td>7,292</td>
<td>2,973</td>
<td>3,206</td>
<td>4,672</td>
<td>7,713</td>
<td>5,130</td>
<td>3,770</td>
<td>2,137</td>
<td>1,837</td>
<td>2,364</td>
</tr>
<tr>
<td></td>
<td>주) 제4군전염병 자료는 환자발생이 보고된 전염병만 제시함</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
</tbody>
</table>

Ⅲ. 법정전염병 감시통계 · 301
표 Ⅲ-2-1-4. 2010년 성별 발생수
Table Ⅲ-2-1-4. Reported cases of selected notifiable
diseases by sex, 2010
§  EIDS : Emerging infectious disease syndrome
† 2010년 신종전염병증후군은 인플루엔자 A/H1N1(2009)으로
(EIDS of 2010 is pandemic influenza A/H1N1(2009))
2010년 통계는 9월 30일까지 신고·보고된 자료임, ‘16년  19주차(5.8~5.14)
<  주간  국내외  메르스  발생  현황  >
질병관리본부  2016.  5.  17
‘16년  19주차(5.8~5.14)  국내외  메르스환자  발생  현황
◈ 4월 이후 메르스 발생 규모 감소, 1차 감염(낙타접촉)을 통한 산발적
환자 발생이 주를 이루고 있음
◈ 지속적인 모니터링 및 국내유입에 대한 대응 준비 필요
□  국외  발생현황(19주차,  5.8~5.14)
○ (전체) ’16.1월 이후 총 107명 발생, 41명(사우디 40, UAE 1) 사망
○ (주간) 0명 발생, 1명 사망
○ (월별) 국가별 환자 발생 현황(보고일 기준)
표 1. 국가별, 월별 메르스 환자 발생현황 (‘16년)
1) 사우디아라비아 여행 후 카타르에서 확진 받은 1명, 발생보고 없이 사망 보고된 1명 포함
2) 바레인에서 확진 받은 사우디국적 환자 1명 포함
3) 태국에서 확진 받은 오만 국적 환자 1명 포함
□ 사우디아라비아  발생  세부현황(19주차,  5.8~5.14)
○ 월별 발생 세부현황
표 2. 사우디아라비아 월별 발생 세부현황 (‘16년)
-  1  -

<table>
<tbody>
<tr>
<td>구분</td>
<td>계</td>
<td>1월</td>
<td>2월</td>
<td>3월</td>
<td>4월</td>
<td>5.1∼5.14</td>
</tr>
<tr>
<td>총계</td>
<td>102</td>
<td>7</td>
<td>20</td>
<td>57</td>
<td>15</td>
<td>3</td>
</tr>
<tr>
<td>1차감염</td>
<td>52</td>
<td>7</td>
<td>13</td>
<td>22</td>
<td>8</td>
<td>2</td>
</tr>
<tr>
<td>2차감염</td>
<td>31</td>
<td>0</td>
<td>4</td>
<td>22*</td>
<td>4</td>
<td>1</td>
</tr>
<tr>
<td>조사중</td>
<td>19</td>
<td>0</td>
<td>3</td>
<td>13</td>
<td>3</td>
<td>0</td>
</tr>
</tbody>
</table> 주간
‘21년  제  14주차  주요  감염병  발생현황  (3.29.~4.4.)
메르스
∙  (사우디아라비아) 환자 발생 지속
출처:    WHO,  ECDC,  각국  보건부 2019년  제  6-7호
국내  주요  감염병  발생  현황
<레지오넬라증  환자발생  증가에  따른  신고강조>
●  발생  현황
-  ‘19년  1월  강원도  동해시  온천  이용자  중  3명에서  레지오넬라증(레지오넬라  폐렴)  발생
-  ‘19년  2월  13일까지  52건  신고  되어  전년  동기간  28건  대비  85.7%  증가
-  레지오넬라증  예방을  위해서는  온천,  목욕장,  건물의  급수시설,  냉각탑  등  인공수계시설의  환경관리  필요
<레지오넬라증  신고  현황  (’14-’19.2.13.)>
<레지오넬라증  신고  현황  (’14-’19.2.13.)>
* 2018, 2019년은 잠정통계로 추후 변경가능성 있으며, 사망건수는 관련 사망 확인 중 (‘19.2.12일 기준)
●  레지오넬라증  감시  강화  당부
-  의료기관에서는  지역사회  폐렴환자  내원  시  온천  등  수계환경  노출력을  확인하여,  레지오넬라증이  의심되는  경우
레지오넬라증  검사  시행  필요
-  레지오넬라증  환자나  의사환자  진료  시  즉시  신고  요망
■  레지오넬라증  검사
(확진검사)  호흡기검체  레지오넬라  배양검사,  레지오넬라  요항원  검사  등
(추정검사)  PCR검사,  단일  항체가  검사  등
*  의료기관  자체검사가  불가능한  경우  시᭼도  보건환경연구원으로  의뢰  가능
1

<table>
<tbody>
<tr>
<td>구분</td>
<td>2014</td>
<td>2015</td>
<td>2016</td>
<td>2017</td>
<td>2018</td>
<td>2019</td>
</tr>
<tr>
<td>신고건수<br/>(사망)</td>
<td>30<br/>(0)</td>
<td>45<br/>(1)</td>
<td>128<br/>(8)</td>
<td>198<br/>(17)</td>
<td>296</td>
<td>50</td>
</tr>
<tr>
<td>발생률<br/>(10만명당)</td>
<td>0.06</td>
<td>0.09</td>
<td>0<br/>.25</td>
<td>0<br/>.38</td>
<td>-</td>
<td>-</td>
</tr>
</tbody>
</table>

2019년 제 6-7호
2019. 2. 15 .
2018년 제21호(’18.5.18-5.24)
2018. 5. 25
국내·외  메르스  발생  현황
사우디아라비아,  의료기관  내  유행  발생
【국외  발생현황】
전체  ‘19.1.1-2.13.  총  확진  66명  발생,  사망  8명
주간  ’19.2.1-2.13일간  확진  47명*  사망  7명  발생
*  사우디아라비아  46명(사망  5),  오만  1명(사망  2)
<국가별  메르스  환자  발생현황(’19년)>
<사우디  감염경로별  발생  현황  (’15-’19.2.13.)>
구분
총계
사우디
UAE
오만
기타*
‘19년
과거발생현황
1월
2월 3월 최근발생일
‘18년
19
14
-
5
-
47
46
-
1
-
-
-
-
-
-
-
’19.2월
’18.5월
’19.1월
’18.9월
147
144
1
1
1
계
66
60
0
6
0
*  18.9월  중동방문  후  입국시  국내에서  확진된  사례로  조사  진행  중
■  오만  발생현황
전체  ‘19.1.1-2.13.  총  확진  6명,  사망  2명  발생
주간  ’19.2.1-2.13일간  확진  1명*,  사망  2명  발생
*  역학적  연관성  확인  중
■  사우디  발생현황
전체  ‘19.1.1-2.13.  총  확진  60명,  사망  6명  발생
주간  ’19.2.1-2.13일간  확진  46명*,  사망  5명  발생
*  1차  감염  15명,  2차  감염  30명,  조사  중  1명
<’19년  사우디  감염경로별  환자  발생  현황>
구분
계
1월
2월
3월
4월
5월
6월
계
60
14
1차감염 24
2차감염 35
조사  중
1
9
5
0
46
15
30
1
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
<사우디  주별  발생  현황  (’14-’19.2.13.)>
【국내  의심환자  신고  현황】
전체  ‘19.1.1-2.13.  의심환자  62명
주간  ‘19.2.1-2.13.  신규  의심환자  16명
*  의심환자  전원  MERS-CoV  음성
<신규  의심환자  현황검사결과  현황>
성별/연령
국적
여행국가
남/53 대한민국
카타르
메르스
음성
검사결과
호흡기바이러스 8종
음성
여/60 대한민국
이스라엘
음성 Respiratory syncytial virus
여/59 대한민국
카타르
여/49 대한민국
남/41 대한민국
UAE
UAE
남/06 대한민국
이스라엘
남/32
캐나다
UAE
음성
음성
음성
음성
음성
남/56 대한민국 카타르(경유) 음성
여/41 대한민국
이스라엘
남/37 대한민국
여/33 대한민국
남/38 대한민국
남/26
캐나다
UAE
UAE
이라크
UAE
음성
음성
음성
음성
음성
Influenza  A(H1N1)
Rhinovirus
Influenza  A(H1N1)
음성
Influenza  A(H1N1)
음성
음성
Rhinovirus
Influenza  A(H3N2)
음성
Influenza  A(H3N2)
여/54 대한민국 이스라엘, 요르단 음성
Influenza  A(H3N2)
여/31 대한민국
남/36 대한민국
UAE
UAE
음성
음성
Influenza  A(H1N1)
Influenza  A(H3N2)
*  메르스  신고대상  방문  국가(지역):  바레인,  이라크,  이란,  이스라엘,
요르단,  쿠웨이트,  레바논,  오만,  카타르,  시리아,  사우디아라비아,
UAE,  예멘
2

2019년 제 6-7호
2019. 2. 15 .
2018년 제21호(’18.5.18-5.24)
2018. 5. 25
국외 주요 감염병 발생 현황
사우디아라비아,  의료기관내  유행  발생
▪  발생현황
-  ’19년    Riyadh주  Wadi  Aldwasir시  내  의료기관에서  총  37명(사망  2)  발생
·  1차  감염  7,  2차  감염  29,  조사  중  1
·  Wadi  Aldwasir  General  Hospital에서  의료진,  방문객,  환자  등  의료기관  전파사례  23명  확인
·  Index  case  낙타  접촉력이  있고  응급실을  통해  내원
·  2.11일부터  1차  감염  또는  감염경로  조사  중인  사례도  보고되고  있어  의료기관  유행사례와의  연관성  조사  중
·  ‘19년  중동지역  발생현황:  사우디아라비아  60명(사망  6명),  오만  6명(사망  2명)
<‘19년  Wadi  Aldwasir시  환자  발생 현황>
<’19년 Wadi Aldwasir시 의료기관 전파사례 발생 현황>
상황평가
∙  병원유행은  메르스  발생양상의  특이한  상황이  아니며  기  알려진  예방수칙이  적절히  이행되지  않아  유행이  발생된
것으로  추정
∙  Wadi  Aldwasir시  유행은  수도  리야드에서  약  700km  떨어져있는  소도시  내에서  제한적으로  발생하고  있어
사우디아라비아  내  또는  국제적  전파  가능성은  낮으나  사우디아라비아  의료기관  유행  등으로  환자가  지속적으로
발생할  경우  바이러스  노출  가능성이  높아지므로  사우디  여행객  진료  시  주의  당부(예방수칙  철저,  신고  강조)
∙  사우디아라비아  및  오만에서  환자가  발생  중으로  유증상자  내원시  여행력‧방문력  확인하여,  의심환자일  경우  귀가
조치나  타  의료기관으로  전원하지  말고,  즉시  관할보건소  또는  1339로  신고하여  주시기  바랍니다.
메르스  의심환자(신고대상)
▶  발열과  호흡기  증상이  있으면서  증상발생  14일  이내에  다음  사항(1항이라도)  해당되는  경우
-  중동지역  방문력  있음
-  증상이  있는  메르스  환자와  밀접한  접촉력이  있음
-  최근  메르스가  유행한  지역(국가)의  의료기관에  직원,  환자로  있었거나  방문력이  있음
-  중동지역  방문  중  낙타접촉,  낙타고기  또는  낙타유  섭취력이  있음
▶  발열  또는  호흡기  증상이  있으면서  증상발생  14일  이내에  메르스  확진환자와  밀접하게  접촉한  자
▶  그  밖에  의료진  또는  역학조사관이  의심환자로  분류한  자
3

2019년 제 6-7호
2019. 2. 15 .
2018년 제21호(’18.5.18-5.24)
2018. 5. 25
DR콩고,  에볼라  유행지속
파키스탄,  장티푸스  환자  증가
▪  발생현황
▪  발생현황
-  ‘18.5.11~‘19.2.13일까지  North  Kivu  주  및  Ituri  주에서  환자
-  ‘16.11월~’18.12월까지  파키스탄  신드(Sindh)주에서
총  829명(확진  768,  추정  54,  사망  521명,  치명률  62.8%)  발생
장티푸스  환자  81,878명(XDR*  5,774  사망  12)  발생
·  주요  발생지역:  Beni  234명,  Katwa  218명,  Mabalako
·  내성  균주가  전국에서  보고되고  있으며  그  중  카라치
106명  발생
(Karachi  69%),  하이데라바드(Hyderabad,  27%)에서
·  의료종사자  65명(사망  22)  포함
전체  발생의  96%  차지
·  2016-2017  절기동안  총  778명(사망  262),  2017-2018
·  연도별  발생(XDR):  ‘16년  11명  →  ’17년  730명  →  ‘18년
절기동안  총  1,376명(사망  483)  발생
5,375명
*  XDR(Extensive  Drug  Resistant)
*    파키스탄  장티푸스  XDR  국제  전파  사례
·  ‘18.1월~10월까지  파키스탄  여행자에서  장티푸스(XDR)
환자  6명보고
·  영국(1),  미국(5)에  거주자로  파키스탄의  카라치,  라호르,
이슬라마바드  여행  시  감염된  것으로  확인
*  미국  CDC는  ‘18.6월  여행자  주의  등급  2단계  발령  중
상황평가
-  DR콩고  에볼라  유행이  지속되고  있으며  새로이  Beni
지역  외  Katwa,  Butembo  지역에서  환자발생  증가
상황평가
-  DR콩고  국경지역과  인접한  우간다,  르완다  및  남수단  등,
난민  이동에  의한  잠재적  전파위험으로  국경  검역,
주의보  발령  등  대응을  강화하고  우간다  등은  의료진을
대상  예방접종을  실시  중
-  WHO(‘19.1.9)는  위험평가  재검토결과  ’국가  및  지역
수준에서  위험도는  매우  높고  세계적인  위험  수준은
낮음‘으로  평가
-  국내로  해당지역  유입  인구가  많지  않으나  유행지역
확대  및  장기화  추세로,  유입사례  발생  가능성을  배제할
수  없는  상황임
-  환자의  유증상  기간  동안  직접접촉에  의한  전파가
가능하기  때문에  환자발견이  지연되는  경우  지역사회로
확산될  가능성은  있음
-  의사(환자)  진료  시  추가  전파가  발생하지  않도록  지체
없이  관할보건소  또는  1339로  신고하여주시기  바랍니다.
4
-  파키스탄에서  현재(2.6일  기준),  매일  수십명의  장티
푸스  환자,  특히  학동기  연령층에서  발생  지속
-  당국은  국제기구가  안전한  식량과  물에  대한  사전
예방  조치  실시  중
-  WHO는  국가  수준에서  XDR  S.  Typhi의  위험은
‘높음‘,  지역  수준의  위험은  ‘중간‘,  전  세계적으로는
‘낮음’으로  평가.
-  그러나  파키스탄  일부  지역에서  일차  항생제에  대한
높은  저항성을  가지고  있는  H58  clone  strain의  순환은
세  가지  수준  모두에서  잠재적  위험을  증가시킴
-  환자,  의사환자,  병원체보유자  진료  시  지체  없이  관할
보건소  또는  1339로  신고하여주시기  바랍니다.

2019년 제 6-7호
2019. 2. 15 .
2018년 제21호(’18.5.18-5.24)
2018. 5. 25
알 림 사 항
5

<table>
<tbody>
<tr>
<td>질병관리본부에서는  의약품안전사용서비스(DUR)  시스템을  활용한  해외감염병  및  발생국가  정보를 <br/>      안내해  드리고  있습니다.  최근  약  처방이  없어도  정보  확인이  가능하도록  기능을  수정하였으니 <br/>      확인하여  주시기  바랍니다. <br/>      1.  개선사항<br/>            (기존  DUR  프로그램)  약  처방  시  해외여행력  확인  가능  →  (새로운  ITS  프로그램)  약  처방  없이 <br/>접수,  진료  시에도  해외  여행력  확인가능<br/>  ◆  해외  감염병  및  발생국가  정보-  4개  감염병  16개국(2018.  6월  기준)<br/> <br/> <br/> <br/>      2.  이용방법<br/>          기존  DUR  사용기관의  경우  청구SW업체  통해  “DUR시스템  기능검증”  후  이용가능,  미사용     <br/>기관의  경우  건강보험심사평가원  홈페이지에서  전용  프로그램  다운*  받아  이용가능<br/>            *  건강보험심사평가원  홈페이지(http://biz.hira.or.kr)에  프로그램  및  매뉴얼  게재<br/> <br/>        3.  설치문의:  건강보험심사평가원  DUR  정보부(033-739~0422~4)로  문의하여  주시기  바랍니다</td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td></td>
<td>해외  감염병(4개)</td>
<td>발생국(16개국)</td>
<td></td>
</tr>
<tr>
<td></td>
<td>메르스</td>
<td>레바논,  바레인,  사우디아라비아,  시리아,  아랍에미리트,  오만,  요르단, <br/>예멘,  이라크,  이란,  이스라엘,  카타르,  쿠웨이트</td>
<td></td>
</tr>
<tr>
<td></td>
<td>라싸열</td>
<td>나이지리아</td>
<td></td>
</tr>
<tr>
<td></td>
<td>에볼라바이러스병</td>
<td>콩고민주공화국</td>
<td></td>
</tr>
<tr>
<td></td>
<td>페스트</td>
<td>마다가스카르</td>
<td></td>
</tr>
<tr>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
</tbody>
</table>, source_sentence: SFTS는 어떤 진단 방법으로 확인하나요?
sentences: <table>
<tbody>
<tr>
<td>연령 및 성<br/>질병명 및 연도</td>
<td></td>
<td>총 계<br/>0 ∼ 9 세<br/>10 ∼ 19 <br/>20 ∼ 29 <br/>30 ∼ 39  <br/>Total<br/>age</td>
</tr>
<tr>
<td></td>
<td></td>
<td>계<br/>남 자<br/>여 자<br/>계<br/>남 자<br/>여 자<br/>계<br/>남 자<br/>여 자<br/>계<br/>남 자<br/>여 자<br/>계<br/>남 자<br/>Total<br/>Male<br/>Female<br/>Total<br/>Male<br/>Female<br/>Total<br/>Male<br/>Female<br/>Total<br/>Male<br/>Female<br/>Total<br/>Male</td>
</tr>
<tr>
<td>제3급</td>
<td>파상풍<br/>2001 <br/>2002 <br/>2003 <br/>2004 <br/>2005 <br/>2006 <br/>2007 <br/>2008 <br/>2009 <br/>2010 <br/>2011 <br/>2012 <br/>2013 <br/>2014 <br/>2015 <br/>2016 <br/>2017 <br/>2018<br/>2019<br/>2020<br/>2021<br/>2022<br/>2023<br/>급성B형간염<br/>2001 <br/>2002 <br/>2003 <br/>2004 <br/>2005 <br/>2006 <br/>2007 <br/>2008 <br/>2009 <br/>2010 <br/>2011 <br/>2012 <br/>2013 <br/>2014 <br/>2015 <br/>2016 <br/>　<br/>2017 <br/>2018<br/>2019<br/>2020<br/>2021<br/>2022<br/>2023<br/>산모B형간염<br/>2001 <br/>2002 <br/>2003 <br/>2004 <br/>2005 <br/>2006 <br/>2007 <br/>2008 <br/>2009 <br/>2010 <br/>2011 <br/>2012 <br/>2013 <br/>2014 <br/>2015 <br/>2016 <br/>2017 <br/>2018<br/>2019<br/>2020<br/>2021<br/>2022<br/>2023<br/>주산기B형간염 2001 <br/>2002 <br/>2003 <br/>2004 <br/>2005 <br/>2006 <br/>2007 <br/>2008 <br/>2009 <br/>2010 <br/>2011 <br/>2012 <br/>2013 <br/>2014 <br/>2015 <br/>2016 <br/>2017 <br/>2018<br/>2019<br/>2020<br/>2021<br/>2022<br/>2023</td> 표  Ⅲ-1-4-14.  급성B형간염  연도별  월별  신고수
Table  Ⅲ-1-4-14.  Reported  cases  of  Acute  Viral  hepatitis  B  by  year  and  month
단위 : 신고수                                                                                                                                                            Unit : No. of  notifications
구분
계
Total
1월
Jan
2월
Feb
3월
Mar
4월
Apr
5월
May
6월
Jun
7월
Jul
8월
Aug
9월
Sep
10월
Oct
11월
Nov
12월
Dec
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
462
289
117
173
155
359
391
392
389
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
28
32
8
12
10
25
20
31
27
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
22
21
11
15
13
28
29
27
25
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
49
27
10
14
10
34
25
35
31
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
60
25
4
16
17
25
37
34
26
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
51
28
10
13
6
32
38
31
41
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
41
22
7
10
15
39
39
37
40
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
33
25
14
23
15
36
33
42
31
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
25
29
11
10
11
28
29
31
32
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
30
31
7
12
8
29
28
30
31
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
35
25
10
13
10
16
38
34
38
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
59
9
12
20
16
35
36
24
33
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
29
15
13
15
24
32
39
36
34
-  173  -
Ⅲ. 법정감염병  전수감시  통계 • 173

표  Ⅲ-1-4-15.  산모B형간염  연도별  월별  신고수
Table  Ⅲ-1-4-15.  Reported  cases  of  HBsAg  positive  maternity  by  year  and  month
단위 : 신고수                                                                                                                                                            Unit : No. of  notifications
구분
계
Total
1월
Jan
2월
Feb
3월
Mar
4월
Apr
5월
May
6월
Jun
7월
Jul
8월
Aug
9월
Sep
10월
Oct
11월
Nov
12월
Dec
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
936
2,438
3,211
3,912
3,468
-
-
-
-
56
103
251
392
355
-
-
-
-
52
106
218
374
274
-
-
-
-
69
117
226
306
352
-
-
-
-
69
139
180
306
312
-
-
-
-
71
145
190
286
283
-
-
-
-
92
192
179
277
276
-
-
-
-
70
176
202
409
310
-
-
-
-
95
656
204
326
271
-
-
-
-
100
213
150
306
237
-
-
-
-
87
172
245
301
252
-
-
-
-
103
183
816
283
250
-
-
-
-
72
236
350
346
296
-
-
-
-
주)  B형간염은  감염병의  진단기준  고시  개정(2016.1.7)에  따라  급성B형간염에  한해  신고토록  변경되었으며,  2016.1.6까지  신고된  산모B형간염은  32건임
174  • 2019  감염병  감시연보
-  174  -

표  Ⅲ-1-4-16.  주산기B형간염  연도별  월별  신고수
Table  Ⅲ-1-4-16.  Reported  cases  of  Perinatal  hepatitis  B  virus  infection  by  year  and  month
단위 : 신고수                                                                                                                                                            Unit : No. of  notifications
구분
계
Total
1월
Jan
2월
Feb
3월
Mar
4월
Apr
5월
May
6월
Jun
7월
Jul
8월
Aug
9월
Sep
10월
Oct
11월
Nov
12월
Dec
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
30
26
59
30
43
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
1
4
3
0
4
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
0
1
8
1
2
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
3
2
4
3
7
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
4
2
2
1
5
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
2
1
1
2
6
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
2
1
1
5
2
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
5
1
6
0
3
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
2
4
2
3
3
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
1
2
1
2
2
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
4
4
3
5
5
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
4
2
21
3
1
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
2
2
7
5
3
-
-
-
-
주)  B형간염은  감염병의  진단기준  고시  개정(2016.1.7)에  따라  급성B형간염에  한해  신고토록  변경되었으며,  2016.1.6까지  신고된  주산기B형간염은  1건임
-  175  -
Ⅲ. 법정감염병  전수감시  통계 • 175

표  Ⅲ-1-4-17.  일본뇌염  연도별  월별  신고수
Table  Ⅲ-1-4-17.  Reported  cases  of  Japanese  encephalitis  by  year  and  month
단위 : 신고수                                                                                                                                                            Unit : No. of  notifications
구분
계
Total
1월
Jan
2월
Feb
3월
Mar
4월
Apr
5월
May
6월
Jun
7월
Jul
8월
Aug
9월
Sep
10월
Oct
11월
Nov
12월
Dec
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
107
194
1,197
139
0
0
0
3
1
0
1
3
3
4
3
0
0
0
3
1
0
1
6
1
0
6
0
7
6
6
26
3
20
14
26
40
28
9
17
34
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
18
21
36
43
67
134
745
88
0
0
0
3
0
0
0
0
0
1
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
2
0
1
1
0
5
1
2
3
3
0
0
0
0
0
0
1
1
1
2
2
0
0
0
1
0
0
0
2
0
0
3
0
3
1
1
11
1
7
7
9
13
11
1
12
15
22
39
415
8
0
0
0
0
1
0
0
1
2
1
1
0
0
0
1
0
0
0
3
1
0
2
0
1
3
1
7
1
10
3
13
18
14
5
1
13
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
0
0
1
0
0
1
0
3
2
3
6
0
1
3
3
4
2
0
0
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
1
0
0
0
0
0
0
1
176  • 2019  감염병  감시연보
-  176  -

표  Ⅲ-1-4-18.  수두  연도별  월별  신고수
Table  Ⅲ-1-4-18.  Reported  cases  of  Varicella  by  year  and  month
단위 : 신고수                                                                                                                                                            Unit : No. of  notifications
구분
계
Total
1월
Jan
2월
Feb
3월
Mar
4월
Apr
5월
May
6월
Jun
7월
Jul
8월
Aug
9월
Sep
10월
Oct
11월
Nov
12월
Dec
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
1,934
11,027
20,284
22,849
25,197
24,400
36,249
27,763
37,361
44,450
46,330
54,060
80,092
96,467
82,868
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
789
1,492
2,389
2,485
1,138
3,498
3,258
3,560
4,801
5,971
6,047
5,914
7,128
9,801
472
934
1,100
1,724
1,040
2,367
1,650
2,000
2,322
3,176
3,109
4,130
3,758
5,562
476
1,225
1,253
2,054
1,415
2,336
1,432
1,868
1,947
2,497
2,902
3,948
4,283
4,679
994
1,949
1,842
2,841
1,755
3,157
1,743
2,816
3,113
3,556
4,132
6,231
1,667
3,296
2,483
3,884
2,358
4,890
2,800
4,627
5,219
4,784
5,691
9,288
1,702
2,646
2,686
4,239
2,831
4,406
2,889
3,712
3,588
3,780
4,751
7,763
7,323
12,875
10,716
6,889
9,256
7,998
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
7
879
1,501
1,702
2,233
2,012
2,449
1,885
2,298
2,560
2,569
3,376
5,206
8,820
7,217
4
477
595
821
972
1,028
1,403
1,075
1,330
1,664
1,693
2,360
3,601
5,770
4,263
4
358
430
794
835
859
1,123
961
1,315
1,774
1,555
2,291
4,333
4,441
3,440
40
631
724
1,164
1,130
1,441
1,768
1,700
2,015
2,549
2,845
3,665
594
1,007
2,051
2,410
1,258
3,500
3,709
3,387
4,449
5,940
5,705
7,395
1,285
1,575
3,441
4,205
1,542
5,023
5,143
4,983
7,371
8,973
8,199
8,341
6,375
11,065
12,238
6,297
11,299
13,757
4,891
7,952
10,920
-  177  -
Ⅲ. 법정감염병  전수감시  통계 • 177 표 Ⅲ-1-4-40. 급성B형간염 감염증 연도별 월별 신고수
Table Ⅲ-1-4-40. Reported cases of Acute Viral hepatitis B by year and month
단위 : 신고수
Unit : No. of notifications
구분
계
Total
1월
Jan
2월
Feb
3월
Mar
4월
Apr
5월
May
6월
Jun
7월
Jul
8월
Aug
9월
Sep
10월
Oct
11월
Nov
12월
Dec
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
462
289
117
173
155
359
391
392
389
382
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
28
32
8
12
10
25
20
31
27
30
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
22
21
11
15
13
28
29
27
25
27
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
49
27
10
14
10
34
25
35
31
32
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
60
25
4
16
17
25
37
34
26
30
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
51
28
10
13
6
32
38
31
41
22
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
41
22
7
10
15
39
39
37
40
24
-  223  -
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
33
25
14
23
15
36
33
42
31
41
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
25
29
11
10
11
28
29
31
32
29
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
30
31
7
12
8
29
28
30
31
33
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
35
25
10
13
10
16
38
34
38
46
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
59
9
12
20
16
35
36
24
33
34
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
29
15
13
15
24
32
39
36
34
34

표 Ⅲ-1-4-41. 산모B형간염 연도별 월별 신고수
Table Ⅲ-1-4-41. Reported cases of HBsAg positive maternity by year and month
단위 : 신고수
Unit : No. of notifications
구분
계
Total
1월
Jan
2월
Feb
3월
Mar
4월
Apr
5월
May
6월
Jun
7월
Jul
8월
Aug
9월
Sep
10월
Oct
11월
Nov
12월
Dec
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
936
2,438
3,211
3,912
3,468
-
-
-
-
-
56
103
251
392
355
-
-
-
-
-
52
106
218
374
274
-
-
-
-
-
69
117
226
306
352
-
-
-
-
-
69
139
180
306
312
-
-
-
-
-
71
145
190
286
283
-
-
-
-
-
92
192
179
277
276
-
-
-
-
-
70
176
202
409
310
-
-
-
-
-
95
656
204
326
271
-
-
-
-
-
100
213
150
306
237
-
-
-
-
-
87
172
245
301
252
-
-
-
-
-
103
183
816
283
250
-
-
-
-
-
72
236
350
346
296
-
-
-
-
-
주)  B형간염은  감염병의  진단기준  고시  개정(2016.1.7)에  따라  급성B형간염에  한해  신고토록  변경되었으며,  2016.1.6까지  신고된  산모B형간염은  32건임
-  224  -

표 Ⅲ-1-4-42. 주산기B형간염 연도별 월별 신고수
Table Ⅲ-1-4-42. Reported cases of Perinatal hepatitis B virus infection by year and month
단위 : 신고수
Unit : No. of notifications
구분
계
Total
1월
Jan
2월
Feb
3월
Mar
4월
Apr
5월
May
6월
Jun
7월
Jul
8월
Aug
9월
Sep
10월
Oct
11월
Nov
12월
Dec
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
30
26
59
30
43
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
1
4
3
0
4
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
0
1
8
1
2
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
3
2
4
3
7
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
4
2
2
1
5
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
2
1
1
2
6
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
2
1
1
5
2
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
5
1
6
0
3
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
2
4
2
3
3
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
1
2
1
2
2
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
4
4
3
5
5
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
4
2
21
3
1
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
2
2
7
5
3
-
-
-
-
-
주)  B형간염은  감염병의  진단기준  고시  개정(2016.1.7)에  따라  급성B형간염에  한해  신고토록  변경되었으며,  2016.1.6까지  신고된  주산기B형간염은  1건임
-  225  -

표 Ⅲ-1-4-43. 일본뇌염 연도별 월별 신고수
Table Ⅲ-1-4-43. Reported cases of Japanese encephalitis by year and month
단위 : 신고수
Unit : No. of notifications
구분
계
Total
1월
Jan
2월
Feb
3월
Mar
4월
Apr
5월
May
6월
Jun
7월
Jul
8월
Aug
9월
Sep
10월
Oct
11월
Nov
12월
Dec
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
107
194
1,197
139
0
0
0
3
1
0
1
3
3
4
3
0
0
0
3
1
0
1
6
1
0
6
0
7
6
6
26
3
20
14
26
40
28
9
17
34
7
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
-  226  -
0
0
1
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
18
21
36
43
67
134
745
88
0
0
0
3
0
0
0
0
0
1
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
2
0
1
1
0
5
1
2
3
3
0
0
0
0
0
0
0
1
1
1
2
2
0
0
0
1
0
0
0
2
0
0
3
0
3
1
1
11
1
7
7
9
13
11
1
12
15
3
22
39
415
8
0
0
0
0
1
0
0
1
2
1
1
0
0
0
1
0
0
0
3
1
0
2
0
1
3
1
7
1
10
3
13
18
14
5
1
13
4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
0
0
1
0
0
1
0
3
2
3
6
0
1
3
3
4
2
0
0
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
1
0
0
0
0
0
0
1
0

표 Ⅲ-1-4-44. C형간염 연도별 월별 신고수
Table Ⅲ-1-4-44. Reported cases of Viral hepatitis C by year and month
단위 : 신고수
Unit : No. of notifications
구분
계
Total
1월
Jan
2월
Feb
3월
Mar
4월
Apr
5월
May
6월
Jun
7월
Jul
8월
Aug
9월
Sep
10월
Oct
11월
Nov
12월
Dec
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
6,396
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
10,811
1,068
9,810
874
11,849
1,152
771
676
966
959
851
868
948
870
1,000
919
916
935
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
1,026
831
802
1,031
1,055
930
1,104
1,125
950
938
823
927
813
700
699
973
696
861
747
987
865
878
786
925
1,015
883
836
887
주)  C형간염은  2017년  지정감염병에서  제3군감염병으로  군분류  변경(표본감시에서  전수감시체계로  전환)되었으며,  2017년  6월  3일부터  집계된  자료임
-  227  -, 0
0
0
1
0
1
1
1
0
0
0
1
2
0
0
0
0
0
2
2
0
1
0
5
1
0
0
0
1
0
1
0
1
0
0
0
0
0
0
1
0
0
0
0
1
0
1
0
0
0
1
0
1
0
0
0
2
1
0
0
1
0
0
0
1
0
0
0
0
2
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
22
19
32
9
22
16
12
17
25
7
12
12
16
27
36
57
22
27
16
5
7
15
14
18
10
34
12
9
14
45
76
9
20
206
118
12
2
3
1
2
2
2
1
9
0
6
42
21
1
1
7
2
4
0
1
0
2
2
1
0
0
0
0
0
0
0
2
0
0
0
0
4
2
0
2
0
0
0
1
0
0
0
0
2
5
0
0
6
0
0
0
0
0
1
0
0
2
0
0
0
1
0
0
0
0
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
6
3
9
1
8
0
1
1
0
4
2
5
7
3
1
1
0
10
2
1
14
3
0
0
2
0
1
2
16
7
10
0
5
15
0
0
2
1
0
0
0
0
2
0
0
4
2
0
1
2
1
0
3
7
14
1
25
8
7
8
5
2
2
7
11
16
9
2
5
7
11
0
5
0
1
2
0
3
3
11
1
12
15
6
4
15
32
3
0
1
0
1
1
1
0
9
0
2
0
10
2
0
0
1
1
3
1
7
0
17
6
2
1
3
2
1
1
7
5
10
1
4
5
3
0
0
0
2
4
1
0
1
7
3
1
2
1
2
4
14
1
0
1
0
0
0
0
1
6
0
0
0
2
0
3
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5
2
3
0
3
8
0
1
1
1
3
2
2
1
0
1
6
1
1
0
0
0
1
4
4
2
3
2
0
2
2
0
1
6
6
1
0
1
0
0
0
0
0
1
0
1
0
2
0
0
0
0
0
0
0
3
0
0
0
0
0
1
0
0
0
1
1
0
0
0
0
0
0
0
1
0
0
0
0
0
2
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
2
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
1
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
* HFRS : Hemorrhagic fever with renal syndrom
† SFTS : Severe fever with thrombocytopenia syndrom
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6
1
0
0
0
0
1
0
0
0
0
0
0
0
0
1
0
0
0
0
1
0
0
0
0
2
0
3
0
2
0
0
29
0
1
0
0
0
2
3
0
5
4
0
0
7
0
1
4
2
0
Gunpo city Gyeonggi
0
Gimpo city
0
Namyangju city
0
Dongducheon city
0
Bucheon city
0
0
Seongnam city Bundang district
0 Seongnam city Sujeong district
0 Seongnam city Jungwon district
0 Suwon city Gwonseon district
0 Suwon city Yeongtong district
Suwon city Jangan district
0
Suwon city Paldal district
0
0
Siheung city
Ansan city Danwon district
0
Ansan city Sangnok district
0
Anseong city
0
0 Anyang city Dongan district
0 Anyang city Manan district
0
Yangju city
Yangpyeong county
0
0
Yeoju city
Yeoncheon county
0
0
Osan city
0 Yongin city Giheung district
Yongin city Suji district
0
Yongin city Cheoin district
0
Uiwang city
0
Uijeongbu city
0
Icheon city
0
0
Paju city
Pyeongtaek city
0
Pocheon city
0
Hanam city
0
Hwaseong city
0
Gangwon-do Gangwon
2
1
Gangneung city
Goseong county
0
Donghae city
0
Samcheok city
1
Sokcho city
0
0
Yanggu county
Yangyang county
0
Yeongwol county
0
Wonju city
0
Inje county
0
Jeongseon county
0
Cheorwon county
0
Chuncheon city
0
0
Taebaek city
Pyeongchang county
0
Hongcheon county
0
Hwacheon county
0
Hoengseong county
0
.Ⅲ 법정감염병 전수감시 통계 • 275
Page 319 - Table 1
제
군3
(Group
)Ⅲ
제 군4
(Group
)Ⅳ
수막구
균성수
막염
Mening-
ococcal
meningitis
레지오
넬라증
Legion-
ellosis
비브리오
패혈증
Vibrio
vulnificus
sepsis
발진열
Murine
typhus
쯔쯔가
무시증
Scrub
typhus
렙토스
피라증
Lepto-
spirosis
브루셀
라증
Bruc-
ellosis
신증후
군출혈열
HFRS*
매독
Syphilis
크로이
츠펠트-
야콥병
Creutz-feldt
Jacob
disease
(CJD)
뎅기열
Dengue
fever
큐열
Q fever
라임병
Lyme
Borrel-
iosis
유비저
Melioi-
dosis
치쿤구
니야열
Chiku-
ngunya
fever
중증열
성혈소
판감소
증후군
SFTS†
지카
바이러스
Classification
감염증
Zika
virus
infection
선천성
기2
기1
Secon-
Conge-
Primary
dary
nital
Page 320
Page 320 - Text
표
Ⅲ
-2-2-1. 2016
년 시군구별 신고수
)
계속(
Ⅲ
법
정
감
염
병
전
수
감
시
통
계
:
단위 신고수
충북 소계
괴산군
단양군
보은군
영동군
옥천군
음성군
제천시
증평군
진천군
청주시 상당구
청주시 서원구
청주시 청원구
청주시 흥덕구
충주시
충남 소계
계룡시
공주시
금산군
논산시
당진시
보령시
부여군
서산시
서천군
아산시
예산군
천안시 동남구
천안시 서북구
청양군
태안군
홍성군
전북 소계
고창군
군산시
김제시
남원시
무주군
부안군
순창군
완주군
익산시
임실군
장수군
전주시
정읍시
진안군
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3
0
0
0
0
0
2
0
0
0
1
0
0
0
0
11
0
0
0
0
2
1
0
1
1
1
2
0
2
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4
0
0
0
1
0
0
2
0
0
0
0
0
1
0
1
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
4
0
0
0
0
0
0
0
0
0
0
0
4
0
0
5
0
0
0
0
0
1
0
0
0
1
1
1
1
0
5
0
0
0
0
0
1
0
0
0
1
2
0
0
0
0
1
5
0
0
0
0
0
0
0
0
0
0
0
5
0
0
3
0
0
0
0
2
0
0
0
0
0
0
0
1
0
4
0
0
0
0
1
0
0
0
1
1
0
0
0
0
0
1
4
0
1
0
0
1
0
0
0
0
0
0
2
0
0
139
2
1
4
1
4
8
13
3
7
15
17
26
26
12
270
5
8
3
13
13
10
4
46
7
36
14
28
45
4
9
25
242
3
52
17
5
3
2
2
14
54
2
1
78
8
1
4
0
0
1
1
1
0
0
0
0
0
1
0
0
0
4
1
0
0
0
0
0
0
0
1
1
0
1
0
0
0
0
5
0
0
0
0
0
1
0
0
0
0
0
4
0
0
2
0
0
0
0
0
0
0
0
0
0
0
0
2
0
2
0
0
0
0
0
1
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3
0
0
0
0
0
0
0
0
0
0
0
3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
314
2
8
1
8
12
21
42
4
7
46
36
32
25
70
640
21
45
9
26
15
6
8
51
4
156
16
97
120
7
12
47
957
12
191
11
22
6
10
6
25
144
9
4
343
168
6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
16
1
1
1
0
0
1
1
0
1
1
1
6
1
1
21
1
1
0
0
0
1
1
0
2
5
0
5
3
1
0
1
33
0
2
4
2
0
0
0
2
8
0
0
12
1
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,243
7
12
42
37
29
80
229
7
35
146
93
145
99
282
4
0
0
0
0
0
0
2
0
0
1
0
0
1
0
2,009
19
67
73
31
92
126
75
91
78
15
463
17
248
516
6
73
38
2,035
32
343
43
128
4
24
11
46
450
29
29
817
63
16
0
1
1
1
2
1
1
1
1
1
0
4
0
0
1
4
9
0
0
0
2
0
1
0
1
1
0
1
2
1
0
8
0
0
0
1
0
2
0
1
0
1
1
0
1
1
5
0
0
0
0
1
0
0
0
0
1
0
1
2
0
0
0
2
0
0
0
0
0
0
0
0
1
0
0
1
0
0
977
38
38
42
65
37
66
83
26
53
89
100
81
143
116
1,483
14
96
51
109
130
108
67
129
47
177
72
142
149
43
78
71
1,281
76
116
108
60
27
56
27
68
215
29
21
328
125
25
1
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
215
4
3
0
2
9
14
37
3
3
25
12
49
46
8
576
52
27
3
35
29
9
6
116
3
87
5
22
114
5
44
19
333
4
89
5
17
2
3
6
10
14
3
5
162
13
0
276 •
2016
감염병 감시연보
Page 320 - Table 1
제
군1
(Group
)Ⅰ
구 분
콜레라
Cholera
장티푸스
Typhoid
fever
파라티
푸스
Paratyp-
hoid fever
세균성
이질
Shigellosis
장출혈성
대장균
감염증
Enterohe-
morrhagic
Escherichi
-a coli
형간염
A
Viral
hepatitis A
제
군2
(Group
)Ⅲ
백일해
Pertussis
파상풍
Tetanus
홍역
Measles
유행성
이하선염
Mumps
풍진
Rubella
형간염
B
급성(
)
Viral
hepatitis B
(Acute)
일본뇌염
Japanese
encephalitis
수두
Varicella
폐렴구균
Streptoc-
occus
pneumon-
iae
제
군3
(Group
)Ⅲ
말라
리아
Malaria
결핵
Tuber-
culosis
한센병
Hansen's
disease
성홍열
Scarlet
fever
Page 321
Page 321 - Text
Ⅲ
법
정
감
염
병
전
수
감
시
통
계
Table -2-2-1. Reported cases of infectious diseases by administrative district, 2016 (Cont'd)
Ⅲ
Unit : No. of notifications
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3
0
0
0
0
0
0
1
1
0
0
0
1
0
0
4
0
0
1
0
0
0
0
2
0
0
0
0
0
0
1
0
3
0
0
0
0
0
0
0
0
0
0
0
1
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
0
0
0
0
0
0
0
0
1
0
0
0
1
0
0
0
2
0
0
0
0
0
0
0
0
1
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
252
13
3
13
23
28
3
2
7
6
57
32
20
41
4
2 1,006
0
0
0
0
0
0
0
1
0
0
0
0
1
0
0
0
21
111
43
68
55
68
48
116
72
106
52
51
35
30
82
48
0 1,029
0
0
0
0
0
0
0
0
0
0
0
0
0
0
69
41
68
130
37
48
70
57
102
33
25
195
120
34
5
0
0
0
0
1
2
0
0
0
0
1
0
0
1
7
0
1
0
0
0
0
1
0
0
1
1
0
2
0
0
1
8
0
0
0
1
0
0
2
0
1
0
1
1
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
43
13
1
3
2
3
4
1
0
1
5
3
1
3
3
20
11
1
1
1
0
0
1
2
0
4
1
2
3
2
2
0
0
0
0
0
0
2
0
1
0
1
1
2
4
65
40
16
0
4
1
6
16
3
8
1
1
3
5
4
7
3
2
1
1
1
0
4
1
3
2
2
0
7
0
8
9
1
1
0
45
16
0
2
1
1
1
5
5
9
2
1
1
6
7
4
2
3
1
1
0
3
0
0
2
0
0
3
1
0
0
0
0
0
2
0
0
2
0
2
0
2
7
0
1
0
5
0
0
0
0
0
0
0
0
3
0
0
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
2
0
1
1
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
1
3
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
2
2
0
1
0
0
0
0
0
0
1
0
0
0
0
0
4
0
0
0
0
0
1
0
0
0
2
0
0
1
0
8
0
0
0
1
3
0
0
1
0
1
1
0
1
0
0
0
8
0
0
0
0
0
0
0
1
1
0
0
6
0
0
18
2
0
1
1
0
0
1
1
1
1
3
3
3
1
12
0
0
0
0
1
1
0
0
0
5
1
2
1
1
0
0
6
0
0
2
0
0
1
1
0
1
0
0
1
0
0
1
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
1
0
0
0
1
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
1
0
0
11
0
1
0
1
0
0
3
1
1
0
0
1
2
1
9
0
3
0
0
0
0
1
0
1
1
0
1
0
0
2
0
3
0
0
0
0
1
0
0
1
0
0
0
1
0
0
* HFRS : Hemorrhagic fever with renal syndrom
† SFTS : Severe fever with thrombocytopenia syndrom
0
0
0
0
0
0
0
0
0
0
Chungcheongbuk-do Chungbuk
Goesan county
Danyang county
Boeun county
Yeongdong county
Okcheon county
Eumseong county
Jecheon city
Jeungpyeong county
Jincheon county
Cheongju city
0
0 Cheongju city Sangdang district
0 Cheongju city Seowon district
0 Cheongju city Cheongwon district
0 Cheongju city Heungdeok district
0
Chungcheongnam-do Chungnam
0
0
0
0
0
0
0
0
0
0
0
Gyeryong city
Gongju city
Geumsan county
Nonsan city
Dangjin city
Boryeong city
Buyeo county
Seosan city
Seocheon county
Asan city
Yesan county
0 Cheonan city Dongnam district
0 Cheonan city Seobuk district
Cheongyang county
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Taean county
Hongseong county
Jeollabuk-do
Gochang county
Gunsan city
Gimje city
Namwon city
Muju county
Buan county
Sunchang county
Wanju county
Iksan city
Imsil county
Jangsu conuty
Jeonju city
Jeongeup city
Jinan county
Jeonbuk
.Ⅲ 법정감염병 전수감시 통계 • 277
Page 321 - Table 1
제
군3
(Group
)Ⅲ
제 군4
(Group
)Ⅳ
수막구
균성수
막염
Mening-
ococcal
meningitis
레지오
넬라증
Legion-
ellosis
비브리오
패혈증
Vibrio
vulnificus
sepsis
발진열
Murine
typhus
쯔쯔가
무시증
Scrub
typhus
렙토스
피라증
Lepto-
spirosis
브루셀
라증
Bruc-
ellosis
신증후
군출혈열
HFRS*
매독
Syphilis
크로이
츠펠트-
야콥병
Creutz-feldt
Jacob
disease
(CJD)
뎅기열
Dengue
fever
큐열
Q fever
라임병
Lyme
Borrel-
iosis
유비저
Melioi-
dosis
치쿤구
니야열
Chiku-
ngunya
fever
중증열
성혈소
판감소
증후군
SFTS†
지카
바이러스
Classification
감염증
Zika
virus
infection
선천성
기2
기1
Secon-
Conge-
Primary
dary
nital
Page 322
Page 322 - Text
표
Ⅲ
-2-2-1. 2016
년 시군구별 신고수
)
계속(
Ⅲ
법
정
감
염
병
전
수
감
시
통
계
:
단위 신고수
8
0
0
0
0
0
0
0
3
3
0
1
0
1
0
0
0
0
0
0
0
0
0
3
2
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6
0
0
0
0
0
3 <table>
<tbody>
<tr>
<td>Figure Ⅲ-5-32. Reported cases of SFTS by month, 2016-2020 ······················································ 408</td>
</tr>
<tr>
<td>Figure Ⅲ-5-33. Reported cases of SFTS by age and sex, 2020 ····················································· 408</td>
</tr>
<tr>
<td>Figure Ⅳ-1-1. The proportion of influenza-like illness visits per 1,000 patients, 2018-2020 · 412</td>
</tr>
<tr>
<td>Figure Ⅳ-1-2. No. of influenza virus isolates, 2020 ········································································· 413</td>
</tr>
<tr>
<td>Figure Ⅳ-1-3. The weekly proportion of influenza-like illness visits per 1,000 patients and</td>
</tr>
<tr>
<td>No. of influenza virus isolates, 2000-2020 ······························································ 413</td>
</tr>
<tr>
<td>Figure Ⅳ-3-1. The proportion of HFMD visits to sentinel sites per 1,000 patient, 2016-2020  416</td>
</tr>
<tr>
<td>Figure Ⅳ-4-1. Reported cases of Gonorrhea by year  ······································································ 418</td>
</tr>
<tr>
<td>Figure Ⅳ-4-2. Reported cases of Chlamydial infections by year  ·················································· 418</td>
</tr>
<tr>
<td>Figure Ⅳ-4-3. Reported cases of Genital herpes by year  ······························································ 419</td>
</tr>
<tr>
<td>Figure Ⅳ-4-4. Reported cases of Condyloma accuminata by year  ················································ 419</td>
</tr>
<tr>
<td>Figure Ⅳ-4-5. Reported cases of Sexually transmitted infections by sex, 2020 ························· 421</td>
</tr>
<tr>
<td>Figure Ⅳ-4-6. Reported cases of Syphilis by sex and age, 2020 ··················································· 422</td>
</tr>
<tr>
<td>Figure Ⅳ-4-7. Reported cases of Gonorrhea by sex and age, 2018 ··············································· 422</td>
</tr>
<tr>
<td>Figure Ⅳ-4-8. Reported cases of Chlamydial infections by sex and age, 2020 ·························· 423</td>
</tr>
<tr>
<td>Figure Ⅳ-4-9. Reported cases of Genital herpes by sex and age, 2020 ······································· 423</td>
</tr>
<tr>
<td>Figure Ⅳ-4-10. Reported cases of Condyloma accuminata by sex and age, 2020 ······················· 424</td>
</tr>
<tr>
<td>Figure Ⅳ-4-11. Reported cases of Human Papilloma virus infection by sex and age, 2020 ····· 424</td>
</tr>
<tr>
<td>Figure Ⅴ-1-2-1. The weekly proportion of Epidemic keratoconjunctivitis per 1,000 outpatients,</td>
</tr>
<tr>
<td>2018-2020 ··················································································································· 438</td>
</tr>
<tr>
<td>Figure Ⅴ-1-2-2. The weekly proportion of Acute hemorrhagic conjunctivitis per 1,000</td>
</tr>
<tr>
<td>outpatients, 2018-2020 ···························································································· 439</td>
</tr>
<tr>
<td>Figure Ⅴ-1-3-1. Incidence rate of Influenza by week, 2020 ·························································· 440</td>
</tr>
<tr>
<td>Figure Ⅴ-1-3-2. Incidence rate of Varicella by week, 2020 ··························································· 440</td>
</tr>
<tr>
<td>Figure Ⅴ-1-3-3. Incidence rate of Mumps by week, 2020 ······························································ 441</td>
</tr>
<tr>
<td>Figure Ⅴ-1-3-4. Incidence rate of Epidemic keratoconjunctivitis by week, 2020 ······················· 441</td>
</tr>
<tr>
<td>Figure Ⅴ-1-3-5. Incidence rate of Hand, foot and mouth disease by week, 2020 ····················· 441</td>
</tr>
<tr>
<td>-  xlv  -</td>
</tr>
</tbody>
</table>

Ⅰ 감염병  감시연보  작성
및  감시  개요
Ⅰ-1.  작성목적  및  근거법령
Ⅰ-2.  법정감염병  분류  및  신고범위
Ⅰ-3.  법정감염병  신고ㆍ보고방법  및  절차
Ⅰ-4.  법정감염병  표본감시체계

Ⅰ 감염병 감시연보 작성 및 감시 개요
I-1. 작성목적 및 근거법령
가.  작성목적
국가  감염병  감시체계를  통해  수집된  신고·보고자료를  분석하여  국민들에게  감염병  발생현황  정보를
제공하고  감염병  예방·관리  정책수립을  위한  국가  기초자료로  활용하기  위해  작성되었습니다.
나.  근거법령
감염병  감시통계는  ｢감염병의  예방  및  관리에  관한  법률｣  제11조  내지  제13조의  규정에  의거
의료기관의  장(의사,  치과의사,  한의사),  부대장  및  그  밖의  신고자  등이  신고·보고한  ʻ감염병발생(사망)
신고ʼ  내용을  기초로  작성되었습니다.
I-2. 법정감염병 분류 및 신고범위
가.  법정감염병  분류  기준
○  제1급감염병： 생물테러감염병  또는  치명률이  높거나  집단  발생의  우려가  커서  발생  또는
유행  즉시  신고하여야  하고,  음압격리와  같은  높은  수준의  격리가  필요한
감염병
○  제2급감염병：전파가능성을  고려하여  발생  또는  유행  시  24시간  이내에  신고하여야  하고,
격리가  필요한  감염병
○  제3급감염병：그  발생을  계속  감시할  필요가  있어  발생  또는  유행  시  24시간  이내에  신고
하여야  하는  감염병
○  제4급감염병：제1급감염병부터  제3급감염병까지의  감염병  외에  유행  여부를  조사하기  위하여
표본감시  활동이  필요한  감염병
[감염병의  예방  및  관리에  관한  법률 제2조제2호  내지 제5호]
-  3  -

나.  법정감염병  환자분류  기준
○  감염병환자：감염병의  병원체가  인체에  침입하여  증상을  나타내는  사람으로서  제11조제6항의
진단기준에  따른  의사,  치과의사  또는  한의사의  진단이나  제16조2에  따른  감염병
병원체  확인기관의  실험실  검사를  통하여  확인된  사람
○  감염병의사환자：감염병병원체가  인체에  침입한  것으로  의심이  되나  감염병환자로  확인되기  전
단계에  있는  사람
○  병원체보유자：임상적인  증상은  없으나  감염병병원체를  보유하고  있는  사람
[감염병의 예방  및  관리에 관한  법률  제2조제13호  내지  제15호]
※ 감염병병원체  확인기관
1.  질병관리청
2.  국립검역소
3.「보건환경연구원법」  제2조에  따른  보건환경연구원
4.「지역보건법」제10조에  따른  보건소
5.「의료법」제3조에  따른  의료기관  중  진단검사의학과  전문의가  상근하는  기관
6.「고등교육법」  제4조에  따라  설립된  의과대학  중  진단검사의학과가  개설된  의과대학
7.「결핵예방법」  제21조에  따라  설립된 대한결핵협회(결핵환자의  병원체를 확인하는 경우만 해당한다)
8.「민법」  제32조에  따라  한센병환자  등의  치료ㆍ  재활을  지원할  목적으로  설립된  기관(한센병환자의
병원체를  확인하는  경우만  해당한다)
9.  인체에서  채취한  검사물에  대한  검사를  국가,  지방자치단체,  의료기관  등으로부터  위탁받아  처리하는
기관  중  진단검사의학과  전문의가  상근하는  기관
[감염병의  예방  및  관리에  관한  법률  제16조의2]
-  4  -

표 Ⅰ-2-1. 법정감염병 분류 및 종류
Table Ⅰ-2-1. The Classification of National Infectious Diseases
(2020년 12월 현재)
1) 신종감염병증후군 : 급성출혈열증상, 급성호흡기증상, 급성설사증상, 급성황달증상 또는 급성신경증상을 나타내는 신종감염병증후군
2) 장관감염증 : 살모넬라균 감염증, 장염비브리오균 감염증, 장독소성대장균(ETEC) 감염증, 장침습성대장균(EIEC) 감염증, 장병원성대장균(EPEC)
감염증, 캄필로박터균 감염증, 클로스트리듐 퍼프린젠스 감염증, 황색포도알균 감염증, 바실루스 세레우스균 감염증, 예르시니아 엔테로
콜리티카 감염증, 리스테리아 모노사이토제네스 감염증, 그룹 A형 로타바이러스 감염증, 아스트로바이러스 감염증, 장내 아데노바이러
스 감염증, 노로바이러스 감염증, 사포바이러스 감염증, 이질아메바 감염증, 람블편모충 감염증, 작은와포자충 감염증, 원포자충 감염증
3) 급성호흡기감염병 : 아데노바이러스 감염증, 사람 보카바이러스 감염증, 파라인플루엔자바이러스 감염증, 호흡기세포융합바이러스 감염증, 리노바이러스
감염증, 사람 메타뉴모바이러스 감염증, 사람 코로나바이러스 감염증, 마이코플라스마 폐렴균 감염증, 클라미디아 폐렴균 감염증
4) 해외유입기생충감염증 : 리슈만편모충증, 바베스열원충증, 아프리카수면병, 샤가스병, 주혈흡충증, 광동주혈선충증, 악구충증, 사상충증, 포충증, 톡소포
자충증, 메디나충증
5) 신고 : 의사, 치과의사, 한의사, 의료기관의 장 → 관할 보건소로 신고
6) 보고 : 보건소장 → 시장ㆍ군수ㆍ구청장 → 특별시장ㆍ광역시장ㆍ도지사 → 질병관리청으로 보고
7) 전수감시 : 감염병의 예방 및 관리에 관한 법률 제11조에 의하여 모든 의사, 치과의사, 한의사, 의료기관의 장, 부대장(군의관), 감염병병원체 확인기
관의 장이 신고 의무를 갖는 감시체계임
8) 표본감시 : 감염병의 예방 및 관리에 관한 법률 제16조 및 제11조제5항에 의하여 표본감시기관을 지정하고 지정된 기관에 한하여 신고를 받아 운영하
는 감시체계임
-  5  -

<table>
<tbody>
<tr>
<td>구분</td>
<td>제1급감염병</td>
<td>제2급감염병</td>
<td>제3급감염병</td>
<td>제4급감염병</td>
</tr>
<tr>
<td>특성</td>
<td>생물테러감염병 또는 치명률이 <br/>높거나 집단 발생의 우려가 커서 <br/>발생 또는 유행 즉시 신고. <br/>음압격리와 같은 높은 수준의 격리가 <br/>필요한 감염병<br/>(17종)</td>
<td>전파가능성을 고려하여 발생 또는 <br/>유행 시 24시간 이내에 신고. 격리가 <br/>필요한 감염병<br/>(21종)</td>
<td>발생을 계속 감시할 필요가 있어 발생 <br/>또는 유행 시 24시간 이내 신고하여야 <br/>하는 감염병<br/>(26종)</td>
<td>유행 여부를 조사하기 위하여 표본감시 <br/>활동이 필요한 감염병<br/>(23종)</td>
</tr>
<tr>
<td>종류</td>
<td>가. 에볼라바이러스병<br/>나. 마버그열<br/>다. 라싸열<br/>라. 크리미안콩고출혈열<br/>마. 남아메리카출혈열<br/>바. 리프트밸리열<br/>사. 두창<br/>아. 페스트<br/>자. 탄저<br/>차. 보툴리눔독소증<br/>카. 야토병<br/>타. 신종감염병증후군1)<br/>파. 중증급성호흡기증후군(SARS)<br/>하. 중동호흡기증후군(MERS)<br/>거. 동물인플루엔자 인체감염증<br/>너. 신종인플루엔자<br/>더. 디프테리아</td>
<td>가. 결핵<br/>나. 수두<br/>다. 홍역<br/>라. 콜레라<br/>마. 장티푸스<br/>바. 파라티푸스<br/>사. 세균성이질<br/>아. 장출혈성대장균감염증<br/>자. A형간염<br/>차. 백일해<br/>카. 유행성이하선염<br/>타. 풍진<br/>파. 폴리오<br/>하. 수막구균 감염증<br/>거.<br/>b형헤모필루스인플루엔자<br/>너. 폐렴구균 감염증<br/>더. 한센병<br/>러. 성홍열<br/>머. 반코마이신내성황색포도알균(VRSA) <br/>감염증<br/>버. 카바페넴내성장내세균속균종(CRE) <br/>감염증<br/>서. E형간염</td>
<td>가. 파상풍<br/>나. B형간염<br/>다. 일본뇌염<br/>라. C형간염<br/>마. 말라리아<br/>바. 레지오넬라증<br/>사. 비브리오패혈증<br/>아. 발진티푸스<br/>자. 발진열<br/>차. 쯔쯔가무시증<br/>카. 렙토스피라증<br/>타. 브루셀라증<br/>파. 공수병<br/>하. 신증후군출혈열<br/>거. 후천성면역결핍증(AIDS)<br/>너. 크로이츠펠트-야콥병(CJD)  및  변종크<br/>로이츠펠트-야콥병(vCJD)<br/>더. 황열<br/>러. 뎅기열<br/>머. 큐열<br/>버. 웨스트나일열<br/>서. 라임병<br/>어. 진드기매개뇌염<br/>저. 유비저<br/>처. 치쿤구니야열<br/>커. 중증열성혈소판감소증후군(SFTS)<br/>터. 지카바이러스 감염증</td>
<td>가. 인플루엔자<br/>나. 매독<br/>다. 회충증<br/>라. 편충증<br/>마. 요충증<br/>바. 간흡충증<br/>사. 폐흡충증<br/>아. 장흡충증<br/>자. 수족구병<br/>차. 임질<br/>카. 클라미디아 감염증<br/>타. 연성하감<br/>파. 성기단순포진<br/>하. 첨규콘딜롬<br/>거. 반코마이신내성장알균(VRE) 감염증<br/>너. 메티실린내성황색포도알균(MRSA) 감염증<br/>더. 다제내성녹농균(MRPA) 감염증<br/>러. 다제내성아시네토박터바우마니균(MRAB) 감염증<br/>머. 장관감염증2)<br/>버. 급성호흡기감염증3)<br/>서. 해외유입기생충감염증4)<br/>어. 엔테로바이러스감염증<br/>저. 사람유두종바이러스 감염증</td>
</tr>
<tr>
<td>감시방법</td>
<td>전수감시7)</td>
<td>전수감시</td>
<td>전수감시</td>
<td>표본감시8)</td>
</tr>
<tr>
<td>신고5)</td>
<td>즉시</td>
<td>24시간 이내</td>
<td>24시간 이내</td>
<td>7일 이내</td>
</tr>
<tr>
<td>보고6)</td>
<td>즉시</td>
<td>24시간 이내</td>
<td>24시간 이내</td>
<td>7일 이내</td>
</tr>
</tbody>
</table>

다.  신고범위
표 Ⅰ-2-2. 법정감염병 신고범위
TableⅠ-2-2. Case Classification of National Infectious Diseases
(2020년 12월 현재)
범례  ○：신고대상임
×：신고대상이  아님
1) 급성출혈열증상, 급성호흡기증상, 급성설사증상, 급성황달증상 또는 급성신경증상을 나타내는 신종감염병증후군
2) 신종인플루엔자：2009-2010년 대유행한 인플루엔자 A(H1N1)pdm09가 아닌 향후 등장할 가능성이 있는 새로운 타입의 인플루엔자를 의미함
(인플루엔자 A(H1N1)pdm09는 신종인플루엔자 신고대상이 아님)
3) 매독 신고범위：제1 ․ 2기 매독, 선천성매독(소아)
-  6  - 표  Ⅳ-1-3.  제3급감염병  연도별  신고수(발생/사망)(계속)
단위  :  신고수
주)  1.  발생률  :  인구  100,000  명당(Incidence  rate  :    per  100,000  population)
2.  1910년  이후  자료는  보건사회부  보건사회통계연보  자료를  인용함
†    SFTS  :  Severe  Fever  with  Thrombocytopenia  Syndrome
3.  웨스트나일열은  감염병의  예방  및  관리에  관한  법률  시행(2010.12.30)에  따라  기존  표본감시에서  전수감시체계로  전환됨
4.  중증열성혈소판감소증후군은  2013년  감염병의  예방  및  관리에  관한  법률  개정으로  신규  지정되었으며,  2013-2015년  발생  및  사망  통계는  확진환자만  포함함
126    2023 감염병 신고 현황 연보

<table>
<tbody>
<tr>
<td>구 분<br/>Classif- <br/>ication<br/>연도<br/>year</td>
<td>제 3 급 ( Class Ⅲ )</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td></td>
<td>웨스트나일열<br/>West Nile fever</td>
<td>라임병<br/>Lyme Borreliosis</td>
<td>진드기매개뇌염<br/>Tick-borne <br/>Encephalitis</td>
<td>유비저<br/>Melioidosis</td>
<td>치쿤구니야열<br/>Chikungunya fever</td>
<td>중증열성혈소판감소증<br/>후군<br/>SFTS†</td>
<td>지카바이러스 감염증<br/>Zika virus infection</td>
</tr>
<tr>
<td></td>
<td>발생률 <br/>발생<br/>사망<br/>Incid- <br/>Case<br/>Death<br/>ence <br/>rate</td>
<td>발생률 <br/>발생<br/>사망<br/>Incid- <br/>Case<br/>Death<br/>ence <br/>rate</td>
<td>발생률 <br/>발생<br/>사망<br/>Incid- <br/>Case<br/>Death<br/>ence <br/>rate</td>
<td>발생률 <br/>발생<br/>사망<br/>Incid- <br/>Case<br/>Death<br/>ence <br/>rate</td>
<td>발생률 <br/>발생<br/>사망<br/>Incid- <br/>Case<br/>Death<br/>ence <br/>rate</td>
<td>발생률 <br/>발생<br/>사망<br/>Incid- <br/>Case<br/>Death<br/>ence <br/>rate</td>
<td>발생률 <br/>발생<br/>사망<br/>Incid- <br/>Case<br/>Death<br/>ence <br/>rate</td>
</tr>
<tr>
<td>1910 <br/>1911 <br/>1912 <br/>1913 <br/>1914 <br/>1915 <br/>1916 <br/>1917 <br/>1918 <br/>1919 <br/>1920 <br/>　<br/>1921 <br/>1922 <br/>1923 <br/>1924 <br/>1925 <br/>1926 <br/>1927 <br/>1928 <br/>1929 <br/>1930 <br/>　<br/>1931 <br/>1932 <br/>1933 <br/>1934 <br/>1935 <br/>1936 <br/>1937 <br/>1938 <br/>1939 <br/>1940 <br/>　<br/>1941 <br/>1942 <br/>1943 <br/>1944 <br/>1945 <br/>1946 <br/>1947 <br/>1948 <br/>1949 <br/>1950 <br/>　<br/>1951 <br/>1952 <br/>1953 <br/>1954 <br/>1955 <br/>1956 <br/>1957 <br/>1958 <br/>1959 <br/>1960 <br/>　<br/>1961 <br/>1962 <br/>1963 <br/>1964 <br/>1965</td>
<td>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-<br/>-</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
</tbody>
</table>

Table Ⅳ-1-3. Reported cases of class  III national notifiable diseases(case/death)(Cont'd)
Unit  :  Case
Ⅳ
법
정
감
염
병
전
수
감
시
상
세
통
계
표
Ⅳ. 법정감염병 전수감시 상세통계표    127, <td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>결핵</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td></td>
<td>870</td>
<td>49</td>
<td>48</td>
<td>57</td>
<td>76</td>
<td>91</td>
<td></td>
<td>98</td>
<td></td>
<td>99</td>
<td>86</td>
<td>74</td>
<td></td>
<td>66</td>
<td>65</td>
<td>61</td>
</tr>
<tr>
<td>Tuberculosis</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>한센병</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td>Hansen's disease</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>성홍열</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td></td>
<td>1</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>1</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td>Scarlet fever</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>수막구균성수막염</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td>Meningococcal meningitis</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>레지오넬라증</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td>Legionellosis</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>비브리오패혈증</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td>Vibrio vulnificus  sepsis</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>발진티푸스</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td>Epidemic typhus</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>발진열</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td>Murine typhus</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>쯔쯔가무시증</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td></td>
<td>210</td>
<td>1</td>
<td>0</td>
<td>0</td>
<td>1</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>3</td>
<td></td>
<td>30</td>
<td>156</td>
<td>19</td>
</tr>
<tr>
<td>Scrub typhus</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>렙토스피라증</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td>Leptospirosis</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>브루셀라증</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td>Brucellosis</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>탄저</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td>Anthrax</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>공수병</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td>Rabies</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>신증후군출혈열</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td></td>
<td>6</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>1</td>
<td></td>
<td>2</td>
<td>3</td>
<td>0</td>
</tr>
<tr>
<td>HFRS*</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>뎅기열<br/>제4군</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td></td>
<td>1</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>1</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td>Dengue fever<br/>Group Ⅳ</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>리슈마니아증</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td>Leishmaniasis</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>큐열</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td>Q fever</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>신종전염병증후군†</td>
<td></td>
<td></td> <tr>
<td>Malaria<br/>Group III</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>결핵</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td></td>
<td>762</td>
<td>45</td>
<td>32</td>
<td>70</td>
<td>71</td>
<td>74</td>
<td></td>
<td>91</td>
<td></td>
<td>75</td>
<td>82</td>
<td>58</td>
<td></td>
<td>46</td>
<td>57</td>
<td>61</td>
</tr>
<tr>
<td>Tuberculosis</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>한센병</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td>Hansen's disease</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>성홍열</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td>Scarlet fever</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>수막구균성수막염</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td>Meningococcal meningitis</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>레지오넬라증</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td>Legionellosis</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>비브리오패혈증</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td>Vibrio vulnificus  sepsis</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>발진티푸스</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td>Epidemic typhus</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>발진열</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td></td>
<td>4</td>
<td>0</td>
<td>1</td>
<td>1</td>
<td>0</td>
<td>0</td>
<td></td>
<td>1</td>
<td></td>
<td>0</td>
<td>0</td>
<td>1</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td>Murine typhus</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>쯔쯔가무시증</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td></td>
<td>263</td>
<td>0</td>
<td>0</td>
<td>1</td>
<td>0</td>
<td>1</td>
<td></td>
<td>0</td>
<td></td>
<td>3</td>
<td>1</td>
<td>2</td>
<td></td>
<td>84</td>
<td>164</td>
<td>7</td>
</tr>
<tr>
<td>Scrub typhus</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>렙토스피라증</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td></td>
<td>2</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td>2</td>
<td>0</td>
</tr>
<tr>
<td>Leptospirosis</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>브루셀라증</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td></td>
<td>1</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>1</td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td>Brucellosis</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>탄저</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td>Anthrax</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>공수병</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td>Rabies</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>신증후군출혈열</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td></td>
<td>30</td>
<td>1</td>
<td>1</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td></td>
<td>1</td>
<td></td>
<td>3</td>
<td>2</td>
<td>2</td>
<td></td>
<td>5</td>
<td>12</td>
<td>3</td>
</tr>
<tr>
<td>HFRS*</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>뎅기열<br/>제4군</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td></td>
<td>5</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>1</td>
<td>0</td>
<td></td>
<td>2</td>
<td></td>
<td>0</td>
<td>1</td>
<td>1</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td>Dengue fever<br/>Group Ⅳ</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>리슈마니아증</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td>Leishmaniasis</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>큐열</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td></td>
<td>4</td>
<td>3</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>1</td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td>Q fever</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr> <tr>
<td>Malaria<br/>Group III</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>결핵</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td></td>
<td>430</td>
<td></td>
<td>31</td>
<td>31</td>
<td>35</td>
<td>34</td>
<td>30</td>
<td>48</td>
<td></td>
<td>52</td>
<td>39</td>
<td>27</td>
<td></td>
<td>32</td>
<td>32</td>
<td>39</td>
</tr>
<tr>
<td>Tuberculosis</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>한센병</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td>Hansen's disease</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>성홍열</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td></td>
<td>1</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>1</td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td>Scarlet fever</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>수막구균성수막염</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td>Meningococcal meningitis</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>레지오넬라증</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td>Legionellosis</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>비브리오패혈증</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td></td>
<td>2</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td></td>
<td>1</td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td>1</td>
<td>0</td>
</tr>
<tr>
<td>Vibrio vulnificus  sepsis</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>발진티푸스</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td>Epidemic typhus</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>발진열</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td>Murine typhus</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>쯔쯔가무시증</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td></td>
<td>28</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
<td></td>
<td>2</td>
<td>19</td>
<td>7</td>
</tr>
<tr>
<td>Scrub typhus</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>렙토스피라증</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td>Leptospirosis</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>브루셀라증</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td>Brucellosis</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>탄저</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td>Anthrax</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>공수병</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td>Rabies</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>신증후군출혈열</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td>HFRS*</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>뎅기열<br/>제4군</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td></td>
<td>1</td>
<td></td>
<td>0</td>
<td>1</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td>Dengue fever<br/>Group Ⅳ</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>리슈마니아증</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td>Leishmaniasis</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>큐열</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td></td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
<td></td>
<td>0</td>
<td>0</td>
<td>0</td>
</tr>
<tr>
<td>Q fever</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>, source_sentence: 최근 몇 년간 SFTS의 발생 추세는 어떤가요?
sentences: Dar es Salaam, Nov. 10 -- EARLY sexual intercourse and excessive use of tobacco are among the factors fuelling increased cases of cervical cancer among women and girls in the country.
Cervical cancer is the most common cancer in Tanzania, whereby statistics show that, excluding human immunodeficiency virus, lower respiratory infections, malaria, diarrheal diseases and TB, cervical cancer kills more women than any other form of illness in the country.
Most cases of cervical cancer are caused by infection with human papillomavirus (HPV), which is preventable with a vaccine.
In an exclusive interview, Ms Mary Ngowi, a health expert at Benjamin Mkapa Hospital (BMH) Oncology via Screening Department said only few women and girls attended went for diagnose of the dangerous disease.
She named Mwanza, Mara and Bukoba as among the regions with high cervical cancer prevalence in the country.
About 3.3 per cent of women in the general population are estimated to harbour cervical HPV-16/18 infection at a given time, and 68.0 per cent of invasive cervical cancers are attributed to HPVs 16 or 18. The Department of Health (DH) today (January 3) urged members of the public to support Cervical Cancer Awareness Month through learning more about cervical cancer and taking effective precautionary measures against cervical cancer, such as receiving human papillomavirus (HPV) vaccinations and undergoing regular cervical screening.

      

     The International Agency for Research on Cancer of the World Health Organization (WHO) has designated January as Cervical Cancer Awareness Month with an aim to raise public awareness and scale up actions related to cervical cancer, thus eliminating it as a public health problem in the next century. In Hong Kong, cervical cancer was the ninth most common female cancer in 2022, with 522 new cases and 167 deaths.

      

     Most cervical cancers are caused by persistent infection with high-risk HPV. Women are recommended to:

 


	
Receive the HPV vaccine before sexual debut;

	
Undergo cervical screening regularly;

	
Practise safe sex (e.g. using condoms and avoiding multiple sexual partners) to prevent HPV infection; and

	
Refrain from smoking, as it may increase the risk of cervical cancer.





     HPV vaccines help prevent cervical cancer and are effective in preventing high-risk HPV, including HPV 16 and 18, with protection rates over 90 per cent. HPV vaccines work best for women who have never been exposed to HPV infection, i.e. before their first sexual encounter. Since the 2019/20 school year, the DH has been providing free HPV vaccinations to eligible Primary Five schoolgirls under the Hong Kong Childhood Immunisation Programme. The DH's School Immunisation Teams provide the first dose of the HPV vaccine to Primary Five female students at their schools, and the second dose will be given to them when they reach Primary Six in the following school year. The second dose coverage rate of HPV vaccination for Primary Six girls in the school year 2022/23 was about 92 per cent.

      

     After reviewing the scientific evidence, updated recommendations from the WHO and overseas experiences in relation to the efficacy and safety of the HPV vaccine, the Scientific Committee on Vaccine Preventable Diseases under the Centre for Health Protection of the DH has recommended the provision of catch-up vaccinations to girls under the age of 18. Therefore, the DH launched a one-off catch-up HPV vaccination programme on December 2, 2024, for female Hong Kong residents born between 2004 and 2008 (i.e. girls aged 18 or below as in 2022, and not covered by the existing programme) to receive free HPV vaccinations. All participants in this programme must have been registered with eHealth. Details of the programme, which lasts for about two years, can be found on the DH's 
website
.

      

     Many women who are infected with HPV or in the early stages of cervical cancer do not have noticeable symptoms. Therefore, women aged 25 to 64 who have had sexual experience should undergo regular cervical screening. The Population Health Survey 2020-22 conducted by the DH revealed that merely half of the eligible women in Hong Kong had ever been screened for cervical cancer. To further increase the screening coverage, the DH promotes the Cervical Screening Programme to the general public through various channels, such as television, radio, social media, the DH's website and posters. Members of the public can also access information about cervical screening via the "@DH mobile application". Since 2023, the DH has been regularly sending notifications to women of the appropriate age group through the Cervical Screening Information System and the eHealth mobile app to remind them to undergo regular cervical screening.

      

     In Hong Kong, Maternal and Child Health Centres (MCHCs) and Woman Health Centres of the DH, non-governmental organisations and private healthcare providers provide cervical screening services. Common screening tests for cervical cancer include the HPV test of cervical samples collected by healthcare professionals and/or Cytology test (also called cervical smear or Pap smear).

      

     At the same time, the Primary Healthcare Commission is actively promoting the "life course preventive care plan". Based on the core principles of prevention-oriented and whole-person care, a personalised preventive care plan will be formulated to address the health needs of citizens across different life stages with reference to the latest evidence. Family Doctors and primary healthcare professionals will collaborate to provide health advice and education on chronic diseases and cancer screening, as well as healthy lifestyles according to age, sex and personal factors such as family history, including cervical cancer.

      

     Women who wish to receive cervical screening at MCHCs can schedule an appointment through the 24-hour hotline 3166 6631. For further information on cervical cancer and screening, please visit the DH's 
website
.
				

				

				
				

				
				
 

				
Ends/Friday, January 3, 2025
				

				 Issued at HKT 18:47
				

				

				 NNNN The Yobe State Ministry of Health and the Yobe State Primary Health Care Board in collaboration with the National Primary Health Care Board among other partners have concluded arrangements for the flagging-off of the Human Papillomavirus Vaccine (HPVV) campaign for prevention against the dangerous killer disease, cervical cancer.
A statement issued by the chairman Yobe State Social Mobilization and Community Engagement who is also the director Information Services of the Ministry of Information, Alhaji Ali Musa Yawale said the exercise meant to cover the 17 local government areas of the state will be officially flagged-off at Government Girls College Damaturu by 10 o'clock in the morning.
The chairman said government and development partners have organised a series of sensitization, enlightenment and mobilization with a view to intimating the public on the importance of the vaccines and the purpose of selecting the cohorts of 9-14 female children.
"In the last few weeks, we were able to organize a series of training, advocacies, sensitization and enlightenment to stakeholders and people on the importance of the vaccine against the killer disease.
"Government and development partners were able to train local government Health Promotion Officers on the new vaccine while tradition and religious leaders, teachers among other stakeholders and the general public were engaged through various means especially radio with a view to achieving the desired objectives.
"This is very important because a study in 2020 across Nigeria said out of the 12, 000 new cases of HPV that causes certain types of cancers including cervical cancer, 8, 000 died indicating about 67% of the new cases.
"The Gardasil 4 vaccine manufactured by Merck & Co., is a human papillomavirus (HPV) vaccine that protects against four HPV types; 6, 11, 16, and 18 and is being pre-qualified by the World Health Organization (WHO). HPV types 16 and 18 are responsible for causing the majority of cervical, anal, oropharyngeal cancers, while HPV types 6 and 11 causes majority of genital warts."
Yawale called on parents, guidance and caregivers to take the opportunity of the vaccine by preventing the ward against the killer disease., 16년  23주차  (6.5-6.11)
2016.  6.  13
질병관리본부
주간  국내외  감염병  동향
◈ (국내) 수족구병 증가 지속, 중증열성혈소판감소증후군 유행시기 진입
◈ (국외) 사우디 메르스 발생 소강 상태, 지카 중남미에서 유행 지속
□  국내  주요  감염병  동향
○ (수족구병) 계절적 유행시기로 증가 지속, 6월말 정점에 이를 것으로 예상
* 최근 5주 수족구병 의사환자(외래환자 1,000명당) : 7.7→10.4→13.9→21.5→31.2
○ (중증열성혈소판감소증후군(SFTS)) 계절적 유행시기 진입
- 5월 이후 환자 발생 증가, 10월까지 지속 예상
* SFTS 환자발생 현황 : 3월 0명→ 4월 3명→ 5월 9명
○ (A형간염) 부산(사상구), 충남(서산, 홍성), 전남(목포), 경남(창원) 중심으로발생증가지속
* 최근 5주 A형간염 신고건수 : 149→150→148→153→150(작년 동기간 주별 평균 38.6건)
□  국외  주요  감염병  동향
○ (메르스) 사우디아라비아에서 소강 상태(’16년 104명)
* 최근 5주 사우디아라비아 메르스 발생 추세 : 3명→0명→1명→0명→1명
○ (지카바이러스) 중남미 등지에서 유행 지속(53개국)
- 일부 중남미 국가는 감소추세, 카리브해 국가들에서 증가 추세(WHO, 5.26)
* 국내 지카 감염자 발생 현황 : 5명 (방문국 : 필리핀(3), 베트남(1), 브라질(1))
○ (조류독감) 중국에서 조류인플루엔자 H7N9, H5N6 인체감염 발생 지속
* 중국내 H7N9 확진자 : ’16.1월20명→2월18명→3월43명→4월4명→5월20명→6월1명
* 중국내 H5N6 확진자 : ’16년9명보고(5월2명)
○ (황열) 앙골라 및 주변국에서 유행 지속, 남미에서 발생 보고
- 앙골라 의심환자 2,893명(확진 788, 사망 325), DR콩고 의심환자 670명
(확진 52, 사망 63), 우간다 의심환자 60명(확진 7)
- 페루 의심환자 32명(확진 14, 사망 8), 브라질 확진환자 1명 보고 16년  25주차(6.19-6.25)
2016.  6.  27
질병관리본부
주간  국내외  감염병  동향
◈  (국내)  수족구  급증  지속,  SFTS  발생증가  및 올해 첫  사망자 발생
◈  (국외)  메르스 사우디 병원 내 유행 및 1차 감염 증가로 6월 발생 크게 증가
□  국내  주요  감염병  동향
○  (수족구병)  계절적  유행시기로  급증  지속
-  6월말  정점에  이르고  8월까지  유행  예상
* 최근 5주 수족구병 의사환자(외래환자 1,000명당) : 13.9→21.5→30.6→36.3→43.5명
○  (중증열성혈소판감소증(SFTS))  계절적 유행시기 진입, 올해 첫 사망자 발생
-  5월  이후  환자  발생  증가,  10월까지  지속  예상
* SFTS 환자발생 현황 : 3월 0명→4월 3명→5월 10명→ 6월(6.22 기준) 4명
□  국외  주요  감염병  동향
○  (메르스)  사우디 병원 내 유행 및 1차 감염 증가 등으로 6월 발생 크게 증가
* 사우디 리야드시 병원(King Khalid) 내 2차 감염(6.16~25) : 22명 (환자 7, 의료진 15)
* 사우디 메르스 발생 현황(최근 5주간) : 0명→1명→1명→25명→11명
○  (지카바이러스)  중남미  등지에서  발생  증가  및  유행  지속(54개국)
-  WHO  긴급위원회  개최  결과  국제공중보건  위기상황  유지  결정(6.14)
○  (조류독감)  중국에서  조류인플루엔자  H7N9  인체감염  발생  지속
* 중국내 H7N9 확진자 : ’16.1월 20명→ 2월 18명→ 3월 43명→ 4월 4명→ 5월 20명
→ 6월 14명
○    (황열)  앙골라  및  주변국에서  유행  지속,  남미에서  발생지역  확대
-  앙골라  의심환자  3,294명(확진  861,  사망  347)  보고
* 확진자 변동 : 483명(3.30) → 653명(4.29) → 788명(6.1) → 847명(6.15) → 861명(6.17)
* DR콩고 의심환자 1,106명(확진 68, 사망 75), 우간다 의심환자 68명(확진 7)
* 남미지역 페루(확진 43), 브라질(확진 1) 외 콜롬비아(확진 1)에서 첫 환자 발생 표
Ⅲ
-1-2-46.
중증열성혈소판감소증후군 연도별 월별 발생수
Table -1-2-46. Reported cases of Severe fever with thrombocytopenia syndrome by year and month
Ⅲ
,
:
단위 환자수 명
계
Total
구분
월1
Jan
월2
Feb
월3
Mar
월4
Apr
월5
May
월6
Jun
월7
Jul
월8
Aug
월9
Sep
월10
Oct
월11
Nov
Unit : case
월12
Dec
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
36
55
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
0
0
0
1
주
년
) 2013 , 2014
년 통계는 확진환자만 집계함
Ⅲ
법
정
감
염
병
전
수
감
시
통
계
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
7
2
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
4
7
10
11
6
9
2
11
5
12
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
2
2
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
0
0
.Ⅲ 법정감염병 전수감시 통계 • 111

<table>
<tbody>
<tr>
<td></td>
</tr>
<tr>
<td>Ⅲ<br/>-1.<br/>연도별 통계</td>
</tr>
<tr>
<td>Ⅲ<br/>-1-3.<br/>연도별 연령별 성별 발생현황</td>
</tr>
</tbody>
</table>

표
단위 환자수 명
-1-3-1.
,
Ⅲ
:
감염병 연도별 및 연령별 성별 발생수
, 2001-2014
연령 및 성
총 계
Total
남 자
Male
계
Total
세
0 ~ 9
age
10 ~ 19
20 ~ 29
30 ~ 39
여 자
Female
계
Total
남 자
Male
여 자
Female
계
Total
남 자
Male
여 자
Female
계
Total
남 자
Male
여 자
Female
계
Total
남 자
Male
질병명 및 연도
제 군1 콜레라
장티푸스
Ⅲ
법
정
감
염
병
전
수
감
시
통
계
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
파라티푸스 2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
세균성이질
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
114 •
2014
감염병 감시연보
162
4
1
10
16
5
7
5
0
8
3
0
3
0
401
221
199
174
190
200
223
188
168
133
148
129
156
251
36
413
88
45
31
50
45
44
36
55
56
58
54
37
927
767
1,117
487
317
389
131
209
180
228
171
90
294
110
99
1
1
6
7
2
3
3
0
5
1
0
1
0
185
116
99
85
97
100
109
77
87
71
79
66
78
117
23
223
49
26
17
37
29
24
25
35
37
32
28
28
408
330
545
241
139
179
56
96
59
82
74
35
129
47
63
3
0
4
9
3
4
2
0
3
2
0
2
0
216
105
100
89
93
100
114
111
81
62
69
63
78
134
13
190
39
19
14
13
16
20
11
20
19
26
26
9
519
437
572
246
178
210
75
113
121
146
97
55
165
63
3
0
0
0
0
0
0
0
0
0
0
0
0
0
39
21
24
17
23
16
27
12
10
11
9
10
7
8
8
38
13
3
3
3
7
12
12
14
9
6
11
2
274
272
471
94
64
110
11
20
16
17
15
4
16
31
2
0
0
0
0
0
0
0
0
0
0
0
0
0
17
10
14
13
7
11
15
3
9
5
5
6
5
4
4
20
10
2
2
2
4
5
7
9
7
3
5
2
140
150
253
54
36
52
4
11
6
11
7
2
8
15
1
0
0
0
0
0
0
0
0
0
0
0
0
0
22
11
10
4
16
5
12
9
1
6
4
4
2
4
4
18
3
1
1
1
3
7
5
5
2
3
6
0
134
122
218
40
28
58
7
9
10
6
8
2
8
16
5
0
0
0
0
0
0
0
0
3
0
0
0
0
41
24
14
18
22
17
36
15
22
22
24
13
14
24
2
36
2
4
2
3
7
1
2
3
2
7
4
3
125
133
218
192
24
58
16
28
12
22
25
12
104
20
4
0
0
0
0
0
0
0
0
2
0
0
0
0
22
11
7
7
11
8
16
6
13
12
16
8
7
9
0
22
1
2
1
1
4
0
2
2
0
2
2
3
59
69
122
110
12
45
10
19
4
8
10
7
63
11
1
0
0
0
0
0
0
0
0
1
0
0
0
0
19
13
7
11
11
9
20
9
9
10
8
5
7
15
2
14
1
2
1
2
3
1
0
1
2
5
2
0
66
64
96
82
12
13
6
9
8
14
15
5
41
9
23
1
0
4
7
3
3
1
0
0
0
0
1
0
75
31
37
33
31
41
30
17
27
12
30
26
14
31
2
73
21
12
9
18
5
10
4
9
13
21
9
7
230
63
62
45
25
36
17
24
22
54
54
25
78
18
18
0
0
2
3
1
2
1
0
0
0
0
0
0
35
18
20
14
17
20
15
7
8
7
19
10
9
14
2
40
7
5
5
12
4
7
3
4
7
12
3
6
103
19
20
24
8
11
7
7
11
16
22
12
29
8
5
1
0
2
4
2
1
0
0
0
0
0
1
0
40
13
17
19
14
21
15
10
19
5
11
16
5
17
0
33
14
7
4
6
1
3
1
5
6
9
6
1
127
44
42
21
17
25
10
17
11
38
32
13
49
10
32
0
1
2
2
1
1
1
0
1
0
0
1
0
50
27
28
14
19
24
33
24
29
22
22
21
28
37
10
94
23
6
6
9
14
3
5
7
11
6
9
5
112
72
100
33
25
47
19
21
10
7
21
9
28
7
25
0
1
1
1
0
0
1
0
1
0
0
1
0
21
18
13
9
12
13
17
9
15
15
13
17
9
21
9
56
15
3
4
9
8
2
4
5
8
3
5
3
39
21
43
14
16
22
9
12
5
3
8
3
10
3

Ⅲ
법
정
감
염
병
전
수
감
시
통
계
Table -1-3-1. Reported cases of infectious diseases by age and sex, 2001-2014
Ⅲ
40 ~ 49
50 ~ 59
60 ~ 69
70 ≤
Age and Sex
여 자
Female
계
Total
남 자
Male
여 자
Female
계
Total
남 자
Male
여 자
Female
계
Total
남 자
Male
여 자
Female
계
Total
남 자
Male
여 자
Female
Unit : case
Year
and Diseases
Group Ⅰ
7
0
0
1
1
1
1
0
0
0
0
0
0
0
29
9
15
5
7
11
16
15
14
7
9
4
19
16
1
38
8
3
2
0
6
1
1
2
3
3
4
2
73
51
57
19
9
25
10
9
5
4
13
6
18
4
36
1
0
1
1
0
2
1
0
1
3
0
1
0
104
61
48
42
38
34
36
44
20
19
16
17
20
27
7
96
19
11
4
10
4
7
4
7
10
9
8
6
72
46
84
30
35
43
10
22
19
33
13
5
17
6
23
0
0
1
0
0
1
1
0
0
1
0
0
0
51
36
28
21
26
19
19
19
11
11
7
10
9
12
5
51
14
9
3
10
3
4
4
5
7
8
7
4
32
19
41
13
14
18
5
16
6
11
11
1
7
5
13
1
0
0
1
0
1
0
0
1
2
0
1
0
53
25
20
21
12
15
17
25
9
8
9
7
11
15
2
45
5
2
1
0
1
3
0
2
3
1
1
2
40
27
43
17
21
25
5
6
13
22
2
4
10
1
21
1
0
1
6
0
0
1
0
0
0
0
0
0
64
28
23
22
33
32
26
51
31
26
22
19
41
57
3
49
5
2
1
5
5
6
3
7
7
5
11
5
55
50
46
32
56
36
19
24
30
38
13
11
17
12
12
1
0
1
3
0
0
0
0
0
0
0
0
0
27
12
9
11
15
15
11
25
17
10
10
8
22
29
2
20
1
2
0
2
4
3
1
6
6
3
6
4
15
11
18
8
22
11
4
9
6
14
7
6
6
2
9
0
0
0
3
0
0
1
0
0
0
0
0
0
37
16
14
11
18
17
15
26
14
16
12
11
19
28
1
29
4
0
1
3
1
3
2
1
1
2
5
1
40
39
28
24
34
25
15
15
24
24
6
5
11
10
31
0
0
2
0
1
0
1
0
3
0
0
0
0
25
23
20
18
12
25
26
16
19
13
13
12
20
36
3
22
4
5
4
1
3
4
4
3
3
3
2
2
39
72
68
35
49
41
24
26
38
26
14
14
11
5
12
0
0
1
0
1
0
0
0
2
0
0
0
0
12
10
8
8
4
11
12
6
11
4
5
4
12
20
1
10
1
2
2
0
2
2
2
2
2
0
0
2
15
21
24
9
16
17
12
9
10
10
4
3
1
1
19
0
0
1
0
0
0
1
0
1
0
0
0
0
13
13
12
10
8
14
14
10
8
9
8
8
8
16
2
12
3
3
2
1
1
2
2
1
1
3
2
0
24
51
44
26
33
24
12
17
28
16
10
11
10
4
11
1
0
0
0
0
1
0
0
0
0
0
0
0
3
6
5
10
12
11
9
9
10
8
12
11
12
31
1
5
1
2
2
1
0
1
2
5
1
1
0
7
20
59
68
26
39
18
15
44
33
31
16
10
23
11
3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
2
5
3
4
2
3
7
4
3
5
8
0
4
0
1
0
1
0
1
2
2
0
1
0
4
5
20
24
9
15
3
5
13
11
9
5
1
5
2
8
1
0
0
0
0
1
0
0
0
0
0
0
0
3
5
5
8
7
8
5
7
7
1
8
8
7
23
1
1
1
1
2
0
0
0
0
3
1
0
0
3
15
39
44
17
24
15
10
31
22
22
11
9
18
9
Cholera
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
Typhoid fever
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
Paratyphoid fever
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
Shigellosis
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
.Ⅲ 법정감염병 전수감시 통계 • 115

표
Ⅲ
-1-3-1.
단위 환자수 명
:
,
감염병 연도별 및 연령별 성별 발생수
, 2001-2014(
)
계속
Ⅲ
법
정
감
염
병
전
수
감
시
통
계
질병명 및 연도
연령 및 성
총 계
Total
남 자
Male
계
Total
여 자
Female
계
Total
세
0 ~ 9
age
남 자
Male
10 ~ 19
20 ~ 29
30 ~ 39
여 자
Female
계
Total
남 자
Male
여 자
Female
계
Total
남 자
Male
여 자
Female
계
Total
남 자
Male
제 군1 장출혈성
2001
대장균감염증 2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
형간염A
제 군2 디프테리아
백일해
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
11
8
52
118
43
37
41
58
62
56
71
58
61
111
-
-
-
-
-
-
-
-
-
-
5,521
1,197
867
1,307
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9
21
5
6
11
17
14
9
66
27
97
230
36
88
3
4
27
57
22
14
20
32
27
23
34
35
27
64
-
-
-
-
-
-
-
-
-
-
3,433
728
494
771
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6
10
2
2
6
8
3
6
28
17
41
103
18
43
8
4
25
61
21
23
21
26
35
33
37
23
34
47
-
-
-
-
-
-
-
-
-
-
2,088
469
373
536
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3
11
3
4
5
9
11
3
38
10
56
127
18
45
6
8
35
63
32
25
28
20
35
39
40
35
39
67
-
-
-
-
-
-
-
-
-
-
29
14
13
8
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9
18
5
6
11
16
14
9
60
24
61
47
21
56
2
4
20
30
16
11
16
12
19
17
19
19
18
40
-
-
-
-
-
-
-
-
-
-
15
8
7
4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6
8
2
2
6
8
3
6
24
16
28
19
12
25
4
4
15
33
16
14
12
8
16
22
21
16
21
27
-
-
-
-
-
-
-
-
-
-
14
6
6
4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3
10
3
4
5
8
11
3
36
8
33
28
9
31
0
0
10
40
2
2
2
8
3
2
4
6
6
13
-
-
-
-
-
-
-
-
-
-
388
86
56
52
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3
1
6
159
4
10
0
0
5
23
1
1
1
6
1
1
3
5
3
9
-
-
-
-
-
-
-
-
-
-
232
48
29
26
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
1
3
73
2
7
0
0
5
17
1
1
1
2
2
1
1
1
3
4
-
-
-
-
-
-
-
-
-
-
156
38
27
26
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
3
86
2
3
2
0
2
3
2
0
0
0
5
2
4
5
0
5
0
0
1
0
1
0
0
0
1
0
2
4
0
2
-
-
-
-
-
-
-
-
-
-
1,753
327
253
328
-
-
-
-
-
-
-
-
-
-
1,011
203
148
183
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
1
0
7
3
3
3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
3
3
1
2
0
1
3
1
0
0
0
4
2
2
1
0
3
-
-
-
-
-
-
-
-
-
-
742
124
105
145
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
1
0
5
0
0
2
1
0
1
4
2
5
1
3
3
5
4
3
4
6
1
0
0
3
2
1
0
2
2
2
1
1
1
2
-
-
-
-
-
-
-
-
-
-
2,443
519
358
545
-
-
-
-
-
-
-
-
-
-
1,590
314
212
336
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
1
1
10
7
4
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
2
3
0
1
116 •
2014
감염병 감시연보, AVIAN INFLUENZA (25): EUROPE (UK) SEAL, HPAI H5N1 ************************************************* A ProMED-mail post http://www.promedmail.org ProMED-mail is a program of the International Society for Infectious Diseases http://www.isid.org Date: Wed 8 Feb 2023 Source: Agriland [edited] https://www.agriland.co.uk/farming-news/bird-flu-found-in-seals-along-scotlands-east-coast/ The H5N1 strain of avian influenza (bird flu), the strain most common to birds during this current outbreak, was found in 4 seals along the east coast of Scotland last week.
The affected seals, one grey seal and 3 harbour seals, were found in 4 coastal locations at Orkney; Highland; Aberdeenshire; and Fife.
There have been other cases of bird flu in Scotland since the turn of the year [2023]: Near the seaside towns of Fraserburgh, Aberdeenshire on 12 Jan 2023; near Tain, Highland on 21 Jan 2023; Near Grantown on Spey, Highland on 24 Jan 2023; Clackmannan, Clackmannanshire, also on 24 Jan 2023; Stranraer, Wigtownshire, Dumfries and Galloway on 28 Jan 2023; and near Crossgates, Fife on 2 Feb 2023.
It is thought that the current outbreak of bird flu, which began in October 2021, is a result of wild birds that are carrying the disease migrating from the east.
It is not possible to determine that bird flu was the sole cause of death in these animals. "
Routine wildlife surveillance in the UK has detected the H5N1 strain in a small number of mammals over the past 2 years, although it is uncertain whether these died from avian influenza of other causes," a spokesperson for NatureScot, which is concerned about the overall current bird flu outbreak, said. "
This is an unusual event in the UK and infection of mammals with influenza of avian origin remains an uncommon infection.
The risk of the H5N1 strain to non-avian UK wildlife remains low."
Aside from the seals, this year [2023], only one other mammal, a fox in Wales, has tested positive [in the UK] for influenza of avian origin.
Last week, UK officials confirmed that "enhanced" mammalian surveillance for avian influenza was initiated at the beginning of the year [2023], mostly targeting mammals found dead near known areas of bird flu transmission.
However, the Animal and Plant Health Agency (APHA) has said that evidence of mammal-to-mammal transmission in the wild remains very limited and data does not suggest widespread mammalian adaption of the virus. "
Infection of mammals with influenza of avian origin remains uncommon and the risk of the H5N1 strain to non-avian UK wildlife remains low," an APHA spokesperson said. "
Samples taken as part of routine wildlife surveillance over the last year have detected the presence of influenza of avian origin in 5 foxes, 4 otters and 4 seals that were found dead -- which is an uncommon event.
Advice remains unchanged to not touch any sick or dead wild animals and make sure to wash your hands thoroughly with soap after contact with any animal."
Chief superintendent of Scottish Society for the Prevention of Cruelty to Animals (SSPCA), Mike Flynn, is also urging people to keep their distance from sick, injured and dead animals. "
We strongly advise that people keep their distance from any sick, injured or dead marine animals.
Dogs should also be kept on a lead around wildlife at all times," he said on behalf of SSPCA. "
Any birds, alive or dead, suspected of having avian flu would be a matter for Defra (the Department for Environment, Food and Rural Affairs) to investigate."
Concerns can also be directed to the SSPCA or NatureScot.
Dead seals, whales and dolphins should be reported to the Scottish Marine Animal Stranding Scheme. [
Byline: Michelle Martin] -- Communicated by: ProMED Rapporteur Mahmoud Orabi [HPAI H5N1 viruses have the ability to infect a number of mammalian species, many being classified in the order Carnivora.
Seals are also part of the Order Carnivora, although they are of the Suborder Pinnipedia (terrestrial carnivores are Fissipedia).
Spread of the virus amongst carnivores is likely attributed to predatory habits, as H5N1 has been isolated from the meat of infected animals and ingestion of infected meat can cause infection.
HPAI H5N8 was detected in 2 grey seals stranded on the Baltic coast of Poland in 2016 and 2017.
In March 2021, the UK notified WOAH about the diagnosis of HPAI H5N8 in the remains of one grey seal and 4 harbour seals from Surrey (20210317.8252821).
Since April 2022 there have been several events of Eurasian HPAI H5N1 in wild carnivores, including seals.
Most cases in seals were recorded in North America.
As noted by Mod.
PMB (20220705.8704251), several subtypes of AI viruses (H7N7, H4N5, H4N6, H3N3 and H10N7) have caused epidemics in harbour seals, but they do not appear to have become established in this carnivore species. -
Mod.
AS ProMED map: Scotland, United Kingdom: https://promedmail.org/promed-post?place=8708269,280 ] See Also 
2021 ---- Avian influenza (45): Europe (UK, Croatia) seal, fox, wild bird, HPAI H5N8, OIE 20210317.8252821 2022 ---- Avian influenza (158): Americas (Canada) seal, HPAI H5N1 20220805.8704881 Avian influenza (146): Americas (USA) seal, HPAI H5N1 20220705.8704251 .................................................sb/arn/may/ml AVIAN INFLUENZA (158): AMERICAS (CANADA) SEAL, HPAI H5N1 ******************************************************** A ProMED-mail post http://www.promedmail.org ProMED-mail is a program of the International Society for Infectious Diseases http://www.isid.org Date: Tue 3 Aug 2022 Source: Tricity News, The Canadian Press report [edited] https://www.tricitynews.com/national-news/highly-pathogenic-avian-influenza-believed-to-be-killing-seals-in-quebec-5654452 Quebec researchers have detected avian flu in at least 2 species of seal, and they fear the virus is to blame for the unusually high number of dead seals reported on the province's shorelines.
A marine mammal research group, the Réseau québécois d'urgences pour les mammifères marins, says about 100 harbour seal carcasses have been found since January [2022] along the south shore of the St. Lawrence River in eastern Quebec -- almost 6 times more than in an average year. "
In June [2022] alone, the number reached 65 carcasses," the research group said in a statement on Tuesday [2 Aug 2022]. "
Avian influenza was quickly suspected of playing a role in the increasing mortality."
About 15 of the dead harbour seals have tested positive for the highly pathogenic H5N1 avian flu, with the 1st case detected in a grey seal last week, said Stéphane Lair, a professor of veterinary medicine at Université de Montréal.
He said the seals most likely were in contact with carcasses of infected eider ducks when they came ashore to give birth at the beginning of the summer. "
Some seals, including the grey seal, are known for eating wild birds ... but not harbour seals," Lair said in an interview. "
They are curious, they will smell carcasses."
Jean-François Gosselin, a biologist with Fisheries and Oceans Canada, said these are the first reported cases of the virus being passed from wild birds to marine mammals in Quebec.
The 1st H5N1 flu cases are believed to have arrived in North America at the end of winter, involving birds that migrated from Europe.
Gosselin said the number of dead seals reported likely understates the reality. "
It's already difficult to count the number of seals that are alive ... carcasses that are beached, or floating between rocks, is even harder," Gosselin said.
He added that it's difficult to monitor all transmission, which most likely is affecting other species -- on land as well as marine mammals.
Gosselin and Lair both said that while they are monitoring the situation, there is no threat of transmission to humans or of endangering the seal population. "
It's normal with an exotic virus ... it's a new virus that enters a new population that was never infected," Lair said. "
The mortality rate will be way higher than if the virus was already circulating naturally." "
We need to be careful about all predators or animals that could be in contact with wild birds," Gosselin said.
Both recommended that people avoid approaching or touching animal carcasses and keep their pets, particularly dogs, away. [
byline: Virginie Ann] -- communicated by: ProMED rapporteur Mahmoud Orabi [Infections by HPAI viruses in mammals are typically not common, but since April 2022 there have been several events of Eurasian HPAI H5N1 in wild carnivores (order Carnivora), most of them in the Americas.
Most reports have been from red foxes (_Vulpes vulpes_, family Canidae), but skunks (family Mephitidae), and raccoons (family Procyonidae), have also been found infected.
Seals are also part of the Order Carnivora, although they are of the Suborder Pinnipedia (terrestrial carnivores are Fissipedia).
In March 2021, there was a report of HPAI H5N8 in harbor seals.
Several subtypes of AI viruses (H7N7, H4N5, H4N6, H3N3, and H10N7) have caused epidemics in harbour seals, but they do not appear to become established in this carnivore species.
HPAI H5N8 was detected in 2 gray seals stranded on the Baltic coast of Poland in 2016 and 2017 ( https://doi.org/10.3201/eid2512.181472 ).
Last month [July 2022] 4 stranded seals tested positive for HPAI H5N1 in Maine, USA. -
Mod.
PMB ProMED map: St. Lawrence River, Quebec, Canada: https://promedmail.org/promed-post?place=8704881,68774 ] See Also 
Avian influenza (146): Americas (USA) seal, HPAI H5N1 20220705.8704251 Avian influenza (139): Americas (USA, Canada) fox, HPAI 20220616.8703889 Avian influenza (131): Americas (USA, Canada) wild carnivores, HPAI H5N1 20220601.8703600 Avian influenza (124): Americas (USA) fox, HPAI H5N1 20220523.8703428 Avian influenza (118): Americas (USA) fox, HPAI H5N1, OIE 20220512.8703221 Avian influenza (115): Americas (Canada) fox, HPAI H5N1, OIE 20220509.8703152 Avian influenza (94): Japan, raccoon dog, HPAI H5N1, update 20220415.8702609 Avian influenza (93): Japan, raccoon dog, HPAI H5N1, RFI 20220413.8702568 Avian influenza (85): Asia (Japan) crow, fox, HPAI H5 20220406.8702440 Avian influenza (47): Europe, poultry, fox, HPAI H5N1, OIE 20220216.8701500 2021 --- Avian influenza (180): Europe (Estonia) fox, HPAI H5N1, OIE 20211222.8700432 Avian influenza (133): Europe (Netherlands) fox HPAI H5N1 20211101.8699389 Avian influenza (117): Europe (Germany) seal, HPAI H5N8 20210924.8698675 Avian influenza, human (02): Russia, H5N8, 1st rep 20210221.8204014 Avian influenza (45): Europe (UK, Croatia) seal, fox, wild bird, HPAI H5N8, OIE 20210317.8252821 .................................................pmb/mj/sh A NUMBER of wild birds across the north-east of Scotland are confirmed to have bird flu.
A record number of cases of avian influenza (bird flu) have been confirmed across Scotland, England and Wales in wild and captive birds this winter.
While avian influenza is not uncommon in winter and the risk to human health from infected birds is very low, a human case of avian ‘flu was confirmed in England earlier this month.
Previously observed seasonal migration patterns suggest an expected increase in flocks of wild birds across the north-east of Scotland over the next few weeks.
pipeline_tag: sentence-similarity
library_name: sentence-transformers
Likes: 0 | All-time downloads: 37
Created: 2025-09-27 06:35:34